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ABSTRACT
Significant numbers of N.brasiliensis were trapped
in mucus on days 10 and 11 of primary infection, trapping
also occurred on day 7. Trapping was also demonstrated
by scanning electron microscopy on day 10 but not on
day 6 of infection, worms were embedded in a thick
blanket of mucus on day 10.
The secretion of rat mast cell protease II (RMCPII)
a specific granule product of mucosal mast cells (MMC)
was examined during N.brasiliensis primary infection.
Peak levels of enzyme occurred in the sera of rats
around day 10 when MMC were either absent or present in
very low numbers. MMC counts were similar whether
stained for NADC-esterase, for RMCPII by immunoperoxidase
or for glycosaminoglycan (GAG) demonstrating the absence
of selective release of RMCPII from MMC. There was a
time- and dose-dependent release of RMCPII into the
serum of rats during systemic anaphylaxis, high levels
of protease were also present in the intestinal lumen
of shocked rats. The systemic concentrations of RMCPII
were highly correlated with the enteric concentrations
of Evan's blue, which were significantly increased
during anaphylaxis. RMCPII could thus increase mucosal
permeability during N.brasiliensis primary infection.
The major source of RMCPII in naive and immune rats
was the jejunum, there being depletion of both MMC and
RMCPII from this site following anaphylaxis. RMCPII was
absent from connective tissue mast cells.
Anaphylactic pathology and permeability changes were
abrogated by prior treatment of primed rats with
corticosteroids. The number of MMC were significantly
reduced following steroid treatment, mast cell changes
occurred 4-24 hours after treatment with steroid. The
fate of MMC was not established.
The number of MMC stained for NADC-esterase and
GAG were always highly correlated and there was a highly
significant relationship between the circulating levels
of RMCPII and GAG during anaphylaxis, secreted GAG may
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CHAPTER 1 General Introduction.
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Introduction
Despite over 50 years of research on the subject of
the expulsion of intestinal nematodes from mammalian
hosts no universally accepted mechanism of expulsion
has been identified. Most workers agree that the
rejection of primary infections with intestinal
helminths involves antibodies and lymphocytes and there
is evidence to implicate a bone marrow component (rev.
Ogilvie & Love, 1974; Wakelin, 1978; Miller, 1984).
However, due to the multiplicity of events promoted by
lymphocytes and the extensive infiltration of the
parasitized mucosa with a variety of cells including
mast cells and basophils (Taliaferro & Sarles, 1939;
Miller, 1984) it would seem that worm expulsion is
likely to be a complex interaction of host responses.
One of the major features of helminthiasis is the
development of inflammatory changes in the mucosa
(Taliaferro & Sarles, 1939) and a long standing theme
is that inflammation may bring about worm expulsion
(Larsh & Race, 1975; Wakelin, 1978). Immediate
hypersensitivity reactions may render the intestine
inhospitable for worm survival (Stewart, 1955), promote
changes in mucosal permeability (Murray, 1972) , induce
mucOS release and the infiltration of other cells such
as eosinophils to the inflamed mucosa (rev. Wakelin,
1978; Wasserman, 1983). The cells most frequently
identified with allergy are mast cells and basophils
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and it has become apparent that mast cells at mucosal
surfaces are quite different from their connective
tissue counterparts. The concept of mast cell
heterogeneity will be reviewed later in this introduction.
It has been assumed for the purpose of this
review that the lymphocytes have already been primed and
the forthcoming discussion will deal only with the
efferent arm of the mucosal response to the intestinal
nematode Nippostrongylus brasiliensis in the rat and, in
particular, the roles of mucosal mast cells (MMC) and
of goblet cell mucus.
As much of this thesis is devoted to a study of the
mucosal, as opposed to connective tissue mast cell
responses to N.brasiliensis. the concept of heterogeneity
within mast cells will be discussed at the beginning of
this chapter.
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Section I Mast cell heterogeneity.
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Mast cell heterogeneity in the rat
Enerback (1966) must be credited with the first
comprehensive study of mast cell heterogeneity through
his studies on fixation and staining properties. However,
60 years earlier Maximow (1906) had drawn attention to a
population of metachromatically granulated cells which
were found in the intestinal mucosa of a number of species.
Maximow (1906) stated that these cells were different from
other mast cells both morphologically and in their
staining properties. These cells were interpreted to be
a special type of mast cell and were termed "atypical
mast cells". The early work of Maximow (1906) has been
reviewed by Michels (1938).
In 1959 Riley had reported that treatment with
compound 48/80 did not affect tissue mastacells or the
histamine content of the small intestine (Riley, 1959) an
observation later to be confirmed in vitro showing
isolated mast cells (atypical-mucosal) to be refractory
to the potent secretagogue 48/80 (Befus, Pearce, Gauldie,
Horsewood & Bienenstock, 1982b). It has become clear
that many of the properties of the familiar rat
peritoneal mast cell cannot be readily extrapolated to
mucosal mast cells (MMC), (Miller, 1980; Enerback, 1981;
Jarrett & Haig, 1984). MMC have been implicated in the
expulsion of N.brasiliensis from the rat (Murray, 1972)
and it is from this system that much of our present




The proliferation of mucosal mast cells (MMC) in
response to parasite infection is thymus-dependent
because thymectomized or T-cell depleted rats and athymic
mice fail to respond to enteric nematodiasis with mucosal
mastocytosis (Mayrhofer, 1979; Mayrhofer & Fisher, 1979;
Crowle & Reed, 1984; Ruitenberg & Elgersma, 1976). This
defect can be repaired by thymic grafts in mice
(Ruitenberg & Elgersma, 1976) or intravenous injection of
normal thymocytes into nude mice (Olsen & Levy, 1976).
An accelerated MMC response to N.brasiliensis in the rat
can also be transferred by immune thoracic duct lymph
cells or the putative T-cell fraction thereof, but not
the B-cell fraction (Nawa & Miller, 1979).
Connective tissue mast cells (CTMC) originate in the
bone marrow (Kitamura, Go & Hatanaka, 1978; Kitamura,
Shimadu, Go, Matsuda, Hatanaka & Seki, 1979) since studies
employing mice with genetically determined large mast cell
granules demonstrated that CTMC in the skin were derived
from bone marrow and were thymus independent (Kitamura
et al., 1979)
Using athymic(deficient in MMC) and W/WV anaemic
mice (deficient in both MMC and CTMC), Crowle & Reed
(1984) were able to show that the MMC defect in athymic
mice could be repaired by thymus grafts, and could be
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corrected by grafts of bone marrow in anaemic W/Wv mice.
It would seem, therefore, that both CTMC and MMC derive
from the bone marrow, MMC needing thymic influences to
develop.
In vitro studies on the proliferation of MMC have
shown that lymphocytes from N.brasiliensis-iafected rats
when stimulated with worm antigen will release factors
which cause the differentiation of MMC from cultures of
normal bone marrow (Haig, McKee, Jarrett, Woodbury &
Miller, 1982). Furthermore, MMC will differentiate from
cultures of bone marrow when treated with the supernatant
from Concanavalin-A stimulated lymphocytes (Haig, McMenamin,
Gunneberg, Woodbury & Jarrett, 1983). The cultured cells
were classified as MMC because they contained rat mast
cell protease II and because of the histochemical
properties of the granule glycosaminoglycans (Haig et al.,
1983; Haig, Jarrett & Tas, 1984).
Cultured mesenteric lymph node cells provide the
best conditioned medium for the growth of MMC, which
would indicate that they are one of the major sources
of primed T-cells. It has been suggested that an expanded
MMC progenitor population leaves the bone marrow and the
proliferation and differentiation of these cells in the
gut is dependent upon the presence of a lymphokine
produced by activated T-cells (Jarrett & Haig, 1984).
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Characteristics of MMC
In a series of papers (Enerback, 1966a,b,c,d)
attention was focused on a population of mast cells in
the lamina propria of the small intestine which could
only be demonstrated when special fixation and staining
techniques were used (Enerback, 1966a,b). Carnoy's
solution and low concentrations of formaldehyde-acetic
acid preserved these cells (MMC) well, whilst normal
aldehyde fixatives did not (Enerback, 1966a). However,
MMC can be demonstrated in normal aldehyde fixed tissue,
if they are stained for 5-7 days in Toluidine blue
(Wingren & Enerback, 1983). A more recent study showed
that brief immersion of tissues in 4% neutral buffered
paraformaldehyde (6 hours) allows both MMC and CTMC to be
stained using conventional techniques (Newlands et ad.,
1984).
In appropriately fixed sections MMC and CTMC differ
in their staining properties (Enerback, 1981). MMC stain
strongly with copper phthalocyanine dyes, whereas CTMC
will take up Safranin in the Astra blue/Safranin sequence.
This suggests that MMC contain a weakly sulphated
glycosaminoglycan (GAG) as opposed to heparin present in
CTMC. Furthermore, MMC do not take up berberine sulphate
(Wingren & Enerback, 1983) which is also indicative of a
low sulphated GAG, and is in agreement with the findings
of Tas & Bernsden (1977) who demonstrated the absence of
heparin in MMC. MMC are also smaller than CTMC and less
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densely granulated (Enerback, 1981).
Mucosal mast cells contain histamine (Enerback &
Wingren, 1980).and are the main repository for histamine
in the intestinal mucosa. Comparison of the histamine
content of isolated MMC and CTMC (Befus e_t al», 1982b)
has shown that MMC contain much less histamine (l*3pg/
cell) than CTMC (15 pg/cell). MMC also differ from
CTMC in their content of serine proteinases and in their
content of 5-HT (Enerback, 1981). These mediators will
be discussed later in this section.
Although both CTMC and MMC have surface IgE another
point of difference between them is that MMC in
Nippostronqylus-infected rats have intracytoplasmic IgE
(Mayrhofer, Bazin & Gowans, 1976). This could provide
an enriched concentration of IgE in intestinal secretions
by migration and shedding of MMC from the mucosa or by
specific degranulation by antigen (Mayrhofer et_ al.. 1976) .
The precise role of IgE in the cytoplasm remains to be
established.
In vivo treatment of rats with agents which cause
degranulation of CTMC, such as compound 48/80 and
polymyxin B, has no immediate effect on MMC, but is
followed by an increase in the number of MMC (Enerback
& Lowhagen, 1979; Enerback, Lowhagen, Lowhagen & Wingren,
1981). The cause of the increase in MMC number is
unclear, but it has been suggested that products released
from degranulating CTMC are involved, however both
10
histamine and 5-HT fail to induce an increase in MMC
when injected in amounts expected to be released from
degranulating CTMC (Enerback et ad., 1981). There are,
therefore, many differences between MMC and CTMC in
the rat and these delineate concepts of mast cell
heterogeneity; they are summarized in Table 1.
Pharmacological properties
Heterogeneity between rat CTMC and MMC is evident
if we consider their responses to a variety of basic
secretagogues and anti-allergic compounds. Thus the
highly potent CTMC secretagogues compound 48/80 and
bee venom peptide 401 are completely without effect on
MMC (Pearce, Befus, Gauldie & Bienenstock, 1982) and,
similarly, phosphatidyl serine, which enhances histamine
secretion from CTMC, does not potentiate histamine
release from MMC (Pearce ejt ad. , 1982) .
Disodium cromoglycate and theophylline which
inhibit antigen-induced histamine secretion from CTMC
are ineffective against MMC, but both cell types are
inhibited by doxantrcxzole (Befus eit ad., 1982b; Pearce
et al., 1982). Additionally, a series of flavonoid
compounds have different orders of anti-allergic
activity for MMC when compared with CTMC (Pearce, Befus
& Bienenstock, 1984). The pharmacological properties
of MMC and CTMC are shown in Table 2.
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Phosphatidyl serine 0 ++b
0 no effect +/++ weak to strong secretagogue activity
++a inhibition of histamine release
++b potentiation of histamine secretion
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Murine bone marrow derived mast cells
Mouse bone marrow cells cultured in the presence of
T cell factors differentiate into a relatively pure
culture of granulated cells which resemble mast cells in
terms of the staining of intracellular granules and
overall ultrastructural morphology (Razin, Cordon-Cardo &
Good, 1981; Schrader, Lewis, Clark-Lewis & Culvenor, 1981;
Sredni, Friedman, Bland & Metcalfe, 1983; Razin, Stevens,
Austen, Caulfield, Hein, Liu, Clabby, Nabel, Cantor &
Friedman, 1984b). Mouse bone marrow derived mast cells
(BMC) contain chondroitin sulphate E proteoglycan in
their secretory granules (Razin, Stevens, Akiyama, Schmid,
i
& Austen, 1982) whereas mouse and rat serosal mast cells
contain heparin proteoglycan (Razin jet _al., 1982; Yurt,
Leid, Austen & Silbert, 1977; Stevens, Razin, Austen,
Hein, Caulfield, Seno, Schmid & Akiyama, 19S3).
Upon in vitro activation with A23187 or with antigen
after passive sensitization with monoclonal IgE, BMC
oxidatively metabolize arachidonic acid through the
5-lipoxygenase pathway to LTC4 and LTB^ and generate
minimal quantities of PGD2 (Razin et _al. , 1982; Razin,
Mencia-Huerta, Stevens, Lewis, Liu, Corey & Austen, 1983;
Mencia-Huerta, Razin, Ringel, Corey, Hoover, Austen &
Lewis, 1983). In contrast, rat CTMC activated
immunologically generate PGD2 and when stimulated with
A23187 produce largely PGD2 with some LTB4 but no LTC4
(Lewis, Soter, Diamond, Austen, Oates & Roberts, 1982;
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Roberts, Lewis, Austen & Oates, 1979).
BMC are also distinguished from the mouse serosal
mast cell by monoclonal antibodies prepared against mouse
macrophages. Both subclasses of mast cell react with
monoclonal B54.2 but only the serosal mast cell with
Bl.l and only the BMC reacts with B23.1 (Katz, LeBlanc &
Russell, 1983).
On the basis of the absence of heparin proteoglycan,
distinct arachidonic acid metabolism, dependence on T
cell factors : interleukin 3 (Razin, Ihle, Seldin,
Mencia-Huerta, Katz, LeBlanc, Hein, Caulfield, Austen &
Stevens, 1984a) and ultrastructural observations, mouse
BMC are thought to represent the murine counterpart of
rat mucosal mast cells.
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Mast cell-derived mediators
The mast cell can release both preformed and
generated (primarily lipid) materials which comprise the
mediators of immediate hypersensitivity. The biochemical
processes that are involved in the activation of mast
cells have been reviewed extensively in recent years
(Ishizaka & Ishizaka, 1978; Ishizaka, Conrad, Schulman,
Sterk & Ishizaka, 1983; Siraganian, 1983; Kennerly, 1984).
Essentially the bridging of cell surface IgE molecules
generates a signal which results " in membrane lipid
metabolism and granule solubilization and discharge.
The mast cell contains, or is capable of elaborating
in excess of twenty mediators (rev. Wasserman, 1980;
Metcalfe, Kaliner & Donlon, 1981; Wasserman, 1983) and
it is not clear whether MMC contain the same profile of
mediators as CTMC since the two cell types differ
functionally and biochemically (Jarrett & Haig, 1984)
Therefore I have selected those mediators known to
be present in rat or putative murine MMC for further
discussion and will indicate some of the possible functions
of these mediators.
Histamine
The mast cell represents the main depot of tissue
histamine and, under physiological conditions, the
tissue content of histamine corresponds to the number of
mast cells (Riley & West, 1953).
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The effects of histamine are mediated by at least
two histamine receptors : HI and H2 receptors on target
cells and tissues (Plaut, 1979). Following release of
histamine from mast cells a number of local and
systemic effects can be observed (rev. Metcalfe et al..
1981; Wasserman, 1983). Release of histamine in the gut
would be expected to lead to cramping, acid and pepsin
release.(Table 3)
Table 3 The effects of histamine mediated by HI or H2
receptors





H2 Augment nasal mucus production





Serotonin (5-Hydroxytryptamine s 5-HT) is present
in rat MMC (Enerback, 1966d, Wingren ejt aT. , 1981,
Wingren, Enerback, Ahlman, Allenmark & Dahlstrom, 1983) ,
but by far the greatest amount of 5-HT is stored in the
platelets(Vanhoutte & Cohen, 1983).
5-HT is active in inducing vasopermeability
responses, and constriction of some smooth muscle and
increases gastrointestinal motility (Metcalfe et al.,
1981).
Oxidative products of arachidonic acid
Arachidonic acid (AA) is liberated from mast cell
membrane phospholipids by the action of phospholipase
A2, phospholipase C and diglyceride lipase (Kennerly,
Sullivan & Parker, 1979) and, once liberated, AA may be
metabolized via two main pathways : cyclooxygenase
leading to the production of prostaglandins (PG) or via
lipoxygenase to generate leukotrienes (LT). It is
unclear whether rat MMC metabolize AA to PG or LT and
hence both classes of mediator will be briefly discussed.
(i) Prostaglandins
Rat serosal mast cells preferentially generate large
amounts of PGD2 (Lewis et al., 1982; Roberts ejt al., 1979).
By contrast, murine bone marrow derived mast cells
generate minimal quantities of PGD2 (Razin £t al., 1983).
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The possible physiological/pathological effects of
PG are extensive (Metcalfe ejt aT. , 1981; Wasserman, 1983)
Liberated PGD2 causes peripheral and central airway
constriction in animals, inhibits platelet aggregation,
elevates cAMP and causes vasodilation and secretion of
mucus from cultured human airways (Wasserman, 1983;
Soter, Lewis, Corey, Austen, 1983; Marom, Shelhamer &
Kaliner, 1981).
(ii) Leukotrienes
The action of 5-lipoxygenase enzymes (rev. Samuelsson,
1983) on AA leads to the production, via a series of
unstable intermediates, to the sulphidopeptide
leukotrienes LTC^, LTD^ and LTE^ or the potent
chemoattractant LTB.. The substance once referred to as
4
slow-reacting substance of anaphylaxis (SRS-A) is now
known to comprise LTC^, LTD^ and LTE^ (Lewis & Austen,
1984).
Mouse bone marrow-derived mast cells metabolize AA
predominantly to LTC4 (Razin e_t aT. , 1983)with the
production of some LTB^ (Mencia-Huerta e_t aT. , 1983) .
In view of the fact that these cells are thought to
represent the murine counterpart of rat MMC, it is
possible that rat MMC likewise generate leukotrienes.
The biological effects of the leukotrienes are listed in
Table 4.
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Table 4 Pharmacological actions of leukotrienes
LTB
4
1. Increase neutrophil granule release and metabolism
2. Chemotactic and chemokinetic for neutrophils and
eosinophils
3. Stimulate neutrophil adherence to endothelial cells
4. Increase vascular permeability
LTC. , LTD . and LTE.4 4 4
1. Constrict smooth muscle (enhance peristalsis)
2. Increase vascular permeability (oedema formation)
3. Generate prostaglandins
4. Increase airway mucus production
5. Vasoconstriction
6. Constrict small airways
References





In 1971 new enzymes were purified from rat small
intestine and skeletal muscle which reacted with apo¬
proteins of pyridoxal enzymes (Katunuma, Kominami &
Kominami, 1971). These proteases were studied further
and shown to have pH optima in the alkaline region,
activity with substrates of chymotrypsin (N-acetyl-
L-tyrosine ethyl ester) but not trypsin and seryl
residues at their active centre (Katunuma, Kominami,
Kobayashi, Banno, Suzuki, Chichibu, Hamaguchi &
Katsunama, 1975).
The enzymes separately purified from skeletal
muscle and small intestine were shown to be distinct
based on the lack of cross reactivity of the protease
from muscle with antisera prepared against the intestinal
enzyme (Katunuma et aT., 1975). It was suggested that
these enzymes, called 'group specific proteases' due to
the apparent limited and selective activity, initiated
the degradation of pyridoxal phosphate enzymes such as
ornithine aminotransferase (OAT) (Katunuma et al., 1975).
The enzyme from small intestine was purified by
Woodbury & Neurath (1978) and the quantitative
relationships of protease to OAT examined. The
disproportionate amounts of protease with respect to OAT
activity in adult rats and the absence of any correlation
in developing rats were inconsistent with the concept
21
that OAT is a physiological substrate for the protease.
2. Mast cell origin of Group specific proteases
The properties of the protease purified from rat
skeletal muscle were found to be identical to that from
rat peritoneal mast cells (Woodbury, Everitt, Sanada,
Katunuma, Lagunoff & Neurath, 1978a). Polyacrylamide
gel electrophoresis demonstrated identical mobilities
corresponding to a molecular weight of 26000 and the
relative amino acid sequences were found to be identical,
furthermore immunodiffusion tests demonstrated that the
two proteases were immunologically identical (Woodbury
et al., 1978a)
Similarly the protease isolated from small intestine
was found to be of mast cell origin (Woodbury, Gruzenski
& Lagunoff, 1978b). This enzyme was localized by
immunofluorescence to the mucosal mast cells of the
lamina propria and intraepithelial cells of the intestine
and also beneath the epithelium of the bronchioles
(Woodbury et al., 1978b). All cells were found to
contain low levels of the protease from skeletal muscle
(Woodbury et al., 1978b).
Although both types of mast cell contained both
intestinal and muscle proteases these enzymes did not
cross-react immunologically (Woodbury et al., 1978b).
Recent studies by Gibson & Miller (1986) have shown that
using monospecific antisera that the enzyme of skeletal
22
muscle is exclusively located in CTMC and the protease
from intestine is present only in MMC.
3. Terminology
To avoid the complicated and confusing names given
to the mast cell proteases it was proposed by Woodbury
& Neurath (1978) that the enzyme in skeletal muscle be
termed RMCPI, and that in intestine RMCPII. This
terminology will be observed throughout this thesis.
4. RMCPI
A chymotrypsin like enzyme was localized to the
mast cell granule by histochemical techniques over 30
years ago (Gomori, 1953), and its presence was further
demonstrated by cleavage of synthetic substrates by whole
mast cells (Benditt & Arase, 1959), cell extracts
(Lagunoff & Benditt, 1963) and granule preparations
(Lagunoff & Pritzl, 1976). This enzyme was termed
chymase (Lagunoff & Benditt, 1963) and had a molecular
weight of 23000-29000 (Kawiak, Vensel, Komander & Barnard,
1971) and was cationic assessed by its mobility at
alkaline pH (Lagunoff, Phillips, Iseri & Benditt, 1964).
RMCPI (chymase) has an apparent molecular weight
by SDS PAGE of 26000 (Woodbury, Everitt & Neurath, 1981).
Amino acid analysis has shown that the enzyme has a
relatively high content of basic residues (19%)
consistent with a pi of 9*5 (Woodbury et al., 1978a).
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The amino acid sequence of the first 51 amino terminal
residues reveals approximately 40% homology with bovine
chymotrypsin A (Woodbury, Katunuma, Kobayashi, Titani &
Neurath, 1978c) and greater than 75% sequence identity
with RMCPII (Woodbury et aT., 1978c). RMCPI is
relatively insoluble requiring high salt concentrations
for its isolation from CTMC or muscle (Woodbury et al.,
1981).
There is a high degree of similarity with neutrophil
cathepsin G (Woodbury & Neulrath, 1980) and it has been
suggested that RMCPI and cathepsin G are one and the
same enzyme (Starkey, 1978). However, reactivity
towards 4-nitroanilide peptides clearly indicates that
the enzymes are quite different (Yoshida, Everitt, Neurath,
Woodbury & Powers, 1980).
The activity of RMCPI is partially masked by its
binding to mast cell heparin (Yurt & Austen, 1977) with
which it is released after activation of isolated mast
cells (Yurt & Austen, 1977). Furthermore, the active
site of RMCPI is partially inhibited in vitro by 5-HT;
at concentrations comparable to those present in the
intact mast cell (Yurt & Austen, 1977).
5. RMCPII
Mucosal mast cells also possess a chymotrypsin like
enzyme with esterase activity (Lagunoff & Benditt, 1963;
Newlands, Huntley & Miller, 1984). Amino acid sequence
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analysis shows RMCPII, like RMCPI, to be a single
polypeptide chain of molecular weight 25000 (Woodbury
et al.. 1978c). Like RMCPI, RMCPII is isolated in a
fully active form and seems to lack a zymogen precursor
(Woodbury & Neurath, 1980). RMCPII has 15% basic and
only 9% acidic residues and is basic at neutral pH, but
not as basic as RMCPI (Woodbury et ad., 1978c).
In contrast to RMCPI, RMCPII is not inhibited by
N-p-tosyl-L-phenylalanine chloromethyl ketone. However,
RMCPII is inhibited by extended peptide chloromethyl
ketones that contain phenylalanine and hydrophobic
residues. The structures of such inhibitors are
analogous to the preferred substrates of RMCPII (Woodbury
& Neurath, 1980).
The cell specific localization of RMCPII suggests
that it is a secretory enzyme (Woodbury & Neurath, 1978)
and hence the measurement of extracellular RMCPII should
provide a specific marker for the in vivo activation of
MMC.
The amount of RMCPII in an adult rat intestine has
been estimated to be 3mg (Woodbury & Neurath, 1978) and
in rats 6-8 weeks old it represents 1% (by weight) of
the total protein of the small intestine (Woodbury &
Neurath, 1978). Unquestionably RMCPII represents a
major protein product of MMC.
25
6. RMCPII, MMC and development
Since RMCPII has been shown to be located in MMC
(Woodbury et _al., 1978b; Gibson & Miller, 1986) then the
number of these cells would be expected to reflect the
concentration of protease in the intestine. Woodbury &
Neurath (1978) examined the levels of RMCPII in the
intestines of developing rats and demonstrated a rapid
4 fold rise in the levels of protease 4-6 weeks after
birth. The levels then decreased to adult levels (0*5
mg RMCPIl/g of tissue). The mast cell response followed
a similar pattern increasing 2 fold between weeks 4 and
6, remaining high and then decreasing to adult numbers
(Woodbury & Neurath, 1978).
7. RMCPII and parasitism
Infection with N.brasiliensis is associated with a
proliferation of MMC in the jejunum, and at the peak of
this response the levels of RMCPII are increased almost
nine fold in the intestinal mucosa (Woodbury & Miller,
1982). Early in the proliferation of MMC, only a
proportion of the cells in the lamina propria stained
for RMCPII with immunoperoxidase, none was stained in
the epithelium (Woodbury & Miller, 1982), although
intraepithelial MMC were detected after staining with
basic dyes. Fourteen to twenty days after infection
and in rats immunized by previous infection, staining
for RMCPII was both stronger and also present in
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intraepithelial mast cells (Woodbury & Miller, 1982).
Woodbury ejt ad. (1978b) were able to demonstrate
RMCPII immunohistochemically in intraepithelial mast
cells of normal rats, in contrast to the results of
Woodbury & Miller (1982). However, this required
fixation by perfusion with paraformaldehyde which
resulted in considerable extracellular fluorescence;
Carnoy's fixation in agreement with the results of
Woodbury & Miller (1982) did not permit the adequate
visualization of intraepithelial mast cells (Woodbury
et al., 1978b).
When the parasites had been expelled (day 12),
MMC numbers were significantly increased, but many of
the MMC (detected by Alcian blue) were found to contain
little protease assessed by the levels of RMCPII in the
jejunum or in mucosal mast cells by immunofluorescence
(Woodbury & Miller, 1982). The failure to detect
protease in intraepithelial mast cells suggests that it
is either not present, present in lower concentrations
(Woodbury & Miller, 1982) or is released disproportionately
to proteoglycan. Granule discharge has been demonstrated
in N.brasiliensis infection (Miller & Walshaw, 1972) and
the low levels of RMCPII are compatible with histochemical
evidence of granule discharge. Selective release of
granule components cannot be ruled out until good
immunohistochemical localization and concomitant
proteoglycan staining can be achieved.
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The finding that RMCPII levels in the gut mucosa
were low when the majority of parasites had been
expelled (Woodbury & Miller, 1982) could mean that MMC
are secreting rather than storing enzyme. This led to
a study of the release of this enzyme into the serum of
rats following challenge with either parasites or
parasite antigens.
Rats primed by infection with N.brasiliensis and
challenged with 5 day old parasites respond by the systemic
release of RMCPII which is both time- and dose-dependent
(Miller, Woodbury, Huntley & Newlands, 1983). Maximal
values (3000ng/ml serum) were observed in recipients of
2665 parasites one hour after challenge. Trace amounts
of protease were also present in naive and primed rats
given saline intraduodenally. Systemic secretion of
RMCPII occurred in naive rats challenged with parasites and
was slower and less pronounced than in primed rats
(Miller et aT., 1983). No RMCPII was present in the
sera of naive rats challenged with day 4 old parasites
supporting the view that the parasite does not produce
mast cell degranulator until it is 5-6 days old
(Miller, 1979b). Few morphological changes were evident
granule exocytosis was not observed in MMC, and the
tissue concentration of RMCPII was unaltered following
worm challenge (Miller et, al. , 1983) .
Soluble Nippostronqylus antigen had no effect when
given either intraduodenally or intravenously to naive
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rats, but one hour after intraduodenal challenge of primed rats
with antigen a concentration of 10*5jig RMCPIl/ml was detected
in the sera (Miller et al.. 1983). Furthermore, after
intravenous challenge of primed rats with antigen there
was substantial release of RMCPII (122jag/ml) and
depletion of both MMC and RMCPII from the intestinal
mucosa (Miller ejt ad., 1983) . Signs of severe
anaphylactic shock were evident ie. hyperaemia, mucus
secretion, epithelial shedding and the appearance of
Evan's blue dye in the gut lumen indicative of increased
epithelial permeability (Miller et al., 1983). These
experiments demonstrate that MMC are activated in
response to parasite antigens and that the measurement
of RMCPII can be used to assess the degree of
activation and participation of MMC.
The stage was set to analyze the release, if any,
of RMCPII into the blood of rats during primary
infection, and two nematode infections were investigated
(Woodbury, Miller, Huntley, Newlands, Palliser & Wakelin,
1984). Following infection with Trichinella spiralis
most of the worm burden was expelled between days 9 and
12, maximal accumulation of MMC occurred on day 12 when
peak levels of RMCPII were detected in the sera.
Significant enzyme release was detected in blood , however
as early as day 6 of infection (Woodbury et al., 1984).
In N.brasiliensis infection protease secretion was less
pronounced than in T. spiralis infection (lOOOngj^compared
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with 4000ng peak levels)• Peak levels of enzyme occurred
on day 9-10 and coincided with worm expulsion. These
results demonstrated for the first time that MMC were
active during the immune expulsion of nematode parasites
(Woodbury et al., 1984).
8. Functions of RMCPI and RMCPII
Although RMCPI (chymase) has been studied for many
years its precise physiological role remains somewhat
obscure. There is evidence to suggest that chymase is
involved in the degradation of connective tissue
proteoglycans (Seppa, Vaananen & Korhonen, 1979), in
the selective degradation of basement membrane type IV
collagen (Sage, Woodbury & Bornstein, 1979) as well as
promoting vascular permeability changes (Seppa, 1978).
The enzyme may, however, have some as yet undefined
intracellular role, an observation supported by the
fact that it is fully active as an esterase and protease
even when bound to mast cell heparin (Yurt & Austen, 1977).
The function of RMCPII is likewise obscure. The
involvement of MMC in parasite expulsion will be
discussed (Section II) and if MMC are part of the host
response to parasitism then RMCPII could play a role in
the events leading to parasite expulsion.
As RMCPI and RMCPII are antigenically distinct
and because RMCPII predominates in MMC, measurement
of this enzyme by immunoassay allows the participation
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of MMC in parasitism and allergic conditions to be
selectively monitored.
Table 5. RMCPII the unique proteinase of rat MMC
Localization





seryl residue at active site
pH optima in alkaline region
active with substrates of chymotrypsin
preferential cleavage of peptide bonds between hydrophobic
residues
cleaves native basement membrane type IV collagen
75% sequence identity with RMCPI in the first 51 amino
terminal amino acids
soluble, not requiring high salt concentrations for its
purification or assay
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Section II Allergy, mast cells and parasitism.
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Parasitism and Allergy
A characteristic feature commonly associated with
helminth infections is the occurence of hypersensitivity
reactions with a proliferation of mast cells and
eosinophils together with the biosynthesis of substantial
quantities of IgE (rev. Murray, 1972; Sadun, 1972;
Askenase, 1980; Jarrett & Miller, 1982; Miller, 1984).
Positive Prausnitz-Kustner reactions have been
demonstrated in man thus providing evidence of the immediate
nature of the hypersensitivity state (Andrews, 1962).
Allergy to helminth antigens is exemplified by the
reactions of animals sensitive to Ascaris species, where
rapid local and occasionally systemic reactions have been
demonstrated in horses challenged with enteric fluid from
A.equorum (Weinberg & Julien, 1911). Cutaneous, asthmatic
and anaphylactic symptoms have also been described in
dogs challenged intradermally with A.lumbricoides and
Toxocara canis antigens (Brunner, Altman & Bowman, 1944).
Laboratory rodents are also demonstrably hypersensitive
to helminths, rats and mice sensitized with N.brasiliensis
T.spiralis.or Nematospiroides dubius and injected with
homologous antigen undergo systemic or local anaphylactic
shock (Briggs & Degiusti, 1966; Urquhart, Mulligan, Eadie &
Jennings, 1965; Panter, 1969; Miller et aJ., 1983).
It became evident that hypersensitivity reactions
expressed as oedema, dermatitis, diarrhoea and even
anaphylactic shock were involved in the pathogenesis of
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parasitic infections (Sadun, 1972). Such reactions are
normally regarded as being harmful to the host but a
constant idea has been that immediate hypersensitivity
mechanisms may play a part in specific protective
responses at mucosal surfaces.
Although the concept of anaphylaxis introduced by
Portier & Richet (1902) to describe the appareht
decreased resistance of animals to foreign protein on a
second exposure and the term 'allergy' introduced by
Von Pirquet (1906) bore striking resemblances to the
observations with helminth antigens, it was not until
the 1950's that the observations of Taliaferro & Sarles
(1939) and Hamann (1943) describing mast cell degranulation
and an increased level of histamine in tissues of
parasitized rats were linked to allergic reactions.
This was chiefly achieved by the identification of mast
cells as the major source of histamine released by
specific anaphylactic degranulation (Mongar & Schild,
1950).
I_gE, Allergy and Parasitism
A fundamental immunological component of immediate
hypersensitivity is the production of IgE which binds to
high-affinity receptors on mast cells and basophils
(Ishizaka ejt aT. , 1983)
Mast cells and basophils are not the only cells to
possess Fc receptors for IgE, macrophages (Dessaint,
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Torpier, Capron, Bazin & Capron, 1979), T-lymphocytes
(Yodoi & Ishizaka, 1979), monocytes (Ferreri, Howland &
Spiegelberg, 1986) and eosinophils (Capron & Capron, 1980)
have all been shown to possess such receptors, albeit of
a lower affinity than those on mast cells and basophils.
The production of substantial quantities of IgE is
one of the most conspicuous events associated with
helminth infestations and N.brasiliensis infection of
rats has proved a useful model to examine the parameters
of IgE production and its role in parasite rejection and
allergic conditions (Jarrett & Miller, 1982).
Conventional passive cutaneous anaphylaxis (FCA)
assays have failed to show any relationship between the
expulsion of N.brasiliensis and the levels of parasite
specific IgE (Ogilvie, 1967: Jarrett, Jarrett, Miller &
Urquhart, 1967); IgE generally being detected in the
sera only after the completion of parasite expulsion
(Ogilvie, 1967). However, if other methods are employed
IgE-like reactivity can frequently be demonstrated
before parasite expulsion is complete. Although in vivo
gut sensitivity to intravenous administration of worm
antigen generally occurs after parasite rejection,
systemic anaphylaxis can be induced as early as 13 to 16
days after infection with N.brasiliensis. the reaction
being confined to the small intestine (Keller, 1970).
Urquhart ejt al (1965) have reported susceptibility to
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systemic anaphylaxis as early as day 7 of infection.
Similarly, peritoneal mast cells are sensitized within
7 to 10 days of infection«(Wilson & Bloch, 1967). A
small degree of bronchial sensitivity to N.brasiliensis
can be demonstrated before IgE is detectable in the sera
(Church, 1975) and active cutaneous anaphylaxis can be
demonstrated as early as day 10 of infection (Jarrett &
Stewart, 1973; Befus, Johnson, Berman & Bienenstock,
1982). It is therefore possible that mast cells are
sensitized with IgE before IgE can be shown to be
present in the sera (Askenase, 1980).
Immediate hypersensitivity and parasite expulsion
Some of the most notable features occurring during
helminth infections are inflammatory changes in the
enteric mucosa with extensive accumulation of mast cells
and basophils (Taliaferro & Sarles, 1939; Wells, 1962;
Murray, Jarrett, Jarrett & Jennings, 1971a; Askenase,
1980; Rothwell & Dineen, 1972).and altered physicochemical
conditions in the gut lumen (Castro, Roy & Stockstill,
1974; Castro, Badial- Aceves, Adams, Copeland & Dudrick,
1976). Consequently a theme expressed in many reviews
on the mechanisms of helminth immunity is that
inflammation may bring about parasite expulsion
(Murray, 1972; Larsh & Race, 1975; Wakelin, 1978).
A relationship between local hypersensitivity and
worm expulsion was demonstrated by Stewart (1955). It
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was shown that adult Haemonchus contortus were
frequently expelled after a further intake of infective
larvae (Stewart, 1953; Stewart, 1955). Coincident with
expulsion there was a rise in whole blood histamine and
a local anaphylactic reaction characterized by abomasal
oedema with increased peristalsis and segmentation
(Stewart, 1953). This expulsion process termed 'self-
cure' (Stewart, 1955) was inhibited by antihistamine
drug treatment, parenteral administration of histamine
or exposure in vitro of the adult worms to histamine
did not have any direct effect on the worms themselves
(Stewart, 1953). Stewart (1955) concluded that
histamine did not act directly on the parasite but the
local hypersensitivity reaction altered the environment
within the abomasum so that the parasite could no
longer survive. Challenge with am unrelated parasite
could also cause expulsion indicating that the mechanism
of expulsion was immunologically non-specific (Stewart,
1953).
This idea was examined by others who studied
infection of rats with N.brasiliensis. a system in which
a clearly demarcated and quantifiable self-cure occurs
(Ogilvie & Jones, 1971). Expulsion of N.brasiliensis
does not require the stimulus of reinfection and starts
usually 10-11 days after infection and proceeds over
several days (Jarrett, Jarrett & Urquhart, 1968; Ogilvie
& Love, 1974).
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At the time of worm expulsion rats are demonstrably
hypersensitive to N.brasiliensis antigens and show
immediate skin reactions on intradermal injection and
anaphylactic shock following intravenous injection of
antigen (Urquhart et aT., 1965). The anaphylactic
reaction is most prominently displayed by gross alterations
in the small intestine with hyperaemia, increased capillary
permeability, mucus secretion, oedema and plasma
leakage into the gut lumen (Urquhart et aT., 1965).
Subsequently a lesion similar to that induced
experimentally was shown to be present in the intestines
of rats during the expulsion of N.brasiliensis (Barth et
al., 1966). The experiments of Urquhart _et aT (1965)
led them to propose that local anaphylaxis may affect
worm expulsion in two ways. Firstly, by physical
changes in the intestine as originally postulated by
Stewart (1955) or secondly, by promoting the passage of
antibody and other serum derived components into the gut
lumen as a result of increased mucosal permeability.
The second hypothesis was tested by Barth ejt aT
(1966) who studied the effect of heterologous intestinal
anaphylaxis in rats harbouring transplanted N.brasiliensis.
These experiments demonstrated that rats given hyperimmune
serum plus anaphylactic shock (egg albumin (EA)
intravenously into EA sensitized rats) expelled worms
sooner than rats given anaphylactic shock or serum alone
(Barth jet aT., 1966) indicating a link between antibody
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and permeability changes.
An increased translocation of plasma-derived
macromolecules into the gut lumen occurs in N.brasiliensis
infected rats (Murray et ad., 1971a, Nawa, 1979) and
ultrastructural studies have shown gaps between
epithelial cells indicative of increased mucosal
permeability (Murray ejt _al., 1971a) . Anaphylactic
degranulation of MMC could promote changes in mucosal
permeability but Nawa (1979) was unable to show any
relationship between MMC counts and permeability. A
different conclusion was reached by Murray et al (1971a)
who demonstrated a close agreement between permeability
and MMC numbers.
MMC and parasites
Mucosal mast cell (MMC) hyperplasia is a prominent
feature following enteric infection with parasite
nematodes (rev. Askenase, 1980; Befus & Bienenstock, 1982;
Miller, 1984) and the role of MMC in the expulsion of
gastrointestinal nematodes remains controversial
(Askenase, 1980). Although nematode infections of
laboratory animals invariably provokes mucosal mastocytosis
(Miller, 1980; Jarrett & Miller, 1982; Miller, 1984), the
precise timing of the onset of mastocytosis and its
relationship to expulsion varies both between different
strains of the same host (Nawa & Miller, 1979; Lee &
Wakelin, 1982) and with different levels of infection
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(Nawa & Miller, 1979).
Experimental infection of rats with N.brasiliensis
is associated with a fluctuation both in number and
distribution of MMC (Miller & Jarrett, 1971; Wells, 1962).
Shortly after this parasite reaches the intestine there
is a marked degranulation of MMC (Miller, 1971) which
may reflect the release from the worms of a mast cell
degranulating agent (Murray, Miller & Jarrett, 1968).
During the exponential rise in MMC there is release of
amines, proteoglycan and basic protein from MMC which
can be detected by electron microscopy and histochemical
techniques (Miller, Murray & Jarrett, 1967; Murray _et
al., 1968; Miller & Walshaw, 1972). It is at this
stage when transformation of MMC into globule leukocytes
is most marked (Miller & Jarrett, 1971) the partially
discharged MMC migrating into the intestinal epithelium
to give rise to GL. If worms are removed by drug
treatment this transformation does not occur (Murray,
Miller, Sanford & Jarrett, 1971b) whereas the rise in
MMC numbers occurs whether the worms have been removed
or not.
Discharge of MMC is also indicated by the detection
of RMCPII in the sera of N.brasiliensis-infected rats,
the levels of this enzyme reach a peak 10-12 days after
infection coincident with worm expulsion (Woodbury et
al.. 1984).
The evidence cited above, of activation of MMC
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during self-cure, has led to the suggestion that they
are involved in the expulsion of nematodes via
anaphylactic triggering and release of mediators when
MMC surface IgE interacts with parasite antigens.
Mediators released from degranulating MMC may affect
the parasite directly (Rothwell, Prichard & Love, 1974),-
alter mucosal integrity (Miller et al«, 1983) and
secretory activity (Castro, 1982) and act on smooth
muscle (Castro, 1981).
The arquements for and abainst a role for MMC in parasite
expulsion
Kinetic studies documenting increased numbers of
intestinal MMC and the relationship of these increases
to parasite expulsion have provided conflicting data as
to the role of MMC. Whilst on one hand mastocytosis
and expulsion are related temporally during T.spiralis
(Alizadeh & Wakelin, 1982), Stronqyloides ratti (Olsen &
Schiller, 1978; Mimori, Nawa, Korenga & Tada, 1982) and
Trichostronqylus columbriformis (Handlinger & Rothwell,
1981) infections of mice,Trats and guinea pigs
respectively the relationship in S.ratti (Carroll,
Mayrhofer, Dawkins & Grove, 1984) or Trichuris muris
(Lee & Wakelin, 1982) infections of mice is less clearcut.
The situation is made even more complex in that
increased numbers of mast cells have been recorded at or
about the time of the expulsion of N.brasiliensis from
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rats (Wells, 1962; Jarrett et al., 1967; Miller & Jarrett,
1971) whereas other reports have shown that the rise
does not occur until the majority of parasites have been
expelled (Keller, 1971; Kelly & Ogilvie, 1972).
Furthermore, in some strains of rats the mast cell response
does not occur until 1-2 days after the onset of
expulsion, but coincides with the final stages of worm
expulsion (Nawa & Miller, 1979).
The overall impression from studies involving mast
cell counts is that no firm conclusions can be made as
to the role of MMC in expulsion. Furthermore it must be
questioned as to whether histological evidence alone
adequately portrays the situation in the parasitized
gut. The latter problem is exemplified by the studies
of Woodbury ejt al. (1984) on the release of RMCPII
during infection of rats with N.brasiliensis. It was
demonstrated that RMCPII was secreted into the serum
and at its peak coincided with parasite expulsion even
though MMC were low in number. Therefore on the basis
of MMC counts alone, a role for MMC would seem unlikely,
but the presence of RMCPII in serum demonstrates that
MMC are activated and their role must be reevaluated in
the light of these studies.
The role of MMC has been further explored by the use
of a variety of drugs which act on or compete with
biogenic amines. Whilst on one hand the antihistamine
promethazine (Urquhart et al., 1965) or promethazine
42
plus anti-serotonin drugs (Murray, Smith, Waddell &
Jarrett, 1971c) or reserpine (Sharp & Jarrett, 1968)
inhibited the expulsion of N.brasiliensis , similar
drugs had no effect when tested by other workers (Keller,
1971; Keller & Ogilvie, 1972). Therefore, whilst some
experiments are in favour of a mast cell involvement in
worm expulsion others reach the opposite conclusions.
However, it is clear that experiments dealing with
mediator antagonists are often flawed because the drugs
have multiple actions and side effects. For example,
although reserpine depletes mast cell amines, treatment
of guinea pigs with this drug renders them dehydrated
through the action of the drug on the enterochromaffin
tissues of the gut (Askenase, 1977).
Of all the drugs tested, the glucocorticosteroids
are those invariably shown to inhibit worm expulsion
(Ogilvie, 1965; Urquhart et ad., 1965). These drugs
suppress the mast cell response to N.brasiliensis
infection (Jarrett et al., 1967) and also block the
rapid expulsion of T.spiralis (Bell, McGregor & Adams,
1982) and N.brasiliensis (Miller & Huntley, 1982b) from
primed rats. Again corticosteroids have a wide spectrum
of actions and their action against MMC requires further
analysis.
The lack of conclusive evidence obtained from drug
blocking experiments, has led to the use of animals
deficient in MMC in order to clarify the role of MMC in
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expulsion. However, even these experiments have failed
to produce unequivocal results, with Uber, Roth & Levy,
£1980) demonstrating normal expulsion kinetics for
N.brasiliensis and Kojima, Kitamura & Takatsu (1980),
Crowle & Reed (1981) and Crowle (1983) showing infection
was prolonged in mast cell-deficient mice. Reconstitution
of W/WV mice (congenitally deficient in MMC) with bone
marrow or spleen cells from +/+ littermates repaired the
mast cell defect, but insufficient data points were
included to comment on the effect of reconstitution on
expulsion (Crowle, 1983). Reconstituted or not, such
mice were slower at rejecting N.brasiliensis than their
normal litter mates (Crowle, 1983). The expulsion of
T.spiralis from mast cell-deficient W/Wv mice is delayed
(Ha, Reed & Crowle, 1983) and transfer of +/+ bone
marrow cells to W/Wv mice accelerates parasite expulsion
(Ha et al., 1983).
It is> important at this point to indicate that the
parameters for the identification of murine MMC have not
been fully established (Miller, 1980). For example, the
granules of intraepithelial lymphocytes exhibit
metachromasia similar to mast cell granules when stained
with Toluidine blue (Guy-Grand, Griscelli & Vassalli,
1978) and the extent to which these cells may have been
misinterpreted as MMC is unclear.
In conclusion, the experimental results, with the
exception of those dealing with the measurement of RMCPII,
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are highly contradictory with regard to the role of MMC
in the expulsion of primary nematode infections. The
observations on the release of RMCPII during expulsion
are to date the most convincing evidence to suggest that
MMC may play some role in expulsion. It is also
reasonable to suggest that, in addition to RMCPII other
mediators may be generated/released and, since mast cells
are capable of producing a wide battery of potent
biologically active compounds, the effects of MMC secretion
could be of great importance in the expulsion mechanism.
Secondary infections - Rapid expulsion
Rapid expulsion (RE) is a phenomenon directed
against infective larvae as they enter the intestine and
is ultra rapid, apparently occurring before establishment
takes place, the worms being expelled within 24-48 hours
of challenge. RE has been described in both rats and
mice challenged with T.spiralis (McCoy, 1940; Russell &
Castro, 1979; Alizadeh & Wakelin, 1982), in rats
challenged with N.brasiliensis (Miller, Huntley & Wallace,
1981b) and in guinea pigs challenged with T.colubriformds
(Rothwell et al., 1974)
Secondary challenge of rats with T.spiralis is
associated with a response that prevents 80% of an
intraduodenal challenge of 7500 larvae from embedding
in the intestine (Russell & Castro, 1979). The host
response occurs within 15 minutes after contact of the
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parasite with the intestinal mucosa, the residual worm
burden being expelled 4-8 days later (Russell & Castro,
1979).
Infective larvae are rejected uninjured and are
able to establish normally in naive rats (Hessell,
Ramaswamy & Castro, 1982; Russell & Castro, 1985)* This
is in agreement with the early observations of McCoy
(1940) who detected a reduced worm burden 12 hours after
secondary challenge of T.spiralis in immune rats, the
worms being infective for naive rats. Two inductive
stimuli are required to promote RE in rats challenged
with T.spiralis. one is a consequence of prior infection
with pre-adult T.spiralis and the second is a non-specific
activation of the intestine, since an unrelated parasite
(Heliqnwsomoides polygyrus)will also promote RE (Bell &
McGregor, 1980).
The relative speed at which challenge infections are
expelled from immune rats and the occurrence of high
levels of parasite-specific IgE and increased numbers of
MMC after the expulsion of primary infections (Murray,
1972) raises the distinct possibility that challenge
infections are expelled by an anaphylactic reaction
(Murray, 1972; Askenase, 1980; Miller, 1984).
Following secondary challenge of rats immune to
T.spiralis there is a rapid accumulation of fluid in
the gut (Castro, Hessell & Whalen, 1979) which is
associated with RE of this parasite (Russell & Castro,
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1979) • Studies _in vitro of these effects have shown
there to be immunologically specific alterations in
trans-epithelial transport of sodium-hexose and an
increase in trans-epithelial electrical potential
difference (Russell & Castro, 1985). Anaphylactic
reactions on exposure to Trichinella antigens may cause
structural/functional changes in the intestinal
epithelium and thus confer resistance to the host
indirectly by modification of the habitat of the
parasite (Castro, 1982; Russell & Castro, 1985). Castro
has proposed that vasoactive intestinal peptide released
from mast cells may play a role (Castro, 1982) or,
alternatively, mediators such as histamine, serotonin or
prostaglandins (Russell & Castro, 1985) may mediate
these effects.
The RE of N.brasiliensis occurs within 4-5 hours of
intraduodenal challenge of primed rats with day 4 old
worms. The response is unaffected by challenge dose,
but is dependent upon the immune status of the host
(Miller et aT., 1981b) Evidence that MMC are involved
in this response has come from a study of the release of
RMCPII during the RE of N.brasiliensis (Miller et aT.,
1983). The release of RMCPII from MMC was examined
following challenge of primed rats with 4 or 5 day old
parasites. Primed rats responded in a dose- and time-
dependent fashion with the secretion into blood of 1-3
pg RMCPIl/ml of serum one hour after challenge (Miller
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et ad., 1983). These results unequivocally demonstrate
MMC secretion during the RE of N.brasiliensis» It
would seem reasonable to suggest that RMCPII secretion
is accompanied by the release of other mediators which
may in concert bring about the rapid expulsion of
N.brasiliensis.
In an attempt to assess the role of immediate
hypersensitivity in the RE of T.spiralis, Bell et al.
(1982) employed various inhibitors of hypersensitivity
and examined their effects on RE. However, no consistent
inhibitory effects could be seen (Bell et al., 1982).
Promethazine, cobra venom factor (anti-complementary) and
cortisone caused some inhibition of RE, but a variety of
antihistamines and anti-5-HT drugs were without effect
on RE (Bell et aJ. , 1982). Furthermore, treatment of
rats with aspirin or indomethacin (anti-prostaglandin/
inflammation) or carbachol (smooth muscle stimulant)
did not prevent RE. It was concluded that immediate
hypersensitivity played a minor role or none at all in
the RE of T.spiralis (Bell ejt al. , 1982).
In guinea pigs infected with T.colubriformis a
role for histamine and 5-HT in parasite expulsion has
been suggested (Jones, Rothwell, Dineen & Griffiths,
1974; Rothwell, Dineen & Love, 1971) the rejection of
transplanted worms being inhibited by anti-histamine
treatment of immune guinea pigs (Rothwell, Love & Evans,
1978).
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There are, however, restrictions which apply to
experiments dealing with mediator inhibition. Firstly,
it is possible that following mediator release local
tissue concentrations are so high that the drugs are
ineffective. Furthermore, the effects of histamine may
be a combination of both HI and H2 receptor activation
such that blockade with one antihistamine is not
sufficient. Secondly, it is not only histamine which
is important in the pathogenesis of allergy, and other
mediators may not be amenable to the pharmacological
regimes used. Thirdly, MMC may not be affected by the
drugs which are known to inhibit mediator release from
CTMC. Any of the above mechanisms may contribute to a
lack of success in demonstrating the inhibition of RE
by anti-allergic compounds (Bell et aT. , 1982).
Glucocorticosteroids have proved universally
effective in inhibiting worm expulsion, blocking the
rapid expulsion of N.brasiliensis (Miller & Huntley,
1982b) and T.spiralis (Bell et aT., 1982), and it is
clear that their potent anti-anaphylactic properties
and effects on MMC in relation to the suppression of





Mucus is usually defined as the viscoelastic fluid
that lines the epithelium of the gastrointestinal,
respiratory and genito-urinary tracts and is a mixture of
large molecular weight glycoproteins (mucins), water,
electrolytes, sloughed epithelial cells, DNA, IgA,
lysozyme, plasma proteins, bacteria and bacterial
products (Forstner, 1978).
Chemical and physical properties
The molecules responsible for the viscous and gel
forming properties of mucus are the glycoproteins or
mucins (Hollander, 1954), which constitute between 1 and
10% by weight of the gel. The bulk of mucus consists of
water, up to 95% by weight, and an electrolyte composition
similar to that of plasma (Hollander, 1963). The
remainder is non dialyzable glycoproteins, proteins, and
nucleic acids (Allen, 1978). Mucus is heterogeneous and
contains, in addition to those substances defined above,
virtually all other constituents found in gastrointestinal
juice (Glass, 1964).
The general features of mucus glycoproteins are
shown in Table 6. Mucins are macromolecules in which the
peptide core, generally between 10 and 30% of weight, is
linked to oligosaccharide side chains by O-glycosidic
bonds between serine and/or threonine and N-acetyl-
galactosamine residues (Ginsberg & Neufeld, 1969; Spiro,
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Table 6 General features of mucin glycoproteins
1. High molecular weight, greater than one million
2. Over 70% carbohydrate by weight
3. Carbohydrate side chains contain : N-acetylglucosamine
N-acetylgalactosamine, galactose, sialic acids and
fucose
4. Do not contain : uronic acids, mannose or glucose
5. O-glycosidic bonds : N-acetylgalactosamine-threonine
(or serine)
6. Carbohydrate side chains : 2-22 sugars in length, often
branched
7. Negatively charged due to sialic acid and ester sulphate
8. Mucins are viscous and form gels
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1970). The oligosaccharide composition is variable but
consists of those sugars listed in Table 6. In all
instances fucose and sialic acids are found at the non-
reducing ends. Carbohydrate side chains vary from 2-15
sugars in length and may be branched (Oates, Rosbottom &
Schrager, 1974). Mannose, uronic acids and glucose are
not present, sulphate is usually present but its linkage
point has not been fully characterized.
Various models of mucin structure have been proposed
and these include the "windmill" model for porcine
gastric mucin (Allen & Snary, 1972), a beaded mucin
model (Robinson & Monsey, 1975) and the "flexible thread"
configuration for rat goblet cell mucin (Forstner, Jabbal
& Forstner, 1973). These structures are stabilized by
non-covalent bonds, disulphide bridges, hydrophobic and
hydrogen bonds (Forstner, 1978), leading to the formation
of a viscous elastic gel typical of mucus (Allen, 1981).
The gel has properties intermediate between those of a
solid gel and a liquid (Litt, Wolf & Khan, 1977) arising
from a balance between polymer-polymer interactions of
the glycoproteins themselves and the polymer-solvent
interactions of the hydrophilic glycoproteins and the
aqueous environment (Morriss & Rees, 1978).
MucuS glycoproteins not only stick to each other,
but to other molecules and cell surfaces (Allen & Minnikin,
1975) ensuring that mucus adheres to the mucosal surface
and provides a slimy coat to facilitate the passage of
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food and faecal material.
Physicochemical function of mucus
Mucus is a product of secretory epithelia which line
internal body cavities where tissue is in contact with
air (as in the lung) or solid material (as in the intestine).
One major function of mucus in the gut is to protect
the delicate mucosal epithelium from damage by the
passage of food and faecal material, and to lubricate the
epithelium so as to ease the transit of contents along
the intestine (Florey, 1955).
Another important feature of the mucus gel is its
ability to retain water (Silverberg, Meyer, Gilboa &
Gelman, 1977) so as to provide a perpetual aqueous
environment for the mucosal surface. Mucus may also
function as a water-proofing agent and hence regulate
epithelial cell hydration (Gibson, Matthews, Minihan &
Patti, 1971; Gordon, 1974). This function is likely to
be related both to the concentration of mucin and the
extent of intertangling of the mucin fibres, and in vitrb
studies have shown that the rate of water permeability
through mucus gels is inversely correlated with the
concentration of mucin glycoprotein (Lukie, 1977).
There is some circumstantial evidence that mucus may
protect against ulceration, hence drugs which inhibit
gastric mucus production such .as aspirin and corticosteroids
aggravate ulceration (Kent & Allen, 1967; Menguy & Masters,
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1963; Menguy & Masters, 1965). In contrast, the anti¬
ulcer agents such as prostaglandins (Bolton, Palmer &
Cohen, 1978; Domschke, Domschke, Hornig & Demling, 1978)
are reported to increase mucus production.
It is often assumed that the mucus layer protects
the gastric mucosa from damage by intraluminal acid.
However the mucus gel does not provide an impenetrable
barrier to acid since it is permeable to H+ ions. It
has been proposed that mucus protects the mucosa by
delaying the diffusion of H+ from the lumen (Heatley,
1959; Williams & Turnberg, 1980) providing a medium for
neutralization of acid by bicarbonate (Williams & Turnberg,
1979).
The mucus gel may protect the underlying epithelium
from proteolytic damage by digestive enzymes, however many
mucus gel secretions are degraded by proteolysis. For
example, pepsin gradually erodes the luminal surface of
the gastric mucus gel (Scawen & Allen, 1977). There is
likely to be a dynamic equilibrium between erosion of the
gel and secretion of mucus, the thick mucus gel restricting
the diffusion of digestive enzymes through the gel matrix.
Mucus and bacteria
In 1955, Florey suggested that mucus in the gut
could entrap bacteria and parasites so as to facilitate
their removal from the intestine by peristalsis (Florey,
1955).. This idea gained further support from the work of
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Dixon (1960) who concluded that mechanical removal by
peristaltic action aided by the secretion of mucus was
probably the main fate of viable bacteria which entered
the small intestine.
For colonization of mucosal surfaces by bacteria,
high affinity interactions of ligands on the organism
with receptors on epithelial cells are essential. Such
receptors are usually glycolipids or glycoproteins
(Jones, 1977) with the properties of blood group
determinants and are, therefore, similar to mucins
(Watkins, 1966).
Protection against bacteria
Mucus may physically shield the receptors on the
epithelial surface and prevent bacterial binding, it may
also act as a barrier through which organisms must
traverse to reach mucosal receptors. For example, whilst
penetrating the mucus gel occasional Vibrio cholerae may
become entrapped within the mucus and not reach the epithelial
surface or penetrate down into the crypt region of the
intestine (Jones, Abrams & Freter, 1976). Such trapping
may facilitate clearance of the mucosal surface as the
mucus is propelled along the gut.
Mucin inhibits the attachment of oral Streptococci
to human buccal epithelial cells and may cause desorbtion
of previously adherent organisms (Williams & Gibbons, 1975).
In this instance mucin may be antigenically similar to the
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epithelial cell receptor and actively compete for the
bacterial ligands. Other evidence of competition for
epithelial cell receptors is given by Strombeck & Harrold
(1974) who found gastric mucin competed with cholera
toxin for binding to small intestinal receptor groups.
Salivary mucin aggregates some pathogenic Streptococci
(Kashket & Donaldson, 1972) such aggregates could be swept
away by saliva and promote bacterial clearance. It has
also been suggested that the epithelial cell receptor
is shed and entrapped in the mucus gel which would aid in
the retention of bacteria in the mucus gel (Fox, 1979).
Blood group-reactive mucins from human saliva bind
and agglutinate Streptococcus mutans and other oral
organisms (Gibbons & Qureshi, 1978; Levine, Hertzberg,
Levine, Ellison, Stinson, Li & Van Dyke, 1978) and whereas
neuraminidase treatment of mucin does not alter binding
of S.mutans. binding of S.sanguis is inhibited, showing
sialic acid to be an important component for the binding
of this organism (Levine ert al., 1978).
Component sugars of mucins may also affect binding,
for example, adsorbtion of S.mutans is inhibited by
galactose (Gibbons & Qureshi, 1979) and the adhesion of
V.cholerae to rabbit brush border membranes is inhibited
by fucose (Jones ejt _al. , 1976) . Since salivary mucin
comprises part of the acquired pellicle of teeth, bacteria-
mucin interactions may enhance or inhibit bacterial
clearance (Levine et al., 1978). If binding is by free
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salivary components, agglutinated bacteria may be rapidly
cleared by swallowing, whereas if mucin is adherent
to teeth, binding and agglutination could increase
bacterial colonization.
Far from being protective, mucus may actually enhance
the virulence of bacteria. Thus various Gram positive
and negative bacteria, if suspended in mucin, initiate
systemic infections more readily than if suspended in
buffer (Anderson & Oag, 1939). However, iron compounds
can replace mucin in the establishment of meningococcal
infections (Calvert, Kenny & Lavergne, 1979) and the >
mucin enhancing effect may be caused by iron atoms bound
to the mucin rather than the glycoprotein content (Ford &
Hayhoe, 1976)
Caecal mucin inhibits the normal bacteriocidal
effects of serum on Escherichia coli (Winses, Midtvedt &
Trippestad, 1976) but this may reflect the presence of
serum inhibitors in the mucin preparation. As mucin
binds avidly to bacteria such as S.mutans (Gibbons &
Qureshi, 1978) such binding may bind blood group
activity to the bacteria and help to avoid antigenic
recognition.
Bacteria, mucus and antibody
Although all classes of immunoglobulin are represented
in intestinal secretions, the predominant secretory
58
immunoglobulin is IgA (Bienenstock & Befus, 1980).
Secretory antibodies are retained within the mucus layer
of the gut by interactions with cystine residues present
in mucins (Walker & Isselbacher, 1977). This stationary
location of antibodies allows for a more effective
interaction with intestinal antigens coming in contact
with the mucosal barrier.
There is decreased adherence of bacteria to epithelial
cells after exposure of the bacteria to specific secretory
IgA, suggesting that secretory IgA (slgA) blocks specific
binding sites on the bacterial cell wall (Williams &
Gibbons, 1972).
Magnusson & Stjernstrom (1982) examined the effects
of slgA on the association of Salmonella typhimurium with
the intestine of the rat and with a column of hog gastric
mucin. It was found that sensitization with slgA
increased the affinity of the bacteria both for the mucus
layer of the intestine and the mucin column, suggesting
that slgA had made the bacteria considerably more
mucophilic and thus indicating a link between antibody
and mucin.
Mucus and intestinal parasites
The association between increased resistance to
nematode parasites and mucus was first reported over 40
years ago by Ackert, Edgar & Frick (1939). It was
suggested that the greater amount of mucus present in
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older chickens was responsible for heightened resistance
to infection with Ascaridia qalli (Ackert ejt ad.,1939).
Furthermore, duodenal mucus from chickens inhibits the
growth of A.qalli in vitro (Frick & Ackert, 1941).
Infection with A.qalli provokes an increase in the
number of goblet cells in the intestinal epithelium
(Frick & Ackert, 1948). Increased numbers of goblet cells
in the gut mucosa have been reported in sheep infected
with Trichostronqylus vitrinus (Jackson, Angus & Coop,
1983) or Oesophaqostomum columbianum (Dobson, 1967) and
in all instances these observations were found to be
associated with increased resistance to infection.
Goblet cell hyperplasia has been shown to occur
during infection of laboratory animals with parasitic
helminths and is temporally related to the expulsion of
N.brasiliensis (Wells, 1963; Miller & Nawa, 1979a,b;
Uber, Roth & Levy, 1981) and T.spiralis (Alizadeh &
Wakelin, 1982) from rats and. mice.
The mechanisms which underlie the increase in goblet
cells have not been fully established, but factors which
influence goblet cells also control MMC (Miller, 1979).
Thus, adoptive immunization with the T-cell enriched
fraction from TDL effectively transfers both goblet cell
and MMC hyperplasia (Miller ejt ad., 1979), as does passive
immunization with hyperimmune serum (Miller & Nawa, 1979a).
Treatment of passively immunized rats with corticosteroids
which reduces the number of MMC (Jarrett ejt ad., 1967)
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or reserpine which depletes mast cell amines (Askenase,
1980) blocks both goblet cell hyperplasia and worm
expulsion (Miller & Nawa, 1979a). These findings
further suggest that MMC, goblet cells, and worm
expulsion could be interlinked.
An increase in the number of goblet cells could
signify that the synthesis and turnover of mucus is
increased at the time of worm expulsion. Miller, Huntley
& Dawson (1981a) have demonstrated that the incorporation
14
of C-glucosamine into mucin was maximal about the time
of worm rejection. Although there is an increase in
the proportion of goblet cells and in the turnover of
mucus during worm expulsion in N.brasiliensis infection
the exact role, if any, of mucus and goblet cells remains
to be elucidated.
Considerably more information has been gained on the
protective anti-parasitic role of mucus from studies of
the rapid expulsion of T.spiralis and N.brasiliensis from
primed rats. During the rapid expulsion of T.spiralis,
larvae fail to penetrate the epithelium and many are to
be found trapped in mucus (Lee & Ogilvie, 1981); the
number of larvae penetrating into-.the epithelium after
intraduodenal challenge of immune rats is approximately
one half of that in control rats 90 minutes after
challenge (Lee & Ogilvie, 1981). After oral challenge
many more worms were found in mucus globules in immune
rats than there were in control animals. The number
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being lower than after intraduodenal challenge, most
probably due to the mucus globules being continually
propelled along the intestine (Lee & Ogilvie, 1982).
Lee & Ogilvie (1981) were able to develop an in
vitro model of mucus trapping which enabled analysis
of the factors which may contribute to trapping.
Firstly, as normal intestinal mucus cannot be obtained
in practical amounts mustard oil was used to stimulate i
the intestine (Lee & Ogilvie, 1981). It is unclear
whether this mucus is typical of mucus in normal animals
consequently experiments dealing with this product may
be based on an artifact.
Infective larvae were incubated at 37°C with immune
or control serum or bile and then were agitated with
mucus for 2 hours. After incubation, the mucus was
layered onto sucrose and incubated in which time
untrapped larvae separate from the mucus layer.
Control or immune mucus trapped about 40% of the
larvae which had been incubated with control serum,
this figure dropped to about 5% after heat inactivation
(56°C) of the serum, indicating that complement was
involved (Lee & Ogilvie, 1982).
Inactivated immune serum trapped 38*5% of larvae with
immune mucus, and the number trapped with control mucus
was similar. Bile, whether from control or immune donors
did not cause trapping (Lee & Ogilvie, 1981).
The in vitro studies suggest that there are two
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systems interacting with mucus to promote trapping a)
the complement system and b) antibody which can be serum
derived and does not appear to be IgA (Lee & Ogilvie,
1981, 1982).
A trapping function has also been suggested during
the rapid expulsion (RE) of N.brasiliensis (Miller,
Huntley & Wallace, 1981b). Perfusion of the small
intestines of naive rats that had been challenged
intraduodenally with pre-adult worms showed that 70-80%
of the challenge dose was adherent to the gut mucosa,
whereas in immune rats only 28-31% of the worms were
attached to the mucosa and 3-23% were enveloped in mucus
(Miller et ;..al., 1981b). Exclusion of the parasites from
the mucosa occurred within 30 minutes of challenge and
significant mucus trapping was noted 2 hours after
challenge (Miller ejt ad., 1981b). It must be questioned
whether mucus trapping is an essential component of RE,
since in the case of N.brasiliensis it occurred at a
stage when the parasites had already moved into the
distal half of the intestine, and it is possible that
after failing to establish they are enveloped in mucus
(Miller eit al., 1981b).
Experiments by Bell, Adams & Ogden (1984) showed that
the RE of T.spiralis may occur in the absence of mucus
trapping. Under normal conditions, in rats primed by
full infection with T.spiralis and challenged orally,
69% of the worms in the gut lumen were trapped in mucus.
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However, if rats were immunized by a T.spiralis infection
truncated by chemotherapy which prevented deposition of
newborn larvae in the tissues, RE occurred but in the
absence of significant mucus trapping. Therefore, to
facilitate mucus trapping systemic exposure to target
antigens is necessary which may happen during the
migration of N.brasiliensis parenterally and, for
T.spiralis. during the deposition of muscle larvae
(Bell ejt aT., 1984). Hessel, Ramaswamy & Castro (1982)
found that 75% of T.spiralis rejected by RE were infective
for naive recipients, which would indicate that few of
them could have really been trapped in mucus. Thus,
whilst mucus trapping has been shown to occur the most
important functional role of mucus may be in preventing
the establishment of the parasite (Miller et al.,1981b).
Support for a 'barrier' role has come from experiments
in which rats were treated with a mucolytic or mustard
oil to disperse or deplete mucus respectively (Miller &
Huntley, 1982a). In both instances worm expulsion was
blocked, indicating that mucus is important in
N.brasiliensis infection. Furthermore, mucus trapping
and RE are blocked by pretreatment of rats with
corticosteroids (Miller & Huntley, 1982b). A similar
steroid abrogation of RE has been demonstrated in
T.spiralis infection (Bell, McGregor & Adams, 1982).
The role of mucus in Entamoeba histolytica infection,
a parasitic protozoan which is able to breach the
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mucosal barrier of the large intestine and cause erosive
lesions (Brandt & Tamago, 1970) has been recently studied.
Within one hour of inoculation of trophozoites into rat
colonic loops considerable numbers of trophozoites were
adsorbed by mucus and, by four hours, they appeared within
the lumen with aggregated sloughed mucus blanket fragments;
as adsorbtion to mucus occurred , motility was reduced
(Leitch, Dickey, Udezulu & Bailey, 1985). It was
concluded that mucus provides a significant barrier to
trophozoite access to the intestinal epithelial target
tissue (Leitch et ad., 1985).
Extracts of intestinal mucus from nematode resistant
sheep have been shown to be potent inhibitors of in vitro
larval migration (Douch, Harrison, Buchanan & Greer, 1983);
extracts from normal or susceptible sheep having no such
effect. The inhibitory extracts had properties and
activities similar to SRS-A (increased skin permeability
and inactivation by arylsulphatase). Although some
activity could have arisen from the tissues, as the mucus
was collected by scraping the mucosa, the results
demonstrate that products of immediate hypersensitivity
may paralyse nematode larvae either directly, or due to
an effect on the quantity or quality of mucus.
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Stimulation of mucus release
A number of different substances have been shown to
induce the release of mucus from goblet cells (Specian &
Neutra, 1982; Neutra, O'Malley & Specian, 1982). These
include irritants such as mustard oil and alcohol,
neurotransmitters, hormones and bacterial toxins (Forstner,
1978). Furthermore, immune complexes and intestinal
anaphylaxis induce release of mucus from rat goblet cells
(Walker, Wu & Bloch, 1977; Lake, Bloch, Sinclair & Walker,
1980; Miller et-al., 1983).
There is abundant information concerning the influence
of mast cell mediators on mucus secretion in the lung
(Kaliner, Marom, Patow & Shelhamer, 1984), and although
the profile of mediators and their interactions may not
be the same in the intestine, it is relevant to note
the mediators shown to have effects in lung.
Cultured human bronchi have been widely used to test
the effects of mediators on mucus release and in this
respect anaphylaxis and histamine (Shelhamer, Marom &
Kaliner, 1980), prostaglandins but not of the Emeries
(Marom, Shelhamer & Kaliner, 1981), monoeicosatetraenoic
acids (Shelhamer et aT., 1980; Marom, Steel, Shelhamer,
Goetzl & Kaliner, 1982a) and the leukotrienes and
(Marom, Shelhamer, Bach, Morton, & Kaliner, 1982b)
induce mucOS secretion. More recently mucos release
by prostaglandin generating factor of anaphylaxis (PGF-A)
has been demonstrated, most probably by increasing the
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generation of lipoxygenase products (Marom, Shelhamer,
Steel, Goetzl.& Kaliner, 1984).
The effects of LTC. and LTD. on mucus release have
4 4
also been studied on canine trachea in vitro. Using this
system LTD^ was 1000 times more potent than LTC^ in
causing mucus release (Johnson & McNee, 1983). Blocking
with diphenylhydramine (H type 1) revealed an as yet
undefined role for histamine in the LTC. enhanced release
4
of mucus (Johnson, Chinn, Morton, McNee, Miller & Nadel,
1983).
Any or all of these mechanisms, as well as non-
immunological stimuli (Forstner, _.1978) , could be involved
in the hypersecretion of mucus during RE, but the
prominence of MMC and evidence that histamine (Kowalowski,
Pachkowski & Secord, 1976) and serotonin (Forstner, 1978)
potentiate mucus release suggests that IgE-mediated
intestinal hypersensitivity reactions play a major role.
It is also possible that mast cell-derived mediators induce
the release of mucus during N.brasiliensis primary infection
where MMC migrate into the epithelium to lie in close
proximity to goblet cells.
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Scope of this thesis
The introduction documents a close interrelationship
between mucus, mucosal mast cells and immediate
hypersensitivity and the role of these three components
in the expulsion of N.brasiliensis will be examined.
The questions asked in this thesis are (i) does mucus
trap parasites during primary infection and could
this be an important mechanism to bring about the
rejection of N.brasiliensis« and (ii) are MMC involved
in expulsion and if so what is their role in relation
to expulsion and mucosal permeability.
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CHAPTER 2 Materials and methods.
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Experimental Animals
Male and female Wistar rats, 10-40 weeks old, were
used for all experiments and for the routine maintenance
of Nippostronqylus brasiliensis♦ For all experimental
proceedures rats were anaesthetized with ether.
Animals were killed by exsanguination from the carotid
artery and, for the preparation of worm antigen, or the
assay of passive cutaneous anaphylaxis, by cervical
dislocation. Both proceedures were performed on ether
anaesthetized rats.
All the rats were bred within the animal breeding
department of the Moredun Research Institute and were
allowed free access to food and water. For experiments
involving collection of tissues or estimation of worm
burdens rats were fasted for 24 hours.
For the collection of faeces and the monitoring
of daily faecal egg production, rats were kept in cages




l*59g of Na^CO^ and 2*93g of NaHCO^ were dissolved
in one litre of distilled water. This buffer was stored
at 4°C for not more than two weeks.
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Phosphate-citrate pH 5*0
Two stock solutions were prepared consisting of
0•1M citric acid and 0*2M disodium hydrogen orthophosphate
24«3ml of citrate and 25*7ml of phosphate were combined
and the volume made up to 100ml with distilled water.
Phosphate-buffered-saline (PBS) pH 7*4
The following chemicals were dissolved in 5 litres
of distilled water; 400g NaCl, lOg KC1, 57*5g Na^HPO^
and lOg KH^PO^. This is a ten times concentrate of PBS
and an appropriate dilution was made before use.
Tris-maleate pH 7*5
24*2g of Tris (hydroxymethyl) aminomethane and
23*2g of maleic acid were dissolved in one litre of
distilled water. 25ml of this solution and 28ml of 0*2M
NaOH were made up to 100ml with distilled water.
Hank's balanced salt solution
Sterilized Hank's balanced salt solution was obtained
from the Microbiology Department, Moredun Research
Institute. One gram of bovine serum albumin (Sigma
Chemical Co. Ltd.) was stirred into 100ml of this solution
before the pH was adjusted to 7»4 with HEPES buffer (Flow
Laboratories)
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100ml of this fixative was prepared with 30ml of
chloroform, 60ml of absolute ethanol and 10ml of glacial
acetic acid.
4% paraformaldehyde
Four grams of paraformaldehyde were dissolved in 100
ml of PBS by heating and stirring on a hot plate. The
fixative was cooled to room temperature before use.
10% aqueous acrolein
The above was prepared by adding 90ml of distilled
water to 10ml of acrolein solution (Sigma). This was
performed in a well ventilated fume cupboard.
Parasitoloqical Techniques
The parasite
The strain of N.brasiliensis used in these
experiments was originally established and maintained
in the Department of Experimental Parasitology,
University of Glasgow, and is now maintained in our
laboratory by passage in Wistar rats.
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Culture and routine maintenance of N.brasiliensis
The techniques used were essentially as described by
Nawa & Miller (1978). Seven days after infection faeces
were collected into water, washed and mixed to form a
thick paste. Previously washed granular charcoal (10-18
mesh, BDH Chemical Co.) was added to the faeces, mixed,
and the preparation incubated on wet filter paper
(Whatman no. 1) in covered Petri dishes in humidified
plastic sandwich boxes inaan incubator at 28°C.
Seven to 14 days after incubation the infective
third stage larvae (L^) were collected into water at
37°C and then transferred to a steel mesh covered with
rice paper (K-dex-8/9, Kleenaroll Ltd, London) through
which they migrated. The larvae were collected by
sedimentation in a filter funnel and then washed
several times with sterile saline. 50pl samples of
thoroughly mixed larval suspensions were counted under
a dissecting microscope. The concentration of the larval
suspension was adjusted to the required dose and 0*5ml
Lnoculated subcutaneously into the flank of anaesthetized
rats.
Faecal egg counts
Faecal egg counts were monitored by using a
modification of the McMaster slide counting technique as
described by Whitlock (1948).
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Method for counting worm burdens
The relationship of the parasite to the intestinal
mucosa and the extent of mucus trapping was as described
by Miller et_ al (1981b). Anaesthetized rats were bled
out from the carotid artery and the entire small
intestine removed. This was divided into two equal lengths
and each portion flushed with 50ml of saline followed
by 10ml of air, lightly adherent mucus and intestinal
contents were dislodged by gently drawing the intestine
between thumb suid forefinger.
The gut washings were emptied into a surgical '
gauze suspended over a 250ml beaker, and the gauze
incubated in saline at 37°C for 1 hour. The number of
worms that had migrated or passed straight through the
gauze were counted and designated FREE in the lumen.
The gauze contents were examined under a stereo
microscope for worms TRAPPED in mucus, using a dissecting
needle to distinguish worms trapped from those lying on
the mucus gel. In addition, the worms that had passed
straight through the gauze were examined for the presence
of adherent mucus.
To count the number of worms ADHERENT to the gut
mucosa, the intestines were divided into 10 equal
lengths and the parasites counted _in situ in
longitudinally opened gut segments. Both gauze and
intestines were examined immediately or stored at -20°C
for analysis at.a later date.
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Preparation of whole worm antigen
Whole worm antigen was prepared as described by
Nawa ejt al (1981). Adult worms were harvested from donor
rats 6-7 days after primary infection, by incubating the
jejunum, slit longitudinally and enveloped in surgical
gauze, in saline for 1 hour at 37°C. The worms were
collected and washed several times in sterile saline by
decantation and sedimentation and their concentration
adjusted to 4000/ml. The worm suspension was homogenized
in a teflon/glass homogenizer cooled in ice and the
homogenate clarified by centrifugation at 2500 revs/min
for 15 minutes (4°C). The supernatant was removed and
kept on ice, the pellet resuspended in the original volume
of saline was homogenized and centrifuged for a second
time. The supernatants were combined and the pooled
antigen preparation stored at -20°C as 2000 worm
equivalents (we) of antigen per ml.
Histology and cell counts
(a) Fixation
Carnoy's fixation
Segments of jejunum and ileum 2 cm in length
(specimens adjacent to those used for RMCPII assay),
mesenteric lymph node, thymus, left lobe of lung, trachea
and tongue were placed in Carnoy's fluid for 24 hours.
Tissues were then processed through a graded ethanol
series, cleared in toluene, and embedded in paraffin wax.
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Sections were cut at 5 jam, deparaffinized in xylene,
rehydrated and stained.
Paraformaldehyde fixation
Portions of jejunum, ileum, stomach, colon and ear
pinnae were fixed for 6 hours in 4% paraformaldehyde and
then transferred to 70% ethanol and stored overnight at
4°C (Newlands et al., 1984). The tissue samples were
dehydrated, processed into wax and sections cut at 5 jam.
(b) Staining
Glycosaminoglycan (GAG)
Carnoy•s-fixed sections were stained with 0*1%
Alcian blue 8GX in 0*7N HC1 pH 0*3 for 30 minutes and
were counterstained with Safranin O in 0*125N HC1 for
5 minutes (Enerback, 1966a). Sections fixed in
paraformaldehyde were stained with Toluidine blue (0*5%
in 0*5N HC1, pH 0*5) for 15 minutes (Enerback, 1966a).
Serine esterase
Esterase activity was demonstrated by incubating
paraformaldehyde-fixed sections in a synthetic esterase
substrate : naphthol AS-D chloroacetate and Fast Garnet
GBC (Gomori, 1953; Huntley et aT., 1984).
Fifteen milligrams of naphthol AS-D chloroacetate
(Sigma) were dissolved in 2ml of dimethylformamide (BDH)
to which was added 5ml of ethylene glycol monomethyl
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ether (BDH), 10ml of Tris-maleate buffer (pH 7*5) and
8ml of distilled water. This solution was added to 15mg
of Fast Garnet GBC salt (Sigma), immediately mixed, and
filtered through a 0»22 pm millipore membrane onto the
slides. Staining was for 5 minutes, followed by washing
with distilled water. Coverslips were mounted with
polyvinyl pyrrolidone (PVP).
Immunoperoxidase staining of RMCPII
Paraformaldehyde fixed sections were first pretreated
with periodic acid and sodium borohydride to block
endogenous peroxidase activity (Heyderman & Neville, 1977)
The sections were rinsed in three 5 minute changes of
lOOmM Tris/HCl (pH 7*4) and incubated overnight in a
humid chamber with a l/50 dilution of rabbit anti-RMCPII
in Tris/HCl containing 10% ovalbumin (Sigma). After a
further three washes in Tris/HCl, sections were incubated
for 1*5 hours with sheep F(ab')2 anti-rabbit Fab
peroxidase conjugate (25pg/ml) (Miller e_t aT. , 1981a)
diluted with Tris/HCl-ovalbumin. After a further three
washes in Tris/HCl, peroxidase activity was revealed
with 3-amino-9-ethyl-carbazole (Graham, Lundholm &
Karnovsky, 1965). For control purposes a 1/50 dilution
of normal rabbit serum replaced anti-RMCPII.
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(c) Cell counting techniques
Mucosal mast cells in jejunum and ileum were counted
per villus crypt unit (VCU) as defined by Miller &
Jarrett (1971), a minimum of 15 VCU was counted for each
section.
Mast cells in tongue, MLN, lung, and thymus were not
enumerated but cell density was a subjective assessment
with(+++) substantial increase, (++) an increase in the
density of mast cells when compared with controls in
which mast cells were either present (+) or completely
absent (-)• Mast cells in trachea were counted per 1mm
length of tracheal mucosa.
Sections of ear pinnae were examined microscopically
and the total number of mast cells enumerated. The areas
of tissue in which mast cells were counted, excluding
cartilage, was measured by projecting the sections onto
equiweight paper using a photographic enlarger and then
calculating the area by weight analysis of the tissue
outline.
To compare MMC counts in jejunum,ileum, colon and
stomach the numbers of MMC/unit area was calculated.
This takes into account the smaller mucosal volume of the
ileum compared to jejunum and relates MMC numbers to
mucosal volume (Pitts & Mayrhofer, 1983). A calibrated
grid was aligned along the muscularis mucosae and the
total number of MMC counted in the grid area. The area
of mucosa was calculated with reference to the calibrated
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grid. Mast cell numbers are expressed as MMC/mm mucosa.
All cell counts were performed using a Leitz Dialux
20EB microscope.
Measurement of IqE antibody
The levels of circulating IgE against N.brasiliensis
were determined by passive cutaneous anaphylaxis (PCA)
(Ovary, 1964). The preparation of worm antigen has
already been described.
Doubling dilutions of test sera were made, and lOOpl
of each were injected intradermally into the shaved backs
of recipient rats maintained under ether anaesthesia.
Seventy-two hours later rats were injected intravenously
with 1000 we of antigen plus 2*5 mg Evan's blue/lOOg body
weight. Reciprocals of the highest dilution of serum
giving a blue spot greater than 5mm in diameter were
determined by examination of the underside of the skin
30 minutes after antigen challenge.
To determine the effects of corticosteroids on PCA,
recipient rats were injected intradermally with immune
serum (doubling dilutions) and immediately injected
with 25 mg/kg methylprednisolone (Upjohn Ltd) or saline
intramuscularly. Steroid or saline treatment was repeated




To measure the permeability of the intestinal
mucosa Evan's blue dye was used as an indicator (Nawa,
1979). Experimental animals were injected intravenously
with Evan's blue and either worm antigen or saline in a
dose of 1ml. The dose was calculated so that, in
addition to 2*5 mg Evan's blue/lOOg body weight, rats
would recei-ve 50-800 we of antigen.
At the end of each experimental time period, rats
were bled out under ether anaesthesia, their entire small
intestines removed, and divided into two equal lengths.
Each half was perfused with 10ml of saline plus 10ml of
air from a 20ml syringe. Intestinal perfusates were
centrifuged for 10 minutes at 10000 rev/min in a Beckman
J2-21 centrifuge at 4°C. The clear supernatants (SOL)
were removed and the pellets (GEL) resuspended in 5ml
of saline and homogenized in a teflon/glass homogenizer.
The concentrations of Evan's blue were measured
spectrophotometrically in both sol and gel after acetone
extraction (Nawa, 1979).
Briefly, 1ml of acetone was added to an equal volume
of sol or gel, mixed well arid centrifuged at 4000 rev/min
for 10 minutes. The optical density of the clear
supernatants was measured in a Pye-Unicam spectrophotometer
at 620nm. The amount of Evan's blue in each sample was
then calculated from an Evan's blue standard curve
prepared from solutions of Evan's blue (0-10 pg/ml)
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assayed as described above.
To determine whether the dye was transuding freely
or bound to protein, both sol and gel phases were treated
with 10% trichloroacetic acid (TCA). More than 90% of the
dye was precipitable with TCA indicating that the dye was
predominantly bound to protein.(Table 1).
Table 1 The precipitation of protein-bound Evan's blue :
its recovery from intestinal perfusates.
SOL GEL
A B A B
Immune
Control 0*2 0(0) 2*9 0(0)
Immunea
Challenge 2-9 0(0) 2*5 0*1(4)
Immuneb
Challenge 8*0 0*5(6*3) 18 0*2(1)
a 5 minutes after challenge b 60 minutes after challenge
A concentration of Evan's blue in sample (pg/ml)
B concentration after TCA precipitation (jig/ml)
values in parentheses refer to the % retained after TCA
precipitation
Note values for both sol and gel were corrected for
background interference from normal gut contents before
and after TCA precipitation.
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Scanning electron microscopy (SEM)
Six rats were infected with 5000 N.brasiliensis
L and three animals were killed on day 6 and the
remaining three on day 10 of infection. The animals were
fasted overnight before sacrifice.
Small intestines from 2 rats at each time point were
removed and divided into two equal lengths. Each half
was perfused with 50ml of saline. The perfusates were
passed over surgical gauze suspended over a 250ml beaker
and the gauzes containing mucus and possible trapped
2
worms were opened flat and 2 cm areas trimmed out from
the central portion of the gauze. These samples were
pinned flat to cork board. The intestines from the
remaining rats were opened longitudinally and small
segments, 25 cm distal to the pylorus and 1*5 cm in
length were pinned flat to cork board and debris gently
brushed from their surface.
Specimens were suspended over 10% acrolein in
screw topped jars and fixed for 1 hour at room
temperature in a well-ventilated fume cupboard (Garland
et al.. 1982). After fixation the specimens, still
attached to cork, were transferred to a solution
containing 3% paraformaldehyde-3% glutaraldehyde in PBS
for 2 hours, trimmed and then left overnight in fresh
paraformaldehyde-glutaraldehyde.
Specimens were then processed according to the
revised - tannin method of Murakami (1974). Tissues
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were first transferred to a solution containing 2%
arginine hydrochloride, 2% glycine, 2% sodium glutamate
and 2% sucrose in distilled water and left overnight at
room temperature. After washing in three 15 minute
changes of distilled water tissues were placed in 2%
tannic acid in distilled water (pH 4*0) and left for
24 hours at room temperature. After a further three
washes the samples were immersed in 2% aqueous osmium
tetroxide for 6 hours and then washed three times with
distilled water. The samples were then dehydrated
through an ascending acetone series (30%, 50% and 80%
30 minutes at each stage) followed by three 30 minute
periods in 100% acetone, after which they were left
overnight in 100% acetone. Samples were then critical
point dried from CO^ and sputter coated with l*5nm of
a gold/palladium mixture. Specimens were examined in
a JEOL electron microscope.
»
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Rat mast cell protease II (RMCPII)
Source
RMCPII was generously supplied by Dr R.G Woodbury
(University of Washington, Seattle) and was prepared
from the intestines of Sprague Dawley rats by affinity-
adsorption chromatography on potato chymotrypsin
inhibitor immobilized on Sepharose 4B (Woodbury & Neurath,
1978) . Antisera to RMCPII had previously been prepared
in rabbits within the Moredun Institute. Anti-RMCPII
antibody had a titre in Ouchterlony gels against antigen
of 32. RMCPII antigen was a lmg/ml solution in PBS and
was stored at -20°C until use.
RMCPII was also provided by Dr S Gibson (Moredun
Institute) prepared from the intestines of N.brasiliensis
infected rats by ion exchange chromatography using a
Pharmacia Fast Protein Liquid Chromatograph with Mono-S
cation exchange column (Gibson & Miller, 1986). This
preparation was, by SDS-PAGE, found to contain a single
polypeptide (Figure 1) indistinguishable both in terms
of molecular weight and reactivity with anti-RMCPII
antibody from that provided by Dr Woodbury.
Specificity of antiserum by gel diffusion
Possible cross-reaction of anti-RMCPII antibody
with RMCPI was checked both in ELISA (see later) and by
gel diffusion. One gram of agarose (BDH) was dissolved
in 100ml of PBS and 3ml was poured onto glass microscope
I II III
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Figure 1. Discontinuous SDS-PAGE gel stained with
Coomassie blue showing in lane I molecular weight standards
(12300-77000 da) and in II and III RMCPII (5pg) and RMCPI
(3pg) respectively.
Standards were cytochrome c(12.3k), myoglobin(17.2k),
chymotrypsinogen A(25.7k), ovalbumin(45k), albumin(66.25k)
and ovotransferrin(77k).
(Photograph kindly supplied by Dr S Gibson)
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slides. Six wells were punched in the agarose
concentrically around a central well using a gel puncher
arid template (LKB) . Ten microlitres of antiserum were
placed in the central well and extracts of peritoneal
mast cells (1-6 x 10^ cells) prepared in 0'15M KC1 and
1•5M KC1 (see preparation of tissues) placed in the
surrounding wells. Both purified RMCPII and jejunal
homogenate were included as positive controls.
Precipitin lines were allowed to develop overnight at
room temperature. The gel was washed extensively in
PBS, pressed and dried. The gel was then stained with
Coomassie blue as described for radialimmunodiffusion.
No precipitin lines were observed against extracts
of peritoneal mast cells even when prepared in 1•5M KC1.
By contrast, strong precipitin lines were observed
against both jejunal homogenates and standard RMCPII
preparations. (Figure 2).
Collection of samples for RMCPII assay
Serum
Rats were anaesthetized with ether and bled out
from the carotid artery. Blood was allowed to clot before
sera was separated by centrifugation. Sera was stored
at -20°C until assay.
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Figure 2. Immunodiffusion demonstrating the specificity
of the anti-RMCPII antibody. Samples were 20jil of :
A purified RMCPII (104pg RMCPIl/ml)
B jejunal homogenate (lOOpg RMCPIl/ml)
C peritoneal mast cell extract in 0*15M KC1




Perfusates were collected as described earlier*
Samples (1ml) of sol and gel were removed and stored at
-20°C•
Tissue samples
Two centimetre lengths of the following tissues
were collected: jejunum (25cm distal to the pylorus),
ileum (10cm proximal to the ileocaecal valve) and colon.
Stomach, mesenteric lymph node (MLN) and trachea were
removed and divided into two portions (one for histology).
Right lobe of lung, spleen, liver, kidney, femoral muscle
and skin were also collected. Samples were rinsed in
saline and all, except skin and muscle, were weighed and
homogenized in 3 volumes of 0*15M KC1 in a teflon/glass
homogenizer. The trachea was prepared in 6 volumes of
KC1. Muscle and skin samples were weighed, diced with
scissors and homogenized in 3 volumes of 1•5M KC1.
Samples of bone marrow were prepared as follows:
bone marrow was obtained by perfusing the femur with
saline (1ml) and the perfusate was rapidly freeze-thawed
in a mixture of dry ice/isopentane followed by warming
in a water bath to 37°C. Cell debris was removed by
centrifugalion and the supernatant stored.
To recover peritoneal cells, exsanguinated rats
i
were injected intraperitoneally with 40ml of ice-cold
saline, the peritoneal washings were aspirated and the
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cells recovered by centrifugation. They were washed
several times with Hank's balanced salt solution
containing 1% BSA and mast cells were counted from an
aliquot of cells that had been diluted 1 part to 9 parts
of Azure A (1%) in 50% propylene glycol. The remaining
cells were pelleted by centrifugation and resuspended in
approximately 3 volumes of 0*15M KC1 or 1*5M KC1 and
freeze-thawed rapidly 5-6 times before centrifugation
to remove cell debris. The concentrations of RMCPII
were analysed in the supernatant fluids.
Measurement of RMCPII
(a) Radial Immunodiffusion
This assay was suitable for the determination of
RMCPII at concentrations greater than 5pg/ml. The
concentrations of RMCPII in sera, intestinal perfusates
and tissue homogenates was measured using minor
modifications of the assay described by Woodbury &
Neurath (1978). An assay gel was prepared from 15ml of
1% agarose in PBS containing a 1/100 dilution of rabbit
anti-RMCPII antibody. Samples and standards (5-2Q0pg)
were applied to the gel and precipitin lines allowed to
develop for 48 hours at 4°C ( 24 hours at room temperature)
The gel was then pressed, dried and washed with three 15
minute changes of PBS and stained with 0*5% Coomassie
Brilliant Blue R250 in ethanol:acetic acid : water
(90 : 20 : 90). The gel was then rinsed with tap water
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and destained with ethanol ; acetic acid : water to
visualize precipitin rings. The diameters of the rings
were then measured and the concentrations of RMCPII
determined from a standard curve. For skin, peritoneal
mast cells and muscle, assay gels were set up both in
standard buffer and in 1*5M KC1 with RMCPII standards for
each buffer system.
(b) Enzyme-linked immunosorbant assay (ELISA)
Principle
1. Antigen is attached to the solid phase microtitre
wells which are then washed.
2. Samples are then mixed with antibody and the
mixture added to, and incubated in the coated wells which
are again washed.
3. Enzyme-labelled anti-globulin (reactive with
antibody used in step 2) is then added, incubated and the
solid phase washed.
4. Enzyme substrate is then added. This is a
competitive inhibition assay with high antigen concentrations
resulting in less colour development at the end of the
test.
Procedure
The assay is essentially similar to that described
by Miller ejt aT (1983) with minor modifications.
1. Plastic, 96 well microtitre plates (Dynatech Laboratories)
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were incubated overnight at 4°C with (150pl/well) RMCPII
at lpg/ml in carbonate-bicarbonate buffer, pH 9*6. The
protease solution was removed and the plates washed 5
times with PBS containing 0*5% ovalbumin and 0*05% Tween
20 (PBS-OVA-T20)•
2. In a separate microtitre plate test sample dilutions
were prepared in PBS-OVA-T20 containing 4% normal rat
serum. The dilution ranges and layout of the samples
and standards is shown in Table 2. Samples and standards
were incubated with 180pl of a 1/3000 dilution of rabbit
anti-RMCPII prepared in PBS-OVA-T20 for 1 hour at 37°C.
Duplicate samples (150pl) were then transferred to the
RMCPII coated plate and incubated in the wells for 2
hours at 37°C. The samples were then removed and the
plates washed 5 times with PBS-OVA-T20.
3. The wells were then incubated with 150pl of sheep
F(ab')2 anti rabbit Fab peroxidase conjugate (Miller et
al.. 1981a) diluted 1/1000 with PBS-OVA-T20 for 1 hour
at 37°C. The plates were then washed 5 times and blotted
dry.
4. Enzyme substrate was then added. This consists of
150pl of freshly prepared o-phenylene diamine (40mg)
dissolved in 100ml of phosphate-citrate buffer plus 40pl
of hydrogen peroxide (30% w/v). Colour development was
stopped by the addition of 50pl of 2*5M sulphuric acid.
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2 3 4 5 12
A - +ve a e e • • • 0
B - +ve b f f . . f
C - +ve c g g ... g
D +ve d h h ... h
Column 1 - blank
2 - positive control (180yil) PBS-OVA-T20 + 4%
normal rat serum (NRS)
3 - standards a 1/2000, b 1/8000, c 1/32000,
d 1/128000 dilution of RMCPII in PBS-OVA-T20-NRS
4 - samples e 1/25, f 1/100, g 1/400, h 1/1600
dilution of test sera in PBS-0VA-T20-NRS
Stage 3 :
180}il of antisera are added to all wells (except column 1)
and after incubation, 2 x 150^1 samples from row A above
are added to rows A and B on the sensitized plate. This
is repeated for row B above (to row C and D) and for rows
C end D.
NRS is added to control for the possible protease-inhibitor
complexes in the samples.
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Plates were read in a Titertek Multiscan reader at
492nm. The concentration of RMCPII ih the unknown
samples was calculated from the 50% end point optical
density changes for both unknown and standard RMCPII
samples. This calculation was performed by
microcomputer using specially designed computer software.
Assay of qlycosaminoqlyean (GAG)
The competitive binding assay as described by Dawes
& Pepper (1982) was used in which test material competes
125
with I-labelled heparin for binding to protamine-
Sepharose. In the current assay system polybrene-
Sepharose replaced protamine-Sepharose and tracer and
standard were heparan sulphate rather than heparin. GAG
was analysed in gut homogenates and perfusates, prepared
as described earlier, and in plasma.
Plasma collection
Glass tubes, marked at the 3ml level, and containing
03ml of the platelet release inhibitor solution (ETP)
which consists of 78mM EDTA, lOmM theophylline, and 0*33pg/
ml prostaglandin E1 were used. The tubes were immersed
in an ice-water mixture so that all the tube below the
3*0ml mark was cooled. Rats were anaesthetized with ether
and the carotid artery sectioned. Blood was immediately
aspirated using a 5ml syringe and transferred to the
cooled sample tube. Following collection the tube was
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capped and pushed further down into the ice mixture.
Samples were maintained at 0°C until separation which
must be within 3 hours of collection. Samples were
centrifuged at 4°C after which the plasma was collected.
Aliquots of 0*7ml of plasma were removed from the
middle one-third of the plasma layer and dispensed into
l*5ml plastic sample tubes. Samples were stored at -20°C.
Assay proceedure
The assay mixture contained 50pl of polybrene-
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Sepharose suspension, 50pl of I-heparan sulphate, 50y.l
of heparan sulphate standard or sample and phosphate
buffer pH 7*7 containing Tween 20 (1%) to a final volume
of 300pl. The concentration of polybrene-Sepharose
which bound 50% of the tracer in the absence of unlabelled
heparan sulphate was used, which was normally a l/25 to
l/50 dilution of the solid phase. Standard heparan
sulphate was serially diluted to 2ng/ml.
Assay tubes were shaken for 16 hours at room
temperature after which the polybrene-Sepharose was washed
twice with assay buffer, the solid phase was then counted
in a gamma counter. The concentration of GAG in the
sample was determined by reference to the standard curve.
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The less I-heparan sulphate bound, the greater the




To compare the means of two samples a Student's t-
test was used. A two tailed alternative was used as no
prior knowledge of experimental outcome was known. The
assumptions made in the test were that the data were
normally distributed and that the true variances of the
two populations to be compared were the same.
Student's t with n^+ n^ - 2 degrees of freedom is
given by
2 _ 2 _ 2
where s = E^(x- x^) + E^x- x^)
nl + n2 - 2
Data were considered significant if the t value was equal
to or exceeded the tabulated value at 5% (P<0*05).
2. Standard error of the mean (SEM)
The standard error of the mean is the error in the
estimation of the mean and is
SEM =s standard deviation
■F
95
3. Fisher exact probability test (Chapter 3)
This test is an extremely useful non-parametric
technique for analysing data when two independent samples
are small in size. It is used when the scores from two
samples all fall into one or the other of two mutually
exclusive classes. The scores are represented by
frequencies in a 2X2 contingency table and for Chapter
3 this was s
Trapping +ve Trapping -ve
Control A B A+B
Infected C D C+D
Total A+C B+D N
A,B, C, and D stand for frequencies and the test
determines whether control and infected differ
significantly in the proportion of pluses and minuses
attributed to them.
(A+B)1 (C+D)I (A+C)i (B+D)1
P = ■
Ni A] Bi Cl Dl
The value yielded will be for a one tailed test, and the
P value calculated is doubled for a two-tailed test.
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4. Mann-Whitney U-test
The U-test may be used to test whether two independent
groups have been drawn from the same population. The U
test is a most useful non-parametric alternative to the
t-test in that it avoids the t-test's assumptions and it
is relatively quick and easy to apply. The null hypothesis
is that population A and B have the same distribution
against the alternative that A is larger than B, or B
larger than A.
Let n^ = the number of observations in A and n2
the number in B. To apply the test, we combine the scores
from both groups and rank these in order of increasing
size. Ties are given the average of the ranks they
would have had if no ties had occurred.
Then U = nin2 + nl^ni +
-
2
or equivalently substituting n^ into this formula and
replacing R^ with R^.
Where R^ and R^ are the sum of the ranks assigned to
groups n^ and n^ respectively.
These two formulas yield different U values eund it is the
t t
smaller required. The larger = U and U=n^n^ - U
Significance of U was obtained by reference to tables.
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5. Regression analysis
This statistical operation was carried out using a
Tektronix microcomputer. The input data (x,y) is fitted
to eight regression equations and the equation which
2
has maximum r value indicated.
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CHAPTER 3 A role for mucus in the expulsion of a primary
N.brasiliensis infection in the rat.
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Introduction
The mechanism of expulsion of intestinal nematodes
is thought to involve the collaboration of immunologically
specific and non-specific components (Ogilvie & Love, 1974
Wakelin, 1978; Miller, 1984) and it has been suggested
that goblet cell hyperplasia and mucus release are part
of the non-specific component of worm expulsion (Miller &
Nawa, 1979a; Askenase, 1980; Uber ert al.. 1980; Levy &
Frondoza, 1983).
Increased mucus secretion could make the environment
unsuitable for parasite establishment by excluding them
from the mucosa (Miller et al., 1981b) or providing a
slippery surface to which damaged parasites cannot
cling (Askenase, 1980). Alternatively, mucus may
physically trap the parasite as observed in the rapid
expulsion of T.spiralis (Lee & Ogilvie, 1981; Bell ejt al
1984) and N.brasiliensis (Miller et ad.,1981b; Miller &
Huntley, 1982a).
The present study was undertaken to determine if
immune exclusion and mucus trapping occurred during the
expulsion of a primary infection with N.brasiliensis.
The results show that a small, but significant, number
of parasites are trapped in mucus at the time of




Eighty-five female rats infected with 5000
N.brasiliensis larvae were used. Groups of 8-10 rats
were killed daily and the numbers and distribution of
worms counted in the small intestine. The worm burdens
are presented in Table 1.
Reduction in total worm burden occurred on day 11
(P< 0*001 vs day 7) when significant losses of lumen-
dwelling parasites (P< 0*05) and of those adherent to the
gut mucosa (P< 0*001) occurred. There was also a reduction
in lumen-dwelling worms on days 9 and 10 (P<0*05 vs day
7). Thirteen days after infection the few remaining
worms within the intestine were predominantly adherent
(Table 1).
Small numbers of worms were trapped in mucus 7-12
days after infection (0*03-1*22%), trapping was maximal
on day 11. Such worms were enveloped in mucus and,
using a dissecting needle, could not be liberated from
the mucus gel. No trapping occurred on days 4, 6 or 13
(Table 2).
Experiment B.
Forty-two female rats were used and groups of 14
were infected with 1000, 3000 or 6000 N.brasiliensis L^.
Six, ten and thirteen days after infection, 5 rats from
each group (4 from those given 6000 L3) were killed and
101
Table 1 Worm distribution following an infection of 5000
N.brasiliensis 1^ s the number of worms free in the lumen
and attached to the gut mucosa.
Daya Free Adherent TWB^5
4 334*0 + 117 351*4 + 106 685*4 ± 211
6 600*3 ± 44 598*4 + 42 1198*7 + 47
7 828*7 + 154 597*6 ± 61 1427*8 + 212
8 812*2 + 171 604*3 + 34 1416*9 + 194
9 448*6 + 86+ 497*4 ± 79 946*5 + 137
10 406*1 + 61+ 516*6 ± 53 924*3 ± 106
11 224*0 ± 49++ 197*2 + 52+++ 426*4 + 100+++
12 140*2 ± 29+++ 194*1 + 39+++ 334*7 ± 62+++
13 18*1 ± 5+++ 31*0 ± 11+++ 49*1 + 16+++
a day after infection
b Total worm burden, including those trapped (see Table 2)
+ P^0*05, ++ P <0*005, +++ P <0*001 when compared with
day 7 (Student's t-test)
all data presented as mean + SEM
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Table 2 The number of worms trapped in mucus recovered by
intestinal perfusion of rats infected with 5000 Nippostrongylus
larvae.
Daya Trapped (mean i SEM)
4 0
6 0
7 1*5 ± 0•3+++
8 0*4 ± 0*2
9 0*5 ± 0*3
10 1*6 ± 0»6+
11 5*2 ± 1•2++
12 0*4 + 0*2
13 0




when compared with day 6 (Fishers exact probability test)
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the numbers of worms adherent to the mucosa, free in the
gut lumen and trapped in mucus determined (Table 3).
Six days after infection the majority of worms were
adherent (72%) in rats infected with 1000 and with
3000 (60%). The converse was true for rats infected
with 6000 where 60% were free in the lumen (Table 3).
Ten days after infection worm distribution was unaltered
in recipients of 3000 whereas rats given 1000 had
an increased proportion of worms free in the gut lumen
(44%). Worms were distributed equally (50% free, 50%
adherent) 10 days after infection with 6000
Significant worm expulsion had occurred in rats that had
been infected with the smallest challenge dose, the worm
burden decreasing by half on day 10 (Table 3), this being
accounted for by a reduction in the number of worms
adherent to the gut mucosa. Rats infected with 6000
lost proportionately more worms from the gut lumen (40%
decrease) than from the mucosa.
Thirteen days after infection expulsion was almost
complete, there being a small residual worm burden in one
rat from each group (Table 3). Trapping of worms in mucus
was observed only on the tenth day of infection (Table 3),
the numbers of parasites trapped in mucus recovered from
rats infected with 3000 being significantly greater
than those from either rats given 1000 (P< 0*001) or
6000 L0 (P^0*05). Between 1 and 2% of worms were
trapped in mucus which is consistent with Experiment A
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Table 3 The effect of different levels of infection on
worm distribution and mucus trapping.
a D
Day Free Adherent Trapped TWB
6 122 + 24 314 +29 0 436 ± 47
A 10 101 ± 11 127 + 18++ 2 + 0•3++a 230 + 27+
13 0 0*2 ± 0*2 0 0*2 ± 0*2
6 369 ± 41 571 + 78 0 940 + 108
10 295 + 45 461 + 40 16 + 2•4++a 772 ± 77
13 2 + 2 26 + 26 0 28 + 28
6 739 + 89 517 ± 57 0 1256 ± 82
10 450 + 83 463 + 63 9 + 0•8+a 922 + 123
13 0 3 + 3 0 3 + 3
a day after infection with either (A) 1000 1^ (B) 3000 1^
or (C) 6000 13
b Total worm burden (TWB) all data presented as mean - SEM
+ P <0*005 ++ P< 0*001 when compared with day 6 (Student's
t-test)
+a P=0*028 ++a P=0*0078 when compared with day 6 or 13
(Fisher's exact probability test)
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(Tables 253).
Worms were enveloped in clear viscous globules of
mucus, occasionally in clumps of 4-5, but mainly as ones
and twos. Trapping in clumps was most obvious in rats
infected with 3000 L^.
Scanning Electron Microscopy (SEM).
The data from the previous two experiments suggested
that the properties of mucus during parasite expulsion
differed from its properties on day 6. Therefore samples
of jejunum and mucus (gauze contents) collected on days
6 and 10 were fixed in acrolein vapour and processed for
examination by SEM.
The disposition of mucus is shown in Figures 1-6.
On day 6 there is little or no mucus present either on
the mucosal surface or around the worms (Figures 1 & 2)
whereas on day 10 worms are embedded in a thick blanket
of mucus, which, in many instances enveloped the worms
(Figures 3-6). These findings were consistent in each
of the 3 rats examined at each time point.
Figure 1. Jejunum day
or attachment of mucus
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6 (x75) note little contact
to parasites.
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Figure 2. Jejunum day 6 (x75) little mucus present,





Jejunum day 10 (x300) attachment of mucus to
envelopment of some areas of the parasite in
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Figure 4. Jejunum day 10 (xl50) parasite embedded in
mucus. Note greater amount of mucus present compared
with day 6.
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Figure 5. Gauze day 10 (x225) parasite embedded in a
thick blanket of mucus.
Ill
Figure 6. Gauze day 10 (x525) mucus covering a worm which
can just be seen (bottom left).
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Discussion
In this study the role of mucus in the expulsion of
N.brasiliensis from the rat was examined and the results
show that (a) small, but significant numbers of worms
were trapped in mucus on days 10 and 11 of infection (b)
none was trapped on days 6 and 13 and (c) a preliminary
examination of the intestines of infected rats by SEM
revealed a thick blanket of mucus enveloping worms on
day 10 but not on day 6 of infection.
To quantitate the numbers of worms trapped in mucus
at each stage of infection the intestinal perfusion
technique originally described by Miller ert ad. (1981b)
was used. Trapping was maximal on days 10 and 11 (1-2%)
but also occurred on day 7 (0*1%). Additional preliminary
evidence that mucus trapping does occur during primary
infection was obtained by using SEM. Whereas on day 6
very little mucus was evident, by day 10 the parasites
were embedded in a thick blanket of mucus (Figures 1-6).
Furthermore, SEM of the contents retained in the gauze
from perfusates on day 10 also revealed worms to be
enveloped in mucus.
Mucus trapping occurs during the rapid expulsion (RE)
of T. spiralis (Lee & Ogilvie, 1981; Bell «?t al., 1984)
and N.brasiliensis (Miller et al., 1981b; Miller &
Huntley, 1982a) from primed rats. Comparison of the
present data with that of Miller et al (1981b) shows that
although the percentage of total worm burden trapped in
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mucus during primary infection (1-2%) is considerably
less than during RE (3-22%), in terms of actual numbers
of worms trapped (1-24) on day 10 of primary infection,
they are similar to the numbers trapped 30 and 60 minutes
after challenge of immune rats (9 and 19 respectively)
(Miller et _al. , 1981b) .
A very conspicuous event in RE is the exclusion of
the parasite from the intestinal mucosa (Russell & Castro,
1979; Miller et al. , 1981b). However in the present
experiments exclusion was not observed, in that at no
stage of primary infection was there a significantly
greater number of worms free in the intestinal lumen.
Could mucus trapping during primary infection
account for the loss of up to 900 worms over a 72 hour
period? It is important to note that although small
numbers of parasites were trapped at each time point
examined, no information can be gained as to the number
of worms trapped over a 24 hour period (ie. the rate of
trapping and loss) between sampling. For example if up
to 16 worms are trapped and expelled per hour then mucus
trapping could be of great significance, as the loss of
only 10 worms per hour is required to expel the worm
burden over a 72- hour period.
It must be questioned whether the perfusion technique
employed was adequate for the quantitative recovery of all
the worms trapped in mucus. Although only a preliminary
study, SEM clearly demonstrated that worms were embedded
114
in mucus which covered the intestinal villi on day 10, it
is not yet known if this mucus is dislodged by perfusion.
Furthermore, experimental animals were routinely fasted
overnight and the effect of this on the trapping of worms
is uncertain as it would have probably affected the
feeding pattern of the parasites which are known to move
into food boluses of fed rats (Croll, 1976).
The absence on day 6, and presence on day 10 of
trapped worms may reflect differences in the solubility
of mucus at these two stages of infection. The solubility
of mucus is strongly influenced by the interactions of
mucin glycoproteins with other luminal constituents.
For example, the viscosity of mucus increases dramatically
after incubation _in vitro with albumin (Forstner, 1978).
Mucosal inflammation could cause mucus to transform
into a more viscous gel.
Infection with N.brasiliensis is associated with an
increased synthesis and turnover of mucin (Miller et_ aT.,
1981a) and goblet cell hyperplasia (Miller & Nawa, 1979a;
Uber ejt aT. , 1980) both of which are temporally related
to worm expulsion. Alterations in the histochemical
properties of goblet cell mucin have been observed
during Nippostrongylus-infection; the mucin staining with
Alcian blue in normal rats and later a proportion (20-30
%) of goblet cells were PAS positive suggesting that
they contained neutral mucin (Miller & Nawa, 1979b).
Since the sialic acids and sulphate groups which confer
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acidic properties to mucins are terminal on carbohydrate
side chains, accelerated goblet cell differentiation may
be accompanied by an incomplete synthesis of mucin
glycoproteins. Secretion of mucin at an earlier stage
of its synthesis could confer considerable differences
both in the solubility of the mucus gel and its
interaction with other components.
In Experiment A, although there were significant
(P^0*05) reductions in the numbers of worms free in the
gut lumen on days 9 and 10 when compared with day 7, a
significant reduction in total worm burden was not
demonstrated until day 11 (P <0*001 vs day 7). The total
worm burden on day 11 was significantly reduced when
compared with day 10 (P< 0*005) this being due to a
reduction in adherent parasites (P^O'OOl). It was over
this time period when mucus trapping was maximal, but
whether trapping could promote the expulsion of
approximately 20 parasites per hour cannot be established
from this data. However, gut motility is increased
during parasitism (Castro, Hessel &i Whalen, 1979; Farmer,
1981) and trapped worms could be rapidly lost from the
intestine. Major worm loss occurred from those adherent
to the mucosa where parasites will first experience
"changes" in mucus.
In conclusion, the data clearly shows that mucus
trapping does occur during the expulsion of N.brasiliensis
Trapping was maximal on days 10 and 11 coincident with
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major reductions in worm burden. The numbers of worms
trapped in mucus were low and without data on the
kinetics of trapping over a 24 hour period definite
conclusions cannot be made. However, if as many as 10
parasites are trapped and expelled per hour trapping
could be of considerable functional significance.
117
CHAPTER 4 N.brasiliensis primary infection : mucosal




Mucosal mastocytosis within the intestinal lamina
propria is a prominent feature following infestation of
laboratory animals with parasitic nematodes (Askenase,
1980; Miller, 1980; Miller, 1984). However the temporal
relationships between the onset of mastocytosis and worm
expulsion has raised doubts as to the involvement of MMC
in the rejection mechanism. For example, mastocytosis
and expulsion are related in T.spiralis infection
(Alizadeh & Wakelin, 1982) whereas mast cell hyperplasia
may occur either during (Murray e_t ad., 1971a) or after
the expulsion of N.brasiliensis (Keller, 1971; Kelly &
Ogilvie, 1972). However,by measuring the concentrations
of RMCPII, a MMC specific proteinase, Woodbury et ad
(1984) were able to demonstrate the secretion of this
enzyme into blood during the expulsion of T.spiralis
and N.brasiliensis. even when MMC were absent or in very
low numbers. This raises the possibility that (a) there
is differential release of protease during infection or
(b) release is from MMC that are not demonstrable by
conventional staining regimes.
The present study was designed to investigate these
two possibilities and shows that there is no evidence to
suggest differential release or secretion by "hidden"
MMC which are undetected by staining for glycosaminoglycan.
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Experiments and Results
Groups of 14 rats were infected with 1000, 3000 or
6000 N.brasiliensis larvae and 5 from each group (4 from
those given 6000 L^) were bled out 6, 10 and 13 days
after infection. An additional group of 5 naive rats was
killed for control purposes.
In rats infected with 1000 or 6000 L„ the immune
3
response, as monitored by faecal egg counts, began on day
9, counts falling to zero 12 days after infection. Egg
counts did not fall until 10 days after infection with
3000 although there were few eggs present on day 12.
This is consistent with the majority of worms being
expelled between 10 and 13 days after infection.
The intestinal worm burden was significantly
(P<0*005) reduced 10 days after infection with 1000
when compared with that on day 6; the worm counts in rats
given the higher doses of larvae were unchanged over this
time period (Table 1). Expulsion was all but complete on
day 13, there being a small residual worm burden in one
rat from each group.
Table 1 Worm burdens (mean t SEM) six, ten and thirteen
days after infection of rats with 1000, 3000 or 6000 L„.3
Day 1000 L„ 3000 L0 6000 L„3 3 3
6 436 t 47 940 ± 108 1256 + 82
10 230 t 27a 772 + 77 922 + 123
13 0*2 t 0*2 28 ± 28 3 1 3
a P<0»005 when compared with day 6 (Student's t-test)
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The concentration of RMCPII in jejunum.
Six days after infection, concentrations of RMCPII
in jejunal homogenates had significantly (P<0*001)
fallen when compared with control values (Table 2). There
was, in addition, significantly less RMCPII in homogenates
prepared from the jejunum of rats infected with 3000 or
6000 than from rats given 1000 (P<0*05, Table 2).
Ten days after infection the levels of RMCPII in
jejunal homogenates were unchanged (Table 2) whereas on
day 13 the concentrations of enzyme had increased
significantly (P< 0*001) when compared with control, day
6, or day 10 values (Table 2).
Systemic levels of RMCPII (Figure 1).
To monitor the appearance of RMCPII in the sera of
infected rats, 5 animals from each group were bled via
the tail vein on day 4 and daily thereafter (except day
12), 4-5 rats were exsanguinated on day 6, 10 and 13.
RMCPII was not detected in the sera of uninfected
control rats. Trace amounts of protease were present
in the sera of rats infected with 1000 L„ 4 and 5 days
S>
after challenge after which on day 6, there was a
highly significant increase in the circulating
concentration of RMCPII (P< 0*005 vs day 5). The levels
of RMCPII rose steadily to reach a peak on day 13
(P^ 0*05 vs day 6) when there was 1043 ng RMCPIl/ml
serum.
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Table 2 The concentration of RMCPII in the jejunum of rats
infected with N.brasiliensis : the effect of different
doses of larvae.
yg RMCPIl/g wet wt tissuea
Day 1000 3000 6000
0 390 ± 13 390 + 13 390 + 13
6 232 ± 20+++a 182 + 3+++a 180 + 0+++a
10 208 ± 13+++a 182 + 3+++a 165 ± 9+++a
13 1327 ± 186+++b 1392 ± 2+++b 1584 ± 181+++b
a the concentration of RMCPII (mean ± SEM) in homogenates
of jejunum prepared from rats infected with 1000, 3000
or 6000 N.brasiliensis l^*
+++a P< 0*001 significant depletion when compared with
controls (day 0)
+++b P < O'OOl significant increase when compared with
controls or day 6 or 10
On day 6 the concentration of RMCPII (1000 1^) was greater
(P<(0*05) than that from 3000 1^ or 6000 1^ infected rats.
On day 10 the mucosal concentration of RMCPII in rats given














































Figure 1. The profiles of release of RMCPII into the
serum of rats infected with 1000 (top), 3000
(centre) or 6000 (bottom). The levels of RMCPII (#)
ng/ml of serum (mean + SEM). Eggs per gram (EPG) faeces
also shown as (<C>) •
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Following infection of rats with 3000 L , trace
amounts of protease were present on day 5, none was
present on day 4. In rats that had been infected for 7
days there was significantly (P< 0*025) more RMCPII
present in the sera when compared with day 5. The levels
of protease reached a peak on day 8 (645 ng/ml) and
remained high on day 9 after which they declined. The
concentration on day 8 was significantly (P<( 0*001)
greater than on day 7 or 13.
A similar response was recorded in rats infected
with 6000 L^, there being 800 ng RMCPIl/ml serum on
day 9 (P<0*001 vs day 6) the concentration remaining
high (625 ng/ml) 13 days after infection.
Comparison of MMC staining methods.
MMC were enumerated both within epithelium and
lamina propria after stainin^with Toluidine blue,
naphthol AS-D chloroacetate (NADC), or with anti-
RMCPII immunoperoxidase, the cell counts are shown in
Table 3. Comparison by regression analysis of the
number of MMC detected by each staining method showed a
highly significant correlation between methods whether
cells were demonstrated by their content of GAG or RMCPII
(Table 4, total cell counts). Furthermore, the
relationship between mast cells (immunoperoxidase, total)
and the mucosal concentration of RMCPII was highly
sighlfdsjaht(y = -163 + 42x, r=0*88, P< 0*001).
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Table 3 The number of MMC in the jejunum of rats detected
by staining for esterase, glycosaminoglycan or RMCPII.
MMC/VCU(mean ± SEM)
Day Esterase Toluidine blue RMCPII
6 6*6 + 0*6 6*2 + 0*4 5*3 + 0-3
A) 10 14 • 7 + 0-9 14 • 2 + 0*6 14*5 + 1*0
13 33*2 + 0*5 33 • 2 + 1*5 33*1 + 0*6
6 5 • 3 ± 0*3 4-5 + 0 • 2+ 5*9 + 0*4
B) 10 9*8 + 0*3 10'0 + 0*4 10 • 4 + 0 • 2
13 33 • 8 + 2*2 36 • 6 + 2*0 34*3 + 2 • 2
6 5*3 + 0*6 5*3 + 0*5 5*6 + 0*4
c) 10 18*5 ± 1*0 16 • 7 + 1*2 17*2 ± 0*8
13 38 *0 +f 2 • 4 37 • 4 + 2 • 8 37 • 9 + 2*4




+ significantly less when compared with esterase (P-C 0*05)
or RMCPII (P<0*01) (Student's t-test)
N.D not done
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Further analysis of the data showed that on day 6 of
infection there was no correlation between cell counts
when NADC and immunoperoxidase or Toluidine blue and
immunoperoxidase methods were compared (Fig. 2). The
relationship between counts of NADC and Toluidine blue
positive cells was however significant (P<0*05). The
mean cell counts (total) on day 6 did not differ
significantly and the poor correlation may reflect a lack
in data "spread" as mast cell counts were predominantly
between 5 and 6 per VCU. Both on day 10 and 13 regression
analysis showed cell counts to be significantly correlated
when staining methods were compared (Fig. 2, Table 3).
Table 4 The relationships between total cell counts on
esterase, Toluidine blue and immunoperoxidase stained
sections.
Data Equation of Best Fit r P
E vs Tb y = l*02x + -0*5 0*98 0*001
Ea vs RC y = 0*99x + -0*003 0*99 0*001
Tb vs RC y = 0*94x + 0*96 0*98 0*001
RC vs Rd y = 42x + -163 O 00 oo 0*001




Figure 2. The relationships on day 6, 10 and 13 between
MMC counts performed on NADC-esterase, Toluidine blue
and immunoperoxidase stained sections.
Symbols for rats infected with 1000L3 (O)» 3000L3 (□ )
and 6000L3 ( ) .
(a) Esterase vs Toluidine blue,
day 6 (y = 0*5x + 2*4, r=0*58)
day 10 (y = 0*65x + 4*3, r=0*87)
day 13 (y = 0*75x + 9*3, r=0*69)
(b) Esterase vs Immunoperoxidase.
day 6 (y = -0*19x + 6*7, r=0*29)
day 10 (y = 0*67x + 4*3, r=0»87)
day 13 (y = 0*89x + 3*9, r=0*90)
(c) Toluidine blue vs Immunoperoxidase.
day 6 (y = -0*36 + 7*5, r=0*47)
day 10 (y = 0*92x + 1*4, r=0*93)
day 13 (y = 0*62x + 12*6, r=0*68)
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Kinetics of MMC following infection*
Six days after infection, the numbers of MMC were
significantly reduced when compared with counts in
uninfected controls (Table 3). This change was apparent
whether cells were demonstrated by their content of
RMCPII (esterase) or GAG,-and although there was no
further depletion of MMC at the two highest levels of
infection after staining for esterase, there was a
significantly greater reduction (P<^0*05) in the number
of MMC demonstrated with Toluidine blue when doses of
3000 and 1000 were compared.
Ten days after infection there was a highly
significant increase in the number of MMC when compared
with day 6, and in animals given 1000 or 6000 L„ the
CP
numbers were greater than in uninfected controls. In
rats that had been infected with 3000 L^, mast cell
changes were less pronounced and although the numbers
were increased on day 10 when compared with day 6, they
had not exceeded the numbers in uninfected controls
(Table 3).
On day 13 the numbers of MMC had increased to be
significantly (P<C 0*001) greater than on day 6 or 10,
but there was no difference between groups infected
with different doses of larvae (Table 3).
Morphology of mast cells during infection.
MMC in normal rats contained numerous small granules
129
which stained an intense red colour with NADC. Six
days after infection MMC were sparse and some villi were
devoid of MMC, those present had poor granule definition.
The cells on day 10 were predominantly immature having
large nuclei and abundant cytoplasm containing few
granules which stained strongly with each of the
techniques used. Occasionally fully mature cells were
present. By day 13, mast cells were mainly mature
containing many closely packed granules.
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Discussion
The histochemical demonstration of rat mucosal mast
cells (MMC) is primarily based upon the staining of mast
cell glycosaminoglycan (GAG) with basic dyes such as
Alcian blue or Toluidine blue (Enerback, 1981). However,
MMC also contain a granule-associated serine proteinase :
rat mast cell protease II (RMCPII) which cam be
demonstrated within MMC by immunocytochemistry (Woodbury
et al., 1978b; Woodbury & Miller, 1982) or by its activity
on synthetic esterase substrates (Newlands et aT., 1984).
In the present study, these three methods have been
compared to determine if there is selective release of
mast cell granule constituents during Nippostrongylus-
infection.
Comparable numbers of MMC were detected after
staining for GAG, esterase or RMCPII. This is in
agreement with previous results (Newlands jet al., 1984)
and occurred on days 6, 10 and 13 of N.brasiliensis
infection (Table 3), indicating no selective loss or
gain of granule constituents.
The mast cell responses were similar, irrespective
of infective dose on days 6 and 13, but on day 10 there
was a significantly greater number of MMC in the
jejunum of rats given 6000 L compared to 1000 L„
(P< 0*025) or 3000 (P<C.0*OO5) indicating that the
higher doses of larvae may have provided greater antigenic
stimulus for the sensitization of T-cells.
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A previous study in which N1MC, detected by their
content of GAG or RMCPII were quantitated (Woodbury &
Miller, 1982) demonstrated a close agreement between the
two methods on day 7 of infection, but on day 12
approximately twice as many cells were detected by their
content of GAG than by staining of RMCPII with
immunoperoxidase. The latter observation is not consistent
with the present results (Table 3). The major difference
in experimental protocol between the present study and
that of Woodbury & Miller (1982) is in tissue fixation.
Woodbury & Miller (1982) employed Carnoy's fixation,
whereas in this study tissues were fixed in four percent
paraformaldehyde which optimizes staining with basic
dyes, NADC and immunoperoxidase (Newlands et_ al» , 1984).
Woodbury & Miller (1982) were unable to detect intra¬
epithelial mast cells even though they contained GAG and
these authors suggested that Carnoy fixation reduces the
sensitivity of the immunoperoxidase technique.
Consequently intraepithelial mast cells which are partially
depleted of protease and other granule constituents are
not detected (Miller & Walshaw, 1972} Huntley ejt al. , 1984).
The numbers of MMC were, in agreement, with previous
results (Woodbury & Miller, 1982; Woodbury et aT., 1984),
low on days 6-10 even when significant enzyme was
detected in the sera (Figure 1). Nevertheless, the numbers
of MMC increased 2-3 fold from day 6 to 10 although the
concentration of RMCPII in the jejunal mucosa remained
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low on day 10, even in groups of rats where MMC
counts were increased. This, as well as the raised
systemic levels of RMCPII, support the view that MMC may
be secreting rather than storing enzyme (Woodbury & Miller,
1982; Woodbury et al.,1984) and the fact that MMC were
predominantly immature and few in number at the time of
maximal enzyme release indicates that they may be more
functionally active than the fully granulated cell. The
concentration of RMCPII and numbers of MMC in the jejunum
increased soon after the completion of parasite expulsion.
In conclusion, the results of this study confirm
previous observations on the relationship between RMCPII
secretion and the onset of worm expulsion (Woodbury et
al. , 1984). However in these studies (Woodbury e_t al. ,
1984) RMCPII was detected in the sera of infected rats
when the numbers of MMC (detected by Alcian blue) were
very low. The enzyme could, therefore, have been
released from MMC which wene undetectable by conventional
techniques. The present investigation examined this
possibility by staining for GAG, RMCPII and esterase and
comparing cell counts. The results have shown that even
early in infection when RMCPII is detectable in the sera
there are few MMC regardless of the technique used
to demonstrate them. The role of MMC in parasite
expulsion will, thus, need to be reevaluated in the
light of these findings.
133
CHAPTER 5 Anaphylactic release of RMCPII and its




It has long been thought that an immediate
hypersensitivity reaction may play some part in the
expulsion of gastrointestinal helminths (rev. Murray,
1972). The role for local anaphylaxis was emphasised
by the studies of Urquhart et aT (1965) who suggested
that anaphylaxis could affect worm expulsion either
by changes in the environment of the parasite or by
potentiating the translocation of parasite-damaging
antibody into the gut lumen as a result of increased
mucosal permeability. Increased mucosal permeability
was subsequently demonstrated in Nippostronqylus-
infection (Murray e_t al. , 1971a; Nawa, 1979) .
The causes of increased mucosal permeability may
be the presence of worms themselves (Nawa, 1979), the
severe inflammatory reaction in response to infection
or the increase in both number and functional activity
of MMC•
The studies in Chapter 4 show that MMC are secreting
RMCPII in response to N.brasiliensis infection even when
MMC are very few in number. The systemic levels reached
a peal: 9-10 days after infection when mucosal permeability
is maximal (Nawa, 1979).
The experiments described in this chapter were
undertaken to analyse the relationship between RMCPII
secretion and gut permeability during systemic
anaphylaxis. The results show that RMCPII secretion
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is directly related to permeability changes in the gut
and indicate that it could, therefore, play some role




Time course of RMCPII release and mucosal permeability
Twenty-five immune and 10 naive rats were used in
this experiment. Twenty immune and five naive rats were
injected intravenously with 500 we of worm antigen plus
Evan's blue. The remaining ten rats were injected with
Evan's blue in saline. Challenge control rats and immune
and naive rats treated with saline were killed 30 minutes
after injection. Immune recipients of antigen were
killed 5, 15, 30, and 60 minutes after injection of
antigen and Evan's blue.
No RMCPII was detected in the sera of saline-treated
immune rats or of naive rats given saline or- antigen
(Table 1). Immune rats injected with antigen responded
by the secretion into the sera of substantial amounts of
RMCPII (Table 1). Regression analysis of these data
(Fig. 1) shows a highly significant correlation between
time after challenge and RMCPII levels in the sera of
immune rats (y = 41 + llx, r=0*87, P<^ 0*001). RMCPII
was detected in the sol and gel phases of intestinal
perfusates from immune rats injected with antigen (Fig.2).
None was present in the sol or gel phases of perfusates
from immune or naive recipients of saline or naive rats
given antigen (Table 2). Although the concentrations of
RMCPII in the perfusates of immune-challenged rats was
not time-dependent it was related both to Evan's blue
accumulation in the intestine and serum levels of RMCPII
(Table 3).
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Table 1 The systemic secretion of RMCPII in primed rats
challenged intravenously with worm antigen.
oupa Challenge'3 TimeC jig RMCPIl/ml
1 Saline 30 0
2 500 we 5 121 + 27
3 500 we 15 190 + 43
4 500 we 30 351 + 95
5 500 we 60 630 + 132
6 500 we 30 0
7 Saline 30 0
a Groups 1-5 immune, 6&7 naive
b rats were challenged intravenously with 500 we of worm
antigen or saline,
c Time after challenge (minutes)
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Figure 1. The levels of RMCPII in the sera of primed
rats plotted against time after challenge with 500 we
of antigen. The mean value for immune rats given
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Figure 2. The partitioning of RMCPII (mean 1 SEM)
between sol and gel phases of intestinal perfusates.
Sol phase (0)» 9el phase (#) and total RMCPII (■)•
Immune control at 30 minutes
The total amount of RMCPII (pg) in the sol (O) was calculated
by multiplying the concentration of RMCPII in the sol (pg/ml)
by the volume of sol. The total amount of RMCPII (pg) in the
gel (#) was calculated by multiplying the concentration of
RMCPII in the gel (pg/ml) by the volume of rehomogenized gel.
The total amount of RMCPII (■) represents the sum of sol and
gel.
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Table 2 The partitioning of RMCPII between sol and gel
phases of intestinal perfusates following intravenous
challenge with worm antigen.










801 + 242 176 + 83 977 ± 322
879 ± 236 156 + 47 1035 ± 276
1020 ± 253 139 ± 52 1159 + 303
1085 + 248 310 + 75 1395 + 315
0 0 0
0 0 0
Distribution (%) 83+2 17+2
of RMCPII
a group status and treatment as described in Table 1
b time after challenge (minutes)
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Table 3 Analysis of the relationships between time,
systemic and enteric secretion of RMCPII, and enteric
accumulation of Evan's blue.
Data Equation of best fit r P
T vs Ra y = 929 + 7-7x 0-25 NS
Rb vs Ra y = -1425 + 4751ogx 0*73 (P <0-001)
Ra vs EBC y = -451 + 881ogx 0-72 (P<0-001)
Ra RMCPII recovered from sol and gel of perfusate (pg)
Rb RMCPII in serum (pg/ml)
EBC Total Evan's blue from sol and gel of perfusate (pg)
T Time after challenge (minutes)
NS Not Significant
Immune rats given saline had significantly less
Evan's blue intraluminally (34 pg/perfusate) than their
challenged counterparts (186 pg/perfusate) at 30 minutes
(P<^0*001, Fig. 3). Five minutes after intravenous
injection of antigen the levels of Evan's blue in the
intestines of primed rats increased two-fold (Table 4,
Fig. 4). Perfusates from naive rats given saline
contained significantly less (P^0-001) Evan's blue
(24pg) than those from naive recipients of worm antigen
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Figure 3. The levels of Evan's blue in the gut lumen
plotted against time after challenge with 500 we.
Mean i SEM for immune control shown at 30 minutes as (O) •
The amount (jug) of Evan's blue represents the total from both
sol and gel phases of each perfusate (see pp 144 for details).
143
Table 4 The distribution of Evan's blue between sol and
gel phases of intestinal perfusates.
Group jag Evan's blue (mean + SEM)
SOL GEL TOTAL
1 11 + 5 23 + 1 34 + 6
2 65 + 11 21 + 2 86 ± 12
3 99 + 14 29 + 6 128 t 20
4 147 + 22 39 + 10 186 + 24
5 195 + 11 86 + 3 281 i 14
6 39 + 2 14 + 1 53 ± 3
7 6*5 + 3 17* 5 + 3 24 ± 2
a see Table 1 for group status and treatments
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Figure 4. The relative contribution of sol (O) and
gel (#) phases to total (■) Evan's blue in the gut
lumen plotted against time after challenge. Immune
recipients of saline, sol (O) » gel (■♦•) and total (□)
shown at 30 minutes (mean + SEM).
The total amount of Evan's blue (pg) in the sol (O) was
calculated by multiplying sol volume by the concentration of
Evan's blue (pg/ml). The amount of Evan's blue in the gel (pg)
was calculated by multiplying the concentration of Evan's blue
in the gel (jug/ml) by the volume of rehomogenized gel and is
shown as (#)
The total amount of Evan's blue (■) represents the sum of sol
and gel.
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group (Table 1). Therefore, if RMCPII secretion had
occurred, it was below the level of detection. Evan's
blue accumulation in the intestines of primed rats was a
function of time after challenge (Fig.3 y = 74 + 3*5x,
r=0»88, P<( 0-001), and there was a highly significant
correlation (Fig.5) between the levels of RMCPII in the
sera and Evan's blue in the gut lumen of these rats
(y = 76 + 0•26x, r=0«87, P< 0-001).
The relationship between RMCPII secretion and
permeability in shocked rats was then examined over a
short time period. The treatment schedules for this
experiment are summarized in Table 5. RMCPII was present
in the serum of primed rats within 90 seconds of injection
with worm antigen (Table 5). None was detected
systemically in primed rats injected intravenously with
ovalbumin or in naive rats given antigen. Analysis of
the relationship between time and the concentrations of
RMCPII in the sera of shocked rats showed that maximal
secretion of RMCPII occurred 6 minutes after challenge,
the levels 15 minutes after challenge being similar to
those at 6 minutes as indicated by the regression
equation of RMCPII levels in serum against time
(y = 149 + -123/x, r=0*85, P< 0-001).
The accumulation of Evan's blue in the gut lumen
(Table 6) was time-dependent, there was a highly
significant correlation between the time after challenge













0 200 400 600 800
pg RMCPII/ml serum
Figure 5. Regression analysis of the relationship
between RMCPII secretion and levels of Evan's blue in
the gut lumen. 5 (□), 15 (■)» 30 (O) and 60 (#)
minutes after challenge.
The amount (pQ) of Evan's blue represents the total from both
sol and gel phases of each perfusate (see pp 144 for details)
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Table 5 The concentrations of RMCPII in the sera of immune
rats challenged intravenously with whole worm antigen.
Timea Challenge*5 pg RMCPIl/ml serum
1*5 500 we 66 + 16
3*0 500 we 106 + 7
6»0 500 we 139 + 3
15*0 500 we 144 + 12
15 »0 1% OVA 0
a Time (minutes) after challenge
b Rats were challenged intravenously with 1ml of saline
containing 500 we of antigen or 1% ovalbumin (OVA) plus
2*5 mg Evan's blue/lOOg body weight.
Table 6 The distribution of Evan's blue between sol and
gel phases of intestinal perfusates from immune rats
injected intravenously with antigen or ovalbumin.
Time yg Evan's blue (mean 1 SEM)
SOL GEL TOTAL
1*5 60 + 14 34 + 9 94 + 23
3*0 68 ± 13 26 + 3 94 + 16
6*0 116 ± 13 32 + 8 148 + 21
15*0 259 ± 66 115 + 29 374 + 91
15 *0 21 ± 6 13 + 2 34 ± 8
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r=0*80, P/ 0*001). There was a significant relationship
between RMCPII secretion into the serum and the levels of
Evan's blue in the gut perfusates (y = 29EXP(0*013x),
r=0*64, P^0*01). Gross examination of the intestines
of primed rats injected with worm antigen revealed
considerable mucosal damage with shedding of epithelium
and accumulation of Evan's blue (Table 7); the intestines
were markedly hyperaemic and in some instances there was
accumulation of blood within the perfusates. By contrast,
the intestines of primed rats injected-with ovalbumin
appeared normal with little signs of gut blueing or
damage•
Table 7 The effect of intravenous administration of worm
antigen on the small intestine of primed rats.
Timea Hyperaemia Epithelial Gut Gelb
Shedding blueing blue
1*5 4/4 3/4 3/4 4/4
3*0 3/4 2/4 4/4 4/4
6*0 3/4 3/4 4/4 4/4
15*0 4/4 4/4 4/4 4/4
15 • 0° 0/4 0/4 0/4 0/4
a time after challenge with antigen (minutes)
b deeply stained mucus and epithelial cells
c primed rats injected with 1% ovalbumin plus Evan's blue
( the numbers in the table represent the numbers of




Eleven primed rats were allocated to four groups and
rats in each group were injected intravenously with worm
antigen plus Evan's blue as summarized in Table 8. All
rats were killed one hour after injection of antigen and
Evan's blue and the concentrations of RMCPII in serum and
intraluminal levels of Evan's blue are shown in Table 8.
In contrast to all other experiments, the intestine was
perfused with 100ml of saline instead of 20 ml.
Both the intestinal accumulation of Evan's blue and
systemic secretion of RMCPII were dose-dependent (for
RMCPII y = -549 + 1461og x, r=0*75, P^O'Ol and for
Evan's blue y = -226 + 561og x, r=0*76, P<0*01). There
was in addition a highly significant correlation between
the concentration of RMCPII in the sera and Evan's blue
in the intestinal perfusates, (y -11 + 0*36x, r=0*97,
P<(0*001, Fig. 6).
A second experiment was carried out using twenty -
nine immune and five naive rats. These were allocated to
groups and treated as described in Table 9. All animals
were killed one hour after injection and the concentrations
of RMCPII in sera and Evan's blue in intestinal perfusates
are shown in Table 9.
No RMCPII was detected in the sera of immune rats
given saline or in the sera of naive rats given antigen.
Despite the relatively poor response to 50-200 we there
was a highly significant dose-dependent release of RMCPII
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Table 8 The systemic secretion of RMCPII and the
intraluminal accumulation of Evan's blue in the small
intestine following challenge of primed rats with whole
worm antigen.
Group Treatmenta RMCPII^ Evan's blueC
1 50 24 1 5 3+4
2 100 110 +67 24 ± 13
3 200 264 + 171 76 + 69
a worm antigen (we) plus Evan's blue by intravenous
injection,
b pg RMCPIl/ml serum (mean + SEM)
c pg Evan's blue/perfusate (mean ± SEM). Note, the
intestine was perfused with 100ml of saline, see
Materials and Methods, and Evan's blue was measured
in the sol phase only.
151
Figure 6. Regression analysis of the levels of RMCPII
in the sera of primed rats and the levels of Evan's
blue in the gut lumen, (total in sol phase only)
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Table 9. The systemic secretion of RMCPII and levels
of Evan's blue detected in the gut lumen following
intravenous challenge with worm antigen.
Group Treatment RMCPIIa Evan':s blueb
I 800 we 498 + 148 198 + 29
II 400 we 295 + 147 138 + 31
III 200 we 7 + 2 35 + 7
IV 100 we 6 4- 2 24 + 2
V 50 we 11 + 11 44 + 11
VI saline 0 21 + 5
VII 400 we 0 24 + 5
a RMCPII (pg/ml serum)
b Evan's blue (pg/perfusate)
all data presented as mean ± SEM
Groups I to VI immune
Group VII naive
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in primed rats given worm antigen (y = -51 + 0*65x,
r=0• 71, P<0*001).
The amount of Evan's blue detected in the perfusates
of immune rats injected with saline and of naive recipients
of antigen did not differ significantly (Table 9). Immune
rats given worm antigen responded with a dose-dependent
increase in the amount of Evan's blue in the gut lumen.
The relationship between dose and Evan's blue was highly
significant (y = 13 + 0*23x, r=0*84, P <( 0*001). On
analysis of regression, systemic RMCPII concentrations
and the amount of Evan's blue in the perfusates were also




Three major findings arise from this study :
(a) RMCPII is secreted systemically in primed rats in a
dose and time-dependent manner following intravenous
challenge with worm antigen; (b) the enzyme is present in
large amounts in the intestinal lumen of these same rats;
arid (c) systemic release of RMCPII is associated with
substantial changes in the permeability of the intestinal
mucosa as measured by an intraluminal accumulation of
Evan's blue dye.
Earlier studies by Miller et aT (1983) showed that
the release of RMCPII into the serum was associated with
an increase in mucosal permeability because Evan's blue
was observed within the gut lumen of shocked rats. By
using the perfusion technique of Nawa (1979), this study
shows that the accumulation of Evan's blue is both time
and dose-dependent and related to the systemic and
enteric secretion of RMCPII.
The permeability of the intestinal mucosa was
determined by measuring the intraluminal accumulation of
Evan's blue dye which combines preferentially with plasma
albumin (Rawson, 1943). More than 90% of Evan's blue
from gut contents end sera was precipitable with 10%
trichloroacetic acid this being in agreement with Nawa's
(1979) observations which confirmed that the dye remained
bound to protein and was not transuding as free dye (see
Materials & Methods). Consequently, the measurement of
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Evan's blue in the gut lumen represents the translocation
of albumin molecules and reflects combined epithelial and
vascular leak of protein.
The method of extraction of Evan's blue (Nawa, 1979)
was modified to recover dye from the sol and gel phases
of each perfusate. Data from the time course experiments
shows that the gel phase contained Evan's blue as early
as 90 seconds after antigen challenge, although the
contribution of gel to the total was a minor one. Even
after homogenization and extraction of the dye into
acetone some dye remained in the pellet which indicates
that the amount of Evan's blue in the gel is likely to be
underestimated.
Relatively large amounts of RMCPII were present in
the" sol and gel phases of perfusates, even within 90
seconds of challenge of primed rats with worm antigen.
Since the translocation of RMCPII into the gut lumen
requires only a change in epithelial permeability (Fig.7),
and the passage of Evan's blue into the gut lumen is a
consequence of both vascular and epithelial permeability
changes (Fig. 7), it would follow that RMCPII release and
hence epithelial permeability occurred before the
development of vascular changes.
The extraction of RMCPII, like that of Evan's blue,
is likely to be incomplete from the gel phase, and is
probably affected by the interactions of RMCPII and the
gel components. The gel phase comprises mucin, epithelial
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cells, and DNA from cell breakdown (Ferencz, Orskov,
Orskov & Klemm, 1980) as well as considerable amounts of
shed epithelium. Because RMCPII is a highly basic
protein (Woodbury & Neurath, 1980) it may interact with
the acidic groups present within mucin glycoproteins
(Woodbury & Miller, 1982). If present in an undegraded
form it could play some role in altering the solubility
of intestinal mucin.
Although the recoveries of both RMCPII and Evan's
blue from the perfusates were correlated, the
relationship was not linear and could mean that there is
a rate-limiting step ie the development of capillary
permeability changes.
The high concentrations of RMCPII in the intestinal
lumen are indicative of the extent of MMC secretion from
the mucosa and provide the most compelling evidence that
this is the major source of enzyme in blood during
systemic anaphylaxis (see also Chapter 6). The function
of RMCPII in vivo has not been determined. However, it
has been shown to have proteolytic activity against
basement membrane type IV collagen (Woodbury & Neurath,
1980) and is effective at concentrations as low as
10 ng/ml in causing the release of epithelial cells from
gut slices in vitro (Woodbury, pers.commun.), RMCPI,
biochemically a similar enzyme to RMCPII (Woodbury e_t al
1978), is additionally active in the degradation of
fibronectin (Vartio, Seppa & Vaheri, 1981). It is,
157
therefore, possible that RMCPII is responsible for
epithelial shedding, although more direct experimentation
would be needed to confirm this hypothesis.
Studies by Seppa (1979) have shown that RMCPI from
rat CTMC is a mediator of vascular permeability in rat
skin and it is possible that RMCPII is likewise involved
in the mediation of mucosal vascular permeability.
However, histamine, arachidonate metabolites, and other
mediators of immediate hypersensitivity (Wasserman, 1983)
released from MMC in conjunction with RMCPII are likely
to be the most significant mediators of vascular
permeability (Fig. 7).
A possible sequence of events occurring in intestinal
anaphylaxis is shown in Fig. 7. This illustration
summarizes the present results and clearly shows that
epithelial permeability precedes vascular changes. By
measuring the accumulation of RMCPII and Evan's blue in
the gut lumen and RMCPII in serum, it has been possible
to dissociate the events of mucosal epithelial
permeability and damage from mucosal vascular permeability
and damage. However, the precise role of MMC and
RMCPII in the pathogenesis of these changes remains to be
determined. That RMCPII is released into the serum in
Nippostronqylus primary infection (Chapter 4) further
supports the view that a mast cell-mediated leak lesion
in the gut may play some role in expulsion (Murray, 1972).
158









Figure 7. Intestinal anaphylaxis in the rat : sequence
of events ?
Left panel. Before challenge with worm antigen. A
mucosal mast cell is depicted in the lamina propria.
IgE is present on the membrane of the cell. Both the
epithelium and endothelium are intact.
Centre panel. Injection of antigen plus Evan's blue.
Antigen (ag) cross-links the IgE molecules present on the
MMC, leading to transmembrane signals and release of
mediators. RMCPII acts on the basement membrane of the
epithelium and causes shedding of epithelial cells. RMCPII
is then able to pass directly into the gut lumen. RMCPII
may also act on the endothelium of the capillary beds :
RMCPII passes into the blood circulation. Other
mediators (vasoactive mediators; VM) may act on either
endothelium or epithelium to facilitate permeability
changes and passage of RMCPII.
Right panel. The endothelium has been made more permeable
and the epithelium is damaged and there is extensive
shedding of epithelial cells. Evan's blue is able to
pass directly into the gut lumen.
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CHAPTER 6 The major source of secreted RMCPII following
systemic anaphylaxis in the rat.
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Introduction
Rat mucosal mast cells are characterized by the
presence within their granules of rat mast cell protease
II (RMCPII) which differs in antigenic properties,
substrate specificity and solubility from a similar
enzyme (RMCPI) present within connective tissue mast
cells (Woodbury & Neurath, 1980; Yoshida e_t ad.,1980).
The relatively high solubility of RMCPII is
associated with its release into the blood circulation
of Nippostronqylus-primed rats challenged either
intravenously with worm antigen (Chapter 5) or
intraduodenally with the homologous parasite (Miller et
al., 1983). This enzyme is also released systemically
during primary infection with N.brasiliensis (Chapter 4;
Woodbury et al., 1984).
The major tissue source of RMCPII is not known, but
published work would seem to suggest that it is the gut
(Miller et al., 1983; Chapter 5). The present study was
undertaken to investigate the tissue distribution of
RMCPII in both naive and immune rats undergoing
anaphylactic shock. The results strongly suggest that
gastrointestinal MMC are the major source of RMCPII.
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Experiments and Results
Kinetics of RMCPII release into blood and its concentrat¬
ion in enteric tissues*
Thirty rats primed twice by infection 5 weeks and
10 days previously and ten naive rats were used. The
treatment schedules are summarized in Table 1; also shown
are the concentrations of RMCPII in the jejunal mucosa
and the numbers of MMC per villus crypt unit in the
j'ejunum. The time course of appearance of RMCPII in the
sera (Chapter 5) is included for information.
Significant decreases occurred both in the numbers
of MMC and the concentration of RMCPII in the j'ej'unum
(Table 1). Reductions were most substantial 4 hours
after challenge (Table 1). Analysis of regression
showed the numbers of MMC and concentations of RMCPII in
the j'ej'unum to be significantly correlated (y = 391 + 82x
r=0*84, P<0*001, Fig.1)•
Intestinal MMC as the major source of secreted RMCPII.
The possibility that RMCPII had been released from
sources other than the gut was considered and the
distribution of RMCPII was examined in other tissues of
naive and immune rats. The concentrations of RMCPII in
samples of lung, trachea, thymus and MLN are recorded in
Table 2.
When compared with naive controls, levels of RMCPII in
immune rats were significantly (P< 0*001) increased in
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Table 1 The levels of RMCPII in jejunum and numbers of
mucosal mast cells (MMC) in immune and naive rats.
Challenge/ RMCPII
:oupa Time*3 Cserum . . djejunum MMC/VCU
I S/30 0 3180 + 137 33*3 + 1*0
I Ag/5 121 2280 + 239 + 24*3 + 3* 6 +
I Ag/15 190 2152 + 472 18*5 + 3* 7+ +
I Ag/30 351 2280 + 305 + 19*4 + 2•9+++
I Ag/60 630 2184 + 289+ 16 *4 + 4* 8+ +
I Ag/240 560 1275 + 65+++ 16*0 + 2 • 5+++
N Ag/30 0 1260 + 60+++ 10*8 + 2•6+++
N S/30 0 796 + 111+++ 10*1 ± 0•8+++
a I immune N naive
b Time after challenge (min) with 500 we of antigen (Ag)
or saline (S).
c pg RMCPII per ml of serum (mean 1 SEM)
d pg RMCPII per g wet weight tissue (mean 1 SEM)
+ P<0*05, ++ P(0*01, +++ P (0*001 when compared with immune





















Figure 1. The relationship between the number of MMC
and the concentration of RMCPII in the jejunum.
Symbols for individual values were as follows
Immune challenge groups (O) 5, (□) 15, (O) 30,
( +) 60, ( <)) 240 minutes after challenge. (■♦•) immune
saline, (#) naive saline and (■) naive challenge.
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Table 2 The distribution of RMCPII in tissues, other than
jejunum, of naive and Nippostronqylus-primed rats.
Challenge3- pg RMCPIl/g wet weight (mean + SEM)
Time*3 Lung Thymus MLN Trachea
S/30 300 t 16 43+2 90 ! 10 322 1 60
Ag/60 280 +25 84 + 10++ 179 + 5+++ 488 1 48
Ag/240 237 £ 24 46+1 97+8 420 + 67
S/30 45 + 0+++ 40 + 3 O + 0+++ 323 + 18
Groups 1, 2, and 3 immune, group 4 naive
a challenge with Ag - 500 w.e. of worm antigen or S-
saline
b time (min) after challenge
++ P<^0*01 and +++ P <C 0*001 when compared with immune
saline challenge group (Student's t-test)
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lung and MLN, although it should be noted that the
concentrations in jejunum were ten times those in the
lung. Challenge of immune rats with antigen did not
alter the concentrations of RMCPII in lung or trachea
(Table 2) . The amounts of RMCPII in thymus and MLN
increased 1 hour after challenge (Table 2) but the levels
at 4 hours were similar to those in immune controls
given saline.
Histological examination of the tissues revealed
that mast cell densities were increased in lung and MLN
in primed rats when compared with naive controls (Table 3)
Few changes were detected in mast cells in any other
organ apart from the intestine (Tables 1 & 3) following
challenge, nor, apart from the intestine was there
evidence of generalized mast cell disruption (Table 3).
Granule exocytosis was observed only in occasional mast
cells in the adventitia of the thymus and tongue.
7
Preparations of peritoneal cells containing 1-6 x 10
mast cells from both primed and naive rats did not contain
any detectable RMCPII. This was true for cells extracted
in 0*15M KCL and also 1*5M KCL, and assayed by
radialimmunodiffusion.
A second experiment was carried out to further
examine the tissue distribution of RMCPII, and to
analyse release from sites other than the jejunum. The
experimental design and challenge regimes are summarized
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Table 3 Assessment of mast cell changes in tissues other
than gut.
b c
MMC/mm mast cell density
Group Trachea Tongue Lung MLN Thymus
I 46 »2 + 4*2 + ++ + +++ +
II 30'5 + 6*7 + +++ + + +
e
+







IV 34* 2 + 1*2 + + +
a group status and treatment as in Table 2
b intraepithelial mast cells per 1mm length of tracheal
mucosa
c mast cell density by subjective assessment : (+++) subs-
antially increased in immune rats when compared with
naive controls in which mast cells were present (+) or
3. absent (-)
d mast cell depletion
e exocytosis of mast cells in adventitia
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in Table 4.
The concentrations of RMCPII in jejunum were
compared with those in ileum and stomach, and throughout
the gastrointestinal tract of immune rats there was a
highly significant (P( 0*001) increase in RMCPII when
compared with naive controls (Table 4). Antigen
challenge was without effect on the concentration of
RMCPII in the ileum, and only at 30 minutes after
challenge did significant depletion from jejunum occur
(Table 4).. By contrast, there was significant depletion
of RMCPII from stomach 10, 30 and 60 minutes after
challenge with worm antigen (Table 4) when compared to
the concentrations in immune rats given saline.
RMCPII was not detected in liver, kidney, spleen or
bone marrow nor in muscle or skin homogenates prepared
and assayed in 1*5M KCL.
Histological examination of jejunum and ileum revealed
an increase in the numbers of MMC present in immune rats
when compared with naive controls (Table 5). This was
true whether MMC were detected by their content of serine
esterase or proteoglycan (Table 5). Antigen challenge
was without effect on the numbers of MMC in jejunum or
ileum (Table 5). In agreement with previous results,
there were significant correlations between the numbers
of MMC in jejunum or ileum and the RMCPII content of each
tissue (for jejunum; y = 384 + 33x, r=0*90, P< 0*001, and
ileum; y = 70 + 25x, r=0*92, P^ 0*001).
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Table 4 The concentrations of RMCPII in jejunum, ileum
and stomach of naive and Nippostronqylus-primed rats.
Challenge^ pg RMCPIl/g wet weight (mean i SEM)
Gpa Time (min) Stomach Jejunum Ileum
I Ag/10 132 + 10+++ 2136 + 375 916 + 113
II Ag/30 151 + 12++ 2358 +
+++
220 1002 + 120
III Ag/60 130 + 8+++ 2406 + 253 1122 + 95
IV S/30 189 + 5 2988 + 137 1104 + 65
V S/30 101 + 5+++ 822 + 72+++ 253 + 14+++
VI Ag/30 105 + 5+++ 792 + 85+++ 312 + 26+++
a Groups I-IV Immune, Groups V and VI naive
b Ag 500we of antigen or S saline intravenously
++ P^0*05, +++ P^ 0*001 when compared with immune rats
given saline (group IV) (Student's t-test)
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Table 5 Enumeration of mast cells stained for proteoglycan
or esterase in jejunum and ileum of naive and immune rats
given saline or worm antigen intravenously.
MMC/VCU (mean ± SEM)
Groupa Esterase Alcian blue
I 52*9 + 7*9 52 #0 + 7*6
II 55-2 + 7*8 56*3 + 8*1
III 67 • 0 + 3*7 70*0 + 11-0
IV 60*1 + 3*7 61 • 2 + 2*5
V 14 * 8 + 0•6+++ 15 • 4 + „ ,+ + +0*6
VI 17*5 + 0•8+++ 18*1 + 0 • 6
I 37*7 + 5*1 35* 3 ± 5*2
II 33* 5 + 2*4 34*0 + 3*2
III 42 • 1 + 4*1 42*0 + 6*0
IV 38*0 + 2 • 8 37*3 + 3*7
V 10*7 +
_ ,+++
0*6 10* 7 + 0* 6+++
VI 11*2 + r\ zl + +0*6 12*0 + 1.5+++
a group status and treatments as described in Table 4
A jejunum, B ileum
+++ P<0*001 when compared with group IV (Student's t-test)
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Response of CTMC to antigen challenge.
The numbers of CTMC in ear pinnae of immune and
naive rats are shown in Table 6. Antigen challenge was
without effect on the density of CTMC in immune and naive
rats, and the mast cell counts were similar whether
demonstrated by the esterase or proteoglycan content of
their granules (Table 6).
Further analysis of the effect of anaphylaxis on
intestinal RMCPII levels.
The lack of reaction in ileum and the sensitivity
of stomach to anaphylactic shock prompted further analysis
of the responses by these tissues. In addition, the
effect of antigen challenge on the levels of RMCPII in
colon was examined 30 minutes after challenge. The
levels of RMCPII in these tissues were determined and
compared to the concentrations in jejunum (Table 7).
The concentrations of RMCPII in stomach, ileum and colon
were, as previously, significantly (P^ 0*001) increased
in immune rats when compared with naive controls (Table 7),
however the levels in these tissues were much lower when
compared with those in jejunum (Table 7). There was no
anaphylactic depletion of RMCPII from ileum or colon,
whereas the concentrations of RMCPII in jejunum and
stomach were reduced 30 minutes after challenge (Table 7)
when compared with immune rats given saline.
The numbers of mast cells per unit area of mucosa
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Table 6 The numbers of CTMC in the ear pinnae of immune
and naive rats challenged with worm antigen or saline.
,,/ 2. b
mast cells/mm tissue
Group Challenge Esterase Alcian blue
I Ag 57-6 1 3-2 57'7 + 2*5
I S 68•7 + 6*9 68•7 ± 3*8
N Ag 82*0 + 4*0 81*2 + 4*8
N S 73* 4 1 5*5 74•8 1 3-8
a animals challenged intravenously with antigen (Ag)
or saline (S) and killed 30 min after challenge
b the total number of mast cells in sections of ear pinnae
were counted and the area of tissue, excluding cartilage,
calculated by weight analysis of the tissue outline.
Alcian blue vs Esterase y=15• 5+0• 78x, r=0»90, P^O'OOl
(Simple regression analysis)
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Table 7 The concentrations of RMCPII at four sites along
the gastrointestinal tract in naive and Nippostronavlus-
primed rats.
Groupa pg RMCPIl/g wet weight tissue (mean + SEM)
Stomach Jejunum Ileum Colon
I I/S 189 t 5 2985 + 235 962 + 79 221 1 9
II I/Ag 155 + 10+ 2100 + 132+ 930 + 18 215 + 11
III N/S 141 t 11+++ 1042 1 43+++ 453 + 9+++ 159 1 5+++
IV N/Ag 131 + 6+++ 1074 + 61+++ 430 1 18+++159 1 6+++
a I - immune or N - naive rats challenged intravenously
with either Ag - 500 w.e. of antigen or (S) Saline
+ P^0*01, ++ P ( 0*001 when compared with group I
(Student's t-test)
Table 8 The number of mast cells per unit area in stomach,
jejunum, ileum and colon in naive and primed rats.
mast cells/mm^ tissue (mean ± SEM)
Group3 Stomach Jejunum Ileum Colon
I 93+3 580 + 22 489 + 19 161 + 11
II 66 t 7++ 391 t 24+++ 433 + 32 113 + 10+
III 63 + 5+++ 194 + 17+++ 176 + 7+++ 81 1 3**
IV 68 t 3+++ 192 + 6+++ 176 t 8+++ 86 1 4+++
a group status and treatment as in Table 7
+ P^O'Ol, ++ P ^.0*005, +++ P<_0*001 when compared with
group I Student's t-test
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are shown in Table 8. All four sites in immune rats
had increased numbers of MMC when compared with those in
naive controls (Table 8, P^ 0*001). After challenge,
there was a reduction in the density of mast cells in
stomach (F<( 0*005), jejunum (P ^0*001) and colon (P<(0*01)
but not in ileum (Table 8)* Although the density of mast
cells in jejunum and ileum were similar there were 2-6
2
times as many cells per mm in the intestine as in the
colon or stomach (Table 8).
Regression analysis of the relationships between mast
cell density and RMCPII concentrations are given in
Table 9. At all four sites along the gastrointestinal
tract the number of MMC/mm correlated with the RMCPII
content of the area (Table 9).
Table 9 Analysis of the relationships between mast cell
density and RMCPII content of stomach, jejunum, ileum and
colon.
Tissue Equation of best fit r P
Stomach y = 67 + l*2x 0*72 0*001
Jejunum y = 155 + 4*8x 0*97 0*001
Ileum y = 187 + l*6x 0*88 0*001
Colon y = 280 + -9125x 0*70 0*001
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Discussion.
This study unequivocally demonstrates that the
unique serine proteinase RMCPII which is a granule product
of MMC (Woodbury ejt al. , 1978b) is most abundant in the
gastrointestinal tract of both naive and Nippostronqylus-
primed rats. Furthermore, following intravenous challenge
of immune rats with worm antigen the concentrations of
this enzyme are reduced in gastric and jejunal mucosae.
In the absence of significant depletion from any other
site, it would seem likely that the gut is the major
source of secreted RMCPII following systemic anaphylaxis
in the rat.
Analysis of other tissues showed RMCPII to be absent
from most sites, and where present, the concentrations
were much lower than those in the jejunal and ileal
mucosae (Tables 2,4 & 7). RMCPII was not detected in
muscle, skin or peritoneal mast cells, even when assayed
in the presence of 1*5M KCL, nor could RMCPII be detected
in peritoneal mast cell extracts by ELISA.
Within the gastrointestinal tract itself there is
considerable variation in the levels of RMCPII, the
highest concentration occurred in the jejunum and
corresponded with maximal numbers of MMC. However,
although there was a 2-3 fold difference in concentrations
of RMCPII in jejunum relative to ileum, there was no such
difference in the density of mast cells in these organs.
This is in agreement with earlier observations (Pitts &
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Mayrhofer, 1983; Saavedra-Delgado, Turpin & Metcalfe,
1984) that when the numbers of MMC are expressed per unit
area they are comparable in both jejunum and ileum.
It may be expected that for an equal weight of
tissue that there would be more mucosa relative to muscle
in jejunum when compared with ileum, thus a 2-3 fold
difference in the amount of RMCPII may reflect a
difference in the amount of mucosal tissue homogenized.
Alternatively, MMC in jejunum may contain more RMCPII
than their counterparts in ileum.
The density of mast cells and the concentrations of
RMCPII were, by regression analysis, highly correlated in
stomach, jejunum, ileum and colon (Table 9). Within each
tissue an increase in the concentration of RMCPII was
accompanied by a similar increase in MMC density
following infection with N.brasiliensis. This increase
was maximal in the jejunum of infected rats, there being
almost a 3-fold increase in both mast cells and RMCPII
concentrations (Table 7).
Increased levels of RMCPII were also recorded in
lung and MLN after infection with N.brasiliensis. Mast
cell infiltration of MLN has been reported in
Nippostronqylus-infected rats (Keller, Cottier & Hess,
1974) and pulmonary mastocytosis has been observed to be
associated with larval migration (Wells, 1971). The
results suggest that a proportion of the additional mast
cells induced by parasite infection are MMC.
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Depletion of RMCPII occurred only in jejunum and
stomach following anaphylactic shock and was associated
with a decrease in the number of mast cells in these
tissues. Although there was also significant depletion
of MMC from colonic mucosae this was not reflected by
RMCPII concentrations which remained unaltered . The
reasons for this are not clear, although it is possible
that released enzyme is not so rapidly cleared from
colonic tissues as from stomach and jejunum. Neither
the number of MMC nor the concentration of RMCPII in
ileum was altered following anaphylaxis. In all four
tissues (Table 7), infection with N.brasiliensis
provoked a highly significant increase in the density
of MMC when compared with uninfected controls.
One interesting finding was that thymus and MLN had
increased levels of RMCPII 60 minutes after challenge
with worm antigen. Serum levels of RMCPII were maximal
at this time and the lymphatic drainage from the gut to
MLN could be a source of increased enzyme concentrations
in these tissues. Since haemoconcentration is a
characteristic feature of anaphylaxis in the rat (Sanyal
& West, 1958), an alternative explanation is that
experimental animals were insufficiently exsanguinated;
the increased levels in thymus and MLN might reflect the
accumulation of plasma-derived RMCPII.
In all instances, the number of MMC detected by their
content of esterase or GAG were very similar (Table 5)
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indicating that when MMC are depleted from the mucosa
both esterase (RMCPII) and proteoglycan are lost from
their granules. This histochemical observation is
further supported by a study in which the GAG content of
plasma and the concentration of RMCPII in the sera of
shocked rats were greatly increased, there being a
highly significant correlation between the circulating
levels of these two products (Chapter 8).
Few changes were recorded amongst the CTMC in the
tongue or adventitia of the thymus following anaphylactic
shock (Table 3). Furthermore, quantitative studies
failed to show any depletion of CTMC from the pinna of
the ear (Table 6) although, in this particular
experiment, anaphylactic shock was not severe and there
was little depletion of MMC from the enteric mucosa (
(Table 4).
The release of RMCPII and its depletion from the
jejunum may be related to the gross mucosal damage
associated with systemic anaphylaxis in the rat. The
lesions occurring during anaphylactic enteropathy
include epithelial sheddding, hyperaemia, mucus secretion
and increased mucosal permeability (Urquhart et al.,1965;
Miller et al., 1983; Chapter 5). A study of the
distribution of secreted RMCPII showed that 1-2 mg of
RMCPII was secreted into the intestinal lumen within
5 minutes of intravenous challenge with worm antigen
these high levels of enzyme persisted for up to 60
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minutes after challenge (Chapter 5). The latter
observations are perhaps the most compelling evidence
that the gut is the major source of secreted RMCPII.
In summary, the present results add further support
to previous studies (Miller et aT., 1983; Chapter 5)
suggesting that the measurement of extracellular RMCPII
provides a unique and selective assay for monitoring
the in vivo activity, predominantly of gastrointestinal
MMC, in hypersensitivity and other immunologically-
mediated responses. They do so by demonstrating that
the gut mucosa is the major source of RMCPII in naive
and Nippostronqylus-immune rats and it would seem likely
that RMCPII released during N.brasiliensis primary
infection is of intestinal mast cell origin.
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Corticosteroids are amongst the most potent and
widely used drugs in the treatment of allergic and
inflammatory conditions in man and domestic animals.
Although they act at a number of different levels and on
a variety of cell types perhaps their most significant
anti-allergic effect is in preventing the generation of
inflammatory mediators (rev. Fahey, Guyre & Munck, 1981;
Fauci, 1978). For example, they suppress histamine
release from isolated rat and murine mast cells (Marquardt
& Wasserman, 1983; Daeron, Sterk, Hirata & Ishizaka,
1982) and human basophils (Schleimer, Lichtenstein &
Gillespie, 1981). Corticosteroids may also act indirectly
to prevent the generation of secondarily formed mediators
of arachidonate metabolism by inhibition of phospholipase
(Heinman & Crews, 1984a; Danon & Assouline, 1978;
Blackwell & Flower, 1979).
Anaphylactic mortality in the rat is prevented by
prior treatment with corticosteroid (Laddu & Sanyal,
1978), and anaphylactic bronchoconstriction is abrogated
by prior treatment of sensitized rats with dexamethasone
(Church, Collier & James, 1972). Steroids are also
known to suppress mucosal mastocytosis in nematode
infections (Jarrett ejt al. , 1967; Olsen & Schiller, 1978)
and to suppress anaphylactic pathology in N.brasiliensis-
primed rats challenged intravenously with worm antigen
(Urquhart et _al. , 1965) .
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In this chapter the results of measuring the
concentration of RMCPII in blood and tissues are
presented in order to analyse the suiti-anaphylactic
activity of corticosteroids and to determine their




Intestinal permeability and RMCPII secretion•
Rats were allocated to groups and were pretreated
with saline or methylprednisolone acetate (25 mg/kg
body weight) by intramuscular injection 24 and 48 hours
before they were challenged intravenously with Evan's
blue dissolved in either saline alone or saline
containing 500 we of worm antigen. Treatment schedules
are summarized in Table 1.
A highly significant (P<( 0*001) four-fold increase
in Evan's blue in the intestinal lumen of sensitized
rats occurred after challenge with worm antigen (Group 1,
Table 2). This response was totally supressed in
sensitized rats that had been pretreated with
prednisolone (Group 2, Table 2). There was release of
RMCPII into the blood and intestinal lumen of rats in
Group 1, but this response was again totally supressed
(P^ 0*001, Mann-Whitney U-test) in rats pretreated with
corticosteroid (Group 2, Table 2). Saline injection of
either untreated or steroid-treated sensitized rats,
and antigen injection into either untreated or steroid-
treated naive rats did not induce any significant
alteration of mucosal permeability or release of RMCPII
(Table 2).
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Table 1 Treatment schedules to determine the effects
of glucocorticosteroids on MMC and intestinal anaphylaxis
b c
Group Status Pretreatment Challenge
1 Immune S Ag
2 Immune C Ag
3 Immune S S
4 Immune C S
5 Naive S Ag
6 Naive C Ag
7 Naive S S
8 Naive C S
a Immune animals infected 1 and 3 weeks earlier with
5000 N.brasiliensis larvae
b S saline C methylprednisolone acetate
c Ag 500 we of antigen S saline
Rats were killed one hour after challenge.
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Table 2 Measurement of gut permeability and RMCPII release
during anaphylaxis in normal end corticosteroid treated
rats.









2 88 + 8 0 0
3 104 + 2 0 0
4 124 + 8 0 0
5 64 + 4 0 0
6 51 + 6 0 0
7 72 + 5 0 0
8 69 + 5 0 0
+ P^ 0*001 when compared with all other groups (Student's
t-test)
* P< 0*001 when compared with all other groups (Mann-Whitney
U-test)
a Group status and treatment as described in Table 1
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Tissue distribution of RMCPII following steroid treatment.
(a) Jejunum; pretreatment of rats with methylprednisolone
significantly (P<( 0*001) depleted the jej'unum of RMCPII
in both immune and naive rats (Table 3). Antigen challenge
of sensitized rats was without effect on the mucosal
concentration of RMCPII when compared to that in immune
rats challenged with saline (Table 3).
(b) Ileum; following pretreatment with corticosteroids,
RMCPII was significantly (P<( 0*001) depleted from both
immune and naive rats when compared with saline inj'ected
controls (Table 4).
(c) Lung; corticosteroids reduced the concentration of
RMCPII in lung homogenates from immune rats (Table 5).
The concentrations in homogenates from naive rats were
too low (^ lOug/g tissue) to be measured by radial-
immunodiffusion, but trace amounts of enzyme were
detected in naive animals that had not been treated with
corticosteroid (Table 5).
(d) Mesenteric lymph node; the concentrations of RMCPII
in the nodes of immune rats challenged with antigen was
unaltered when compared with those in immune rats given
saline, but corticosteroids depleted the immunized node
of RMCPII (Table 5). The values in nodes of untreated
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Table 3 The effect of anaphylaxis and corticosteroid
treatment on the concentration of RMCPII (pg/g wet weight




1 1780 + 120 29*6 + 1*7 30'0 + 2*0
2 215 + 25+ 3*3 + 0 • 3+ 3*6 + 0 • 2+
3 1840 + 84 32 • 6 + 1*0 32 • 9 + 1*5
4 165 + 33+ 3 • 8 + O • + 4*0 + 0 • 3+
5 534 + 51 6*8 + 0*5 7*7 + 0-3
6 252 + 57+ 2*1 + 0 • 2+ 2*5 + 0 • 2+
7 576 + 51 7*5 + 0*5 8*3 + 0*5
8 210 + 30+ 2*4 + 0 • 2+ 2*4 + 0 • 2+
a group status and treatment as described in Table 1
+ P< 0*00.1 significant depletion of RMCPII and MMC
following steroid treatment when compared with saline
controls
Regression analysis
Alcian blue vs Esterase y=0*45+0*99x, r=0*99
Esterase vs RMCPII y=6408+54*9x, r=0*97
All data presented as mean ± SEM
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Table 4 The effect of anaphylaxis or corticosteroid
treatment on the numbers of MMC and concentration of
RMCPII in the ileum of immune and naive rats.
Groupa RMCPIIb MMC/VCU
Alcian blue Esterase
1 471 + 19 15*9 + 1*5 16*0 + 1*4
2 106 + H1 O
+





3 517 + 13 17*4 + 0*8 18*0 + 1*0
4 98 + 5+ 2*8 + 0»3+ 2*8 + +r~i9o
5 195 + 10 4*0 + 0*1 4*3 + 0*1
6 61 + 5+ 1*4 + 0 • 2+ 1*3 ± o • CO +
7 200 + 6 4*2 + 0*2 4*4 + 0*4
8 60 + 0+ 1*4 + 0 • 2+ 1*4 + O . i-1 +
a group status and treatments as described in Table 1
b pg RMCPIl/g wet weight tissue
+ P^ 0*001 significant depletion following steroid
treatment (Table 3)
Regression analysis
Alcian blue vs Esterase y=0,07+l«0x, r=0*99
Esterase vs RMCPII y=58*7+24x, r=0*92
All data presented as mean t SEM
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naive rats were, like those in lung, at the limit of
the detection of the assay system (Table 5).
Mast cell changes following corticosteroid treatment.
Pretreatment of rats with corticosteroid
significantly (P< 0*001) reduced the numbers of MMC in
the jejunum (Fig.l) and ileum of naive and immune rats.
The results were similar whether the cells were detected
with Alcian blue or by their content of non-specific
esterase (Tables 3 & 4). The numbers of MMC in the
jejunal or ileal mucosa of primed rats were unaltered
after challenge with worm antigen (Tables 3 & 4).
Because of the anisotropic distribution of mast cells in
lung and MLN, a semi-quantitative assessment of cell
density was employed. Glucocorticoid treatment of
sensitized rats caused an apparent reduction in density
of mast cells in both tissues, whereas antigen challenge
was without effect (Table 5). Relatively few mast cells
were present in the lungs of naive rats and in the MLN
they were distributed in the capsule with few being
located in the cortex. Corticosteroids had no
discernible effect on pulmonary mast cells in naive rats,
but slightly reduced the density of mast cells in the
cortex of MLN (Table 5).
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Table 5 The concentration of RMCPII and numbers of MMC in
lung and MLN of naive and immune rats after anaphylactic
shock or corticosteroid treatment.
Groupa jig RMCPIl/g tissue mast cell
(mean ± SEM) density
Lung MLN Lung
1 219 ± 24 86 + 16 +++





3 182 ± 17 90 ± 0 +++





5 10 10 +
6 0 0 +
7 10 10 +












a group status and treatment as in Table 1
+ P < 0*05 ++ P^O'Ol (Student's T-test)
* P <^0*001 (MannWhitney U-test) significant depletion
following corticosteroid treatment
subjective assessment of mast cell density:- (+++)
substantial increase when compared with naive controls (+)
o some depletion of mast cells following steroid treatment
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Figure 1. Tissue sections stained with naphthol AS-D
chloroacetate from (a) saline and (b) corticosteroid-
treated rats. Note the substantial depletion of MMC
after treatment. (Magnification x 275).
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The response of CTMC to corticosteroid treatment.
Corticosteroid treatment did not alter the numbers of
mast cells in the ear pinnae of naive rats (Table 6).
2
Recipients of saline had 56+4 mast cells/mm tissue and,
in corticosteroid treated rats there were 53 t 3 mast
2
cells/mm tissue. Similarly, antigen challenge of naive
2
rats was without effect on CTMC (53 1 6 mast cells/mm ).
The numbers of CTMC stained with Alcian blue when
compared with the numbers containing esterase activity
were, by simple regression analysis, significantly
correlated (y = 12*8 + 0*78x, r=0»81, P<0»001).
PCA reactivity of serum following corticosteroid treatment.
Serum taken from rats before they were treated with
methylprednisolone (PCA titre 280 ± 114) and serum taken
from the ' Similarly, PCA titres measured before saline
treatment of immune control rats (176 + 39) were unaltered
48 hours later.
The effect of corticosteroid treatment on PCA.
The PCA titre ( ^ 40) in naive rats injected
intradermally with immune serum and then treated with
methylprednisolone was significantly (P<0*001) reduced
when compared with similarly sensitized rats (352 + 78)
treated with saline (Fig.2).
same rats immediately before antigen challenge (PCA, 280 ± 114)
had identical PCA values.
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Table 6 The effect of corticosteroid treatment on CTMC
in the pinna of the ear of naive rats.
a 2





C/S 53 1 3 53+1
a see Table 1 for treatment schedules
Alcian blue vs Esterase y=12*8+0*78x, r=0*81, 0*001
Figure 2. The effect of corticosteroid pretreatment
on rat homologous passive cutaneous anaphylaxis.
(a) pretreated with saline.
(b) pretreated with 25 mg/kg methylprednisolone.
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Levels of RMCPII in blood after depletion of MMC by
steroids.
In order to determine whether steroid induced
depletion of MMC resulted in the release of RMCPII into
blood, 15 naive rats, allocated to 3 groups, were bled
via the tail vein and immediately injected
intramuscularly with saline, methylprednisolone (25 mg/kg)
or betamethasone (2 mg/kg). They were bled 1, 4 and 24
hours later and rats given betamethasone exsanguinated
at 24 hours. The remaining 10 rats were given a second
dose of saline or methylprednisolone and blood samples
were taken 1 and 4 hours later; all were exsanguinated
24 hours after the second injection (Table 7).
At no time was RMCPII detected in the blood by ELISA.
There was, however, depletion of MMC in rats treated with
methylprednisolone (3*7 * 0*5 MMC/VCU) or betamethasone
(5*6 + 0*2 MMC/VCU) when compared with saline treated
controls (10*3 + 0*5 MMC/VCU). The numbers of MMC detected
by either esterase stain or Alcian blue were very similar
and by regression analysis there was a highly significant
correlation between the two staining methods (y = -0*19 +
0*94x, r=0*93, P< 0*001). Similarly, the concentration of
RMCPII was reduced (P<0*001) in the jejunum of rats
treated with either methylprednisolone (313 jig/g 1 48)
or betamethasone (493 + 33) when compared with saline
controls (784 j; 24). There was, in addition, a highly
significant correlation between the numbers of MMC detected
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Table 7 The effect of pretreatment of naive rats with
betamethasone or methylprednisolone on the concentration
of RMCPII and numbers of MMC in the jejunum.
MMC/VCU
pg RMCPIl/g wet wt Alcian blue Esterase
A 493 ± 33 5*6 + 0*2 4*4 + 0*1
B 313 + 48 3*7 + 0*5 3*6 ± 0*4
C 784 ± 24 10•3 ± 0*5 9*7 ± 0*5
A 2 mg/kg betamethasone 24 hours previously
B 25 mg/kg methylprednisolone 24 and 48 hours previously
C saline 24 and 48 hours previously
Treatment with either betamethasone or methylprednisolone
caused a significant (P< 0*001) reduction in both RMCPII
and number of MMC (Student's t-test).
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with esterase stain and the concentration of RMCPII in
the jejunum of the three groups of rats (y = 164 + 61x,
r=0* 87, P< 0*001).
Dose-response relationship.
Rats immunized twice by infection with N.brasiliensis
were injected intramuscularly with saline or with 1, 5, or
25 mg/kg methylprednisolone acetate 24 and 48 hours before
they were bled out and killed. When compared with saline
injected controls, methylprednisolone caused a dose-
dependent depletion of RMCPII from the mucosa, (Table 8).
The data fitted the following regression equation :
(y = x/-0*002 + 0*004x, r=0*81) indicating that 5 mg/kg
methylprednisolone was as effective as 25 mg/kg in
depleting MMC from the jejunal mucosa. Furthermore, the
reduction in numbers of MMC (esterase) was highly
correlated with the loss of jejunal RMCPII (y = -69 + 61x,
r=0*98).
Time Course of Mast Cell Changes.
Immune rats were given intramuscular injections of
25 mg/kg methylprednisolone and groups of 4 were killed
1, 4, and 24 hours after steroid treatment. An additional
4 rats were killed 24 hours after saline treatment. No
significant depletion of RMCPII or MMC from the jejunum
was detected until 24 hours after corticosteroid treatment
(Table 9). These data would indicate that mast cell
changes occur between 4 and 24 hours after steroid
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Table 8 The effect of dose of methylprednisolone on the




















10 • 4 ± 0*7*
5*9 t 0*2
4*7 ± 0*2^
* significant depletion (P< 0*001) when compared with
saline controls (Student's t-test)
a dose of methylprednisolone (mg/kg body weight)
Regression analysis
Alcian blue vs Esterase y=-0*45+0*99x, r=0*99)
b pg RMCPIl/g tissue
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administration.
Table 9 The effect of time after administration of
methylprednisolone on the concentration of RMCPII and
number of MMC in the jejunum of immune rats.
Time RMCPII^ MMC/VCU
(hr) Alcian blue Esterase
1 1357 + 185 22 • 8 ± 1*1 22•7 ± 2*0
4 1327 + 82 23 • 7 + i-1 . to 22•6 + 0*9
24 570 + 30* 7-6 1
*
in•o N•O+1o•CO
24a 1395 + 169 23 • 3 + 2 • 2 24* 9 1 1*3
a saline treated control, all other groups were given
2 x 25 mg/kg methylprednisolone
* P< 0*001 when compared with 24 hour saline group
all data presented as mean ± SEM
Regression analysis
Alcian blue vs Esterase, y = 0*84 + 0*96x, r=0*97
b yxg RMCPIl/g tissue
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Discussion
The two principal effects of corticosteroid treatment
described in this study are (a) suppression of the
anaphylactic release of RMCPII into intestinal secretions
and (b) depletion of MMC and RMCPII from the intestinal
mucosa. These events may, therefore, be related to the
suppression of intestinal anaphylaxis.
These results confirm previous observations that
corticosteroids suppress the development of anaphylactic
pathology in the gut (Urquhart at aT., 1965) there being
no detectable permeability changes in corticosteroid
treated rats challenged with worm antigen (Table 2). In
addition, they extend earlier observations by showing that
fully mature MMC in normal and immune rats are depleted
following corticosteroid treatment. By contrast, CTMC in
the pinna of the ear were apparently unaffected. The
latter finding indicates a further important functional
difference between CTMC and MMC in the rat.
Significant depletion of MMC and RMCPII occurred
between 4 and 24 hours after injection of steroid, and may
explain why in previous studies (Church & Miller, 1978)
optimal inhibition of anaphylactic bronchoconstriction was
not observed until 12-24 hours after administration of
dexamethasone. The extreme sensitivity of MMC to steroid
was indicated by the fact that as little as 1 mg/kg
methylprednisolone caused a significant reduction in their
numbers.
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Although depletion of MMC occurred 4-24 hours after
methylprednisolone treatment there was no detectable
release of RMCPII into the serum at 1, 4 or 24 hours. It
is possible that mast cells die without releasing granule
products or are lysed following steroid treatment as has
been reported for rat thymocytes (Munck & Brinck-Johnsen,
1968).
Corticosteroid treatment of rats passively sensitized
intradermally with immune serum caused:.a significant but
incomplete inhibition of passive cutaneous anaphylaxis.
Since the binding of IgE is not impaired by steroids
(Daeron e_t ad.,1982; Marquardt & Wasserman, 1983) and
because in this study, methylprednisolone failed to
suppress the circulating levels of IgE, two mechanisms
of inhibition may be considered: (i) inhibition of mediator
release and (ii) modification of the response of target
organs to mast cell-derived mediators. The extent to
which the intestinal response was suppressed by the known
capacity of steroids to decrease permeability in vascular
beds (Benditt, Schiller, Wong & Dorfman, 1950) or cause
vasoconstriction (Barry & Woodford, 1974) cannot be
determined from the present data. It is, however, possible
that both mechanisms operate in the suppression of
intestinal permeability changes.
Many possible mechanisms have been put forward to
explain corticosteroid-mediated inhibition of mediator
release from CTMC, but it is not clear if they are
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directly applicable to MMC. Changes in intracellular
c-AMP, which would favour inhibition of mediator release,
are unchanged in both dexamethasone treated rat and
murine mast cells (Marquardt & Wasserman, 1983; Daeron ejt
ad.,1982). Effects both upon arachidonic acid metabolism
(Hong & Levine, 1976) and inhibition of its release from
the cell membrane by lipomodulin-like proteins (Hirata,
Schiffman, Venkatsubramanian, Salomon & Axelrod,1980;
Blackwell, Carnuccio, Di Rosa, Flower, Parente & Persico,
1980; Blackwell & Flower, 1983) have been considered
important in the suppression of mast cell function.
Another interesting hypothesis is that steroids impair
mitochondrial function (Grosman & Jensen, 1984) and it may
be that MMC have a greater energy requirement than CTMC.
The precise action of steroids in the inhibition of mast
cell exocytosis remains obscure. However, a mechanism
which takes into account many earlier observations has
recently been proposed (Heinman & Crews, 1984b) suggesting
that the steroid would act via a cytoplasmic receptor
which when activated migrates to the nucleus and induces
the synthesis of specific proteins (lipomodulin ? ).
These proteins would then interfere with the coupling of
IgE to calcium influx. Phospholipid methylation has been
implicated in the coupling of IgE to calcium influx and
the release of arachidonic acid, phospholipid methylation
being inhibited by steroids (Daeron e_t aJ. , 1982). The
result would be an inhibition of the calcium-dependent
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release of mast cell mediators.
Corticosteroids are known to inhibit goblet cell
differentiation (Miller & Nawa, 1979a), to prevent self-
cure of N.brasiliensis infected rats (Ogilvie, 1965;
Jarrett ejt al. , 1967), to inhibit rapid expulsion of
N.brasiliensis (Miller & Huntley, 1982b) and T,spiralis
(Bell et_ af., 1982) and to abrogate both immune exclusion
and mucus trapping in N.brasiliensis-primed rats (Miller
& Huntley, 1982b). These mechanisms are thought to involve
an immediate hypersensitivity reaction (rev. Miller, 1984)
and it is therefore possible that the corticosteroid-
mediated suppression of worm expulsion may be related to
the capacity of corticosteroids to deplete fully mature
MMC from the intestinal mucosa.
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CHAPTER 8 The presence in blood of both glycosaminoglycan
and RMCPII following systemic anaphylaxis in the rat.
206
Introduction
A theme throughout this study has been the high
correlation between the numbers of MMC containing
esterase and those containing glycosaminoglycan (GAG).
Since the number of MMC that stain either for esterase
or GAG were substantially reduced following anaphylactic
shock and this was associated with the appearance, in
blood, of RMCPII it follows that GAG might also be
detected in the blood of shocked rats.
The results show that there is indeed a systemic
release of GAG which was highly correlated with the
levels of RMCPII in blood thereby suggesting that GAG
released during anaphylaxis could be of MMC origin.
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Experiments and Results
Fifteen female rats immunized 3 and 8 weeks earlier
with 6000 N.brasiliensis larvae were randomly allocated
to 3 groups of 4 and one group of 3 rats and were
challenged intravenously with 1000, 500, or 250 worm
equivalents (we) of adult worm antigen or saline. For
control purposes 4 naive rats were challenged with 500
we intravenously. One hour after challenge the animals
were exsanguinated under ether anaesthesia and the
concentrations of GAG and RMCPII determined in blood
plasma and serum respectively and in gut perfusates and
mucosal homogenates.
RMCPII was present only in the sera of immune rats
challenged with worm antigen (Table 1) and in these same
rats there was a 10-fold increase in the concentration of
GAG in plasma when compared with immune recipients of
saline, or naive rats given antigen (Table 1, Fig.l).
Although, in this particular experiment, the release of
RMCPII and GAG was independent of the dose of antigen,
there was a highly significant correlation between the
concentrations of RMCPII and GAG (y = 2110 + 17x, r=0*93,
P< 0*001; Fig.2) which would indicate that they may have
been released from the same source.
Intestinal perfusates from primed, challenged rats
contained 1144-2085pg RMCPII (Fig.l), whereas perfusates
from control animals were devoid of enzyme (Table 2).
There was, in addition, a concomitant, highly significant
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Table 1 The concentrations of RMCPII and GAG in the
blood of naive and immune rats challenged intravenously



























Group 1 -naive, Groups 2-5 -immune
a rats challenged intravenously with worm antigen or
saline.
+ P <.0*001 when compared with group 2 (Mann-Whitney U-test)
* P <, 0*001 when compared with group 2 (Student's t-test)



































Figure 1. Top panel. Total recoveries of RMCPII
(mean ± SEM) in intestinal perfusates (#-#) and the
concentration of RMCPII in the jejunal mucosa (pg/g wet
weight, ) of immune rats given worm antigen or
saline (dose =s 0) . The numbers of MMC per villus crypt
unit (VCU) are also shown (mean i SEM, O-O)•
Individual symbols showing the concentration of RMCPII
in perfusates (■♦) and gut homogenates (□) as well as
the number of MMC (O) are also shown for naive rats
given 500 we.
Lower panel. The concentrations of RMCPII
in serum (mean 1 SEM#)and GAG in plasma (mean ± SEMj£g)
are plotted against the dose of worm antigen. Values
from immune rats given saline are plotted at the zero
dose and naive rats given antigen are shown as (O)
RMCPII and (□) for GAG.
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Table 2 The concentration of RMCPII in jejunum and gut




















a group status and treatments
b the concentration of RMCPII
c the concentration of RMCPII
+ P^O'OOl when compared with
group (2) Student's t-test.
as described in Table 1
in jejunum (pg/g wet weight)
in gut perfusates (pg)
immune saline challenge
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(P<^0*001) depletion of RMCPII and MMC from the mucosa
of primed rats challenged with antigen (Fig.l, Table 2)
when compared with control values. Analysis of GAG in
gut perfusates and homogenates is likely to be complicated
by endogenous GAG additional to that contained in mast
cells, and no significant change in mucosal levels was
detected, however antigen challenge caused a significant
increase in GAG in perfusates from immune rats when
compared with immune rats given saline (Table 4).
Mast cell depletion from the jejunal mucosa was
detected both with Toluidine blue and naphthol AS-D
chloroacetate-(Table 3); the correlation between the
two methods was highly significant (y = -2*3 + l*lx,
r=0*98, P< 0*001; Fig.3) suggesting that both proteoglycan
























0 200 400 600 800
/jg RMCPII/ml serum
1000
Figure 2. Regression analysis of the concentrations of
RMCPII in serum against GAG in plasma (y = 2110 + 17x,
r=0*93, P <0*001)• Plasma was not obtained from one rat
given 500 we.
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Table 3 Mast cell numbers as determined by their content







MMC/VCU (mean + SEM)
Toluidine blue








10*60 ± 0* 53+
9*66 + 0•63+
12*06 + 1*01+
a treatments as described in Table 1
+ P <0*001 when compared with group 2 (Student's t-test)
215
Figure 3. Regression analysis between the numbers of
MMC enumerated with Toluidine blue and with NADC-esterase
(y = -2•3 + 1•lx, r=0*98, P< 0-001).
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a treatment as described in Table 1
+ P< 0*001 when compared with Group 2 (Student's t-test)
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Discussion
The appearance in blood of RMCPII and GAG was
examined in naive and Nippostronqylus-primed rats
challenged with worm antigen. The results show that the
systemic release of these two products occurred only in
immune recipients of antigen, there being a 10-fold
increase in the concentration of GAG in the plasma of
these same rats when compared with immune recipients of
saline or naive rats given antigen.
There was, as described previously (Chapter. 5),
substantial secretion of RMCPII into the gut lumen and a
concomitant fall in the mucosal concentration of this
enzyme (Miller et aJ., 1983; Chapter 6) in primed antigen
challenged rats. This was paralleled by a reduction in
the number of MMC detected either with Toluidine blue or
naphthol AS-D chloroacetate, there being a highly
significant correlation between the two staining methods
indicating that both proteoglycan and serine esterase
are lost from discharging MMC.
Although these studies failed to show a change in
the mucosal concentration of GAG, probably for technical
reasons associated with a high background of tissue GAG,
the concentration of GAG in plasma was highly correlated
with the release, into serum, of RMCPII. As the major
source of RMCPII is the enteric mucosa (Chapter 6),it
would seem likely that GAG in plasma is also released
from this site, with the MMC being the most obvious source.
218
More conclusive evidence that MMC are the source of
secreted GAG must await further analysis. However, it is
relevant to note that rat MMC proteoglycan is, like that
in the murine mast cell cultured _in vitro from bone
marrow (Razin et aJ., 1982), non-heparin proteoglycan
(Tas & Bernsden, 1977). Furthermore, whereas the heparin
proteoglycan of rat CTMC forms an insoluble complex with
neutral proteases (Schwartz, Riedel, Caulfield, Wasserman
& Austen, 1981) which remains cell-associated even after
the secretory granules have released soluble mediators,
the chondroitin sulphate E proteoglycan of the murine
cultured mast cell is not substantially retarded in it's
diffusion into the microenvironment (Razin et ad., 1983).
Taken together the high correlation between systemic
RMCPII and GAG concentrations and of MMC stained for
esterase or proteoglycan would indicate that these
products are released in parallel following intestinal
anaphylaxis, and as the MMC is the source of RMCPII, then
it would seem likely that GAG is also of MMC origin. If,
as the present study suggests, proteoglycans from MMC are
highly soluble, this is yet another example of the
biochemical and functional differences between MMC and
CTMC in the rat.
CHAPTER 9 Final discussion and conclusions.
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This thesis has set out to examine the role of (a) mucus
and (b) mucosal mast cells (MMC) in the expulsion of N.
brasiliensis from the rat. A long standing theme in
immunoparasitology is that nematode infections of
laboratory animals may be expelled as a consequence of
sin immediate hypersensitivity reaction. As mast cells
are an important component of hypersensitivity reactions
it was one aim of this thesis to reevaluate the role of
these cells in the rejection of N.brasiliensis. using
the MMC-specific proteinase RMCPII as a marker for the
secretory activity of MMC. In view of the relationship
between hypersensitivity, mast cells and mucus, especially
in the lung, one chapter of this thesis was devoted to
a study of the possible protective role of gastrointestinal
mucus in N.brasiliensis primary infection. The possible
relationship between these results and mast cell
activity will be discussed.
In Chapter 3 the numbers of worms trapped in mucus
during N.brasiliensis primary infection were quantitated
and the results have shown that a significant number of
worms are trapped in mucus on days 10 and 11 of infection.
These macroscopic observations were corroberated by the
use of SEM which showed worms to be embedded in a thick
blanket of mucus on day 10 but not on day 6 of infection
when mucus was sparse. The actual number of worms trapped
was very small (less than 20) and it is important to
rationalize whether mucus trapping is likely to be a
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significant mechanism leading to the expulsion of
N.brasiliensis from the rat.
Based solely on the proportions of worms trapped
at each time point examined it would seem improbable
that trapping could be responsible for the expulsion of
up to 1000 worms over 2-3 days. It must be remembered
that the situation is not static arid the data represents
those worms trapped only at the time of sampling and
thus if 10 worms are trapped and expelled per hour then
trapping could be of great significance. More detailed
kinetic studies would be needed to clarify worm loss
versus trapping, but the fact that trapping has been
observed in this study suggests that mucus trapping
could be a significant mechanism whereby N.brasiliensis
is expelled from rats.
It is not clear whether the increased capacity of
mucus.-on days 10 and 11 to trap worms is due to changes
in quality or quantity. There is a well known
association between mucus release and mediators of
immediate hypersensitivity, where mast cell mediators
have been shown to induce the release of mucus in the
nose and lung (Kaliner ejt aT. , 1984) . Mast cell
secretory activity may either (a) give rise to mucus
secretagogues and hence increase the quantity of mucus
(b) give rise to mediators which interact with mucus and
alter its properties or (c) cause an increase in the
influx of plasma proteins into the gut lumen where they
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may interact with mucin and affect the solubility of
the mucus gel.
The second part of this thesis was an experimental
investigation into the role of MMC in the rejection of
N.brasiliensis. Firstly, the histochemical demonstration
of MMC in parasitized tissues and their enumeration and
secondly the measurement of their secretory activity in
response to parasite antigens. To monitor the secretion
by MMC use was made of rat mast cell protease II (RMCPII)
which is uniquely found in MMC (Woodbury ejt al.. , 1978b;
Gibson & Miller, 1986). This enzyme is highly soluble
making its immunoassay straightforward in tissues and
sera (Woodbury ejt al., 1981).
The results of several workers (Nawa & Miller, 1979;
Woodbury & Miller, 1982; Woodbury et al., 1984) were
confirmed in that during primary infection with N.brasiliensis
MMC counts were low when the parasites were being expelled
(Chapter 4). In agreement with the earlier studies of
Woodbury et al. (1984) RMCPII secretion was maximal
about 10 days after infection even though the mucosal
concentration of this enzyme and numbers of MMC were
depressed below control values. Neither the concentration
of RMGPII in serum or numbers of MMC were affected by
differing challenge doses of larvae (Chapter 4).
As MMC counts were low when maximal enzyme secretion
was recorded it is possible that RMCPII was released
from MMC that could not be detected using conventional
"
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staining for glycosaminoglycan (ie Alcian blue or
Toluidine blue). To examine this eventuality, sections
were stained for glycosaminoglycan, for RMCPII and for
naphthol AS-D chloroacetate esterase activity and the
MMC counts compared. Similar cell counts were obtained
irrespective of the method of demonstration, although it
should be noted that staining for esterase activity makes
cell counts very easy to perform because the reaction
produces a dense red colour in MMC. The comparability
of the cell counts obtained with these three methods
reduces the likelihood of selective release of granule
constituents or that secretion was from a MMC population
which could not be detected by conventional staining
techniques.
This experiment demonstrates that functions of MMC
cannot be determined from histochemical criteria alone
since release of a specific granule product was maximal
even when cell numbers were at a low level. The role of
MMC has, therefore to be reevaluated in the light of.
these observations.
What role, if any, has RMCPII and MMC in the
expulsion of N.brasiliensis primary infections? It has
been suggested that MMC may play a role in altering
mucosal permeability (Murray, 1972), but the precise
involvement of MMC is not clear. Whilst on one hand
Murray e_t aT.(1971a) showed permeability to be maximal
when numbers of MMC were maximal, Nawa (1979) was
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unable to agree with this relationship and demonstrated
that maximal permeability occurred before MMC increased
in number and that the parasites themselves were likely
to be the major cause of increased mucosal permeability.
However, both sets of data must be reevaluated in the
light of the present findings which demonstrate the
release of RMCPII in the absence of high numbers of
MMC.
The possible role of RMCPII in causing permeability
changes was examined in rats after anaphylactic shock,
where Miller jet _al. (1983) have previously demonstrated
an increase in mucosal permeability. The passage of
Evan's blue, which was used to assess mucosal permeability,
into the gut lumen was both time- and dose-dependent in
primed rats challenged intravenously with worm antigen.
There was a highly significant correlation between the
levels of RMCPII in the serum of shocked rats and the
levels of Evan's blue in the gut lumen. These results
indicate that RMCPII may be responsible for anaphylactic
permeability changes in the gut mucosa, and it is
possible that RMCPII may cause localized changes in gut
permeability during N.brasiliensis primary infection.
In Chapter 6 the results of a study of the major
source of RMCPII released during anaphylaxis were
presented. The results demonstrated that the jejunum
contained the highest concentration of RMCPII in naive
and Nippostrongylus-immune rats. Following anaphylaxis
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the concentration of RMCPII was reduced only in the
gut, gross depletion of protease being paralleled by a
reduction in the number of MMC. No RMCPII was present
in liver, kidney, spleen, bone marrow or muscle from
both naive and immune-* rats. Both lung and MLN had
increased concentrations of RMCPII following infection
but there was no anaphylactic depletion from these sites
and the results would therefore suggest that RMCPII
present in the serum during anaphylaxis is of intestinal
MMC origin.
More compelling evidence that intestinal MMC are the
major source of secreted RMCPII came from a study of the
kinetics of the anaphylactic release of RMCPII (Chapter
5). The release of protease into serum was time- and
dose dependent in primed rats challenged intravenously
with worm antigen, no protease was detected in the sera
of naive rats challenged with antigen. Furthermore,
RMCPII was detected in intestinal perfusates from primed-
challenged rats , the release of enzyme into the gut
lumen occurring as rapidly as 90 seconds after
challenge with antigen. The appearance of RMCPII in the
gut lumen is perhaps the most compelling evidence that
intestinal MMC are the main source of secreted RMCPII
during systemic anaphylaxis.
Although the concentrations of RMCPII in the sera
of rats during primary infection are very much lower than
those during anaphylaxis the results from Chapter 6 would
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suggest that RMCPII present in the sera of rats during
N.brasiliensis primary infection is of intestinal MMC
origin, where it may directly affect the permeability
of the intestinal mucosa. However, release from other
sites especially lung cannot be excluded as a possible
source of protease during primary infection.
The data from the distribution study (Chapter 6)
allows for an estimation of the amount of RMCPII per
MMC in stomach, jejunum, ileum and colon in naive and
immune rats.
3
If we assume that 1 litre = 1 kg then lg = 1cm
3
and lmg = 1mm . Then for naive (N) and immune (I) rats
we have:









This calculation shows that there is a marked
difference in the amount of RMCPII per MMC at the four
sites examined. The values for jejunum are very close



















RMCPII content of cultured rat MMC (26pg/l0 cells).
Whether the differences at the four sites are 'real' or
related to the amount of mucosa relative to muscle which
will affect the concentration of RMCPII per gram wet
weight of tissue is unclear.
The glucocorticosteroids have proved to be the
most effective drugs at blocking the expulsion of primary
and secondary N.brasiliensis infections (rev. Miller,
1984) and in Chapter 7 the effects of these drugs on
systemic anaphylaxis and permeability changes was
examined. It was found that short term treatment with
corticosteroids decimated the MMC population not only in
jejunum and ileum but also in lung and MLN. As little
as lmg/kg methylprednisolone caused a highly significant
reduction in the numbers of mast cells and concentration
of RMCPII in the jejunum. Mast cells were depleted
from the mucosa between 4 and 24 hours after steroid
treatment and in all instances these events were
paralleled by a reduction in the levels of RMCPII.
Corticosteroid treatment suppressed the development of
anaphylactic pathology in the gut, there being no
detectable permeability changes in rats challenged with
worm antigen.
No evidence of steroid-induced mast cell degranulation
was obtained but in hindsight blood samples taken between
4 and 24 hours would have been valuable. The possibility
that corticosteroids cause depletion of MMC through the
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action of steroids on T-cells cannot be ruled out, which
would mean that MMC have an obligate dependence on
T-cell-derived factors (eg IL-3) for their continuing
survival. Interestingly, ljiM dexamethasone interrupts
the proliferation of mouse bone marrow-derived mast cells
after a preincubation of 24 hours (Lewis, Robin & Austen,
1985), which would support a T-cell involvement.
Whatever their ultimate fate, which is well worthy of
further study, MMC show an extreme sensitivity to
corticosteroids not shown by their connective tissue
counterparts.
That MMC are depleted and expulsion of N.brasiliensis
is prevented by steroid treatment would suggest that
MMC are involved in expulsion. However, the effects of
corticosteroids on eosinophils, basophils and mucus
secretion/synthesis must all be considered as possible
explanations for the steroid-induced inhibition of worm
expulsion, but the profound effects of corticosteroids
on MMC would suggest that they could be crucial to
worm expulsion.
If it is assumed on the basis of the secretion of
RMCPII that MMC are involved in the the expulsion of
a primary infection of N.brasiliensis it is important
to ascertain their role and the possible interactions
with other components of the mucosal immune response.
The data from this thesis and other published work
would suggest that day 10 is an important time in the
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course of N.brasiliensis infection. Around this time
RMCPII secretion is maximal, mucus trapping can be
demonstrated and gut permeability is increased (Nawa,
1979). The secretion of RMCPII could, as has been
proposed by others (Woodbury et al., 1984), promote
changes in mucosal permeability leading to an increased
translocation of antibody and complement into the gut
lumen. Other mediators such as the leukotrienes and
histamine could increase capillary permeability, and
promote the release of mucus from goblet cells which
would interact with antibody and perhaps the
leukotrienes to produce a mucus gel which would trap
parasites. Histamine and leukotrienes could then act
on smooth muscle, increase peristalsis and purge the host
of trapped parasites. This proposal is attractive and
demonstrates a clear relationship between goblet cell
mucus, mast cells and the mediators of hypersensitivity.
However, the mode of activation of MMC in the absence of
detectable IgE (Jarrett, Haig & Bazin, 1976) remains to
be established.
In secondary challenge, the role of MMC and release
of mast cell-derived mediators is more clear cut. There
is a high level^of IgE in the serum (Jarrett et aJ., 1976)
and abundant MMC (Miller, 1970)• A similar scheme of
events, but of increased tempo, could operate during
rapid expulsion the immediate hypersensitivity response
being of greater intensity leading to the loss of
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parasites over a shorter time period (Miller et^ al.,
1981b).
MMC and goblet cell mucus would seem to provide
a system to cause the expulsion of N.brasiliensis from
the rat. However, it is possible that a wide range of
cells including basophils and eosinophils could be involved
in the mucosal immune response to N.brasiliensis
infection. In as far as MMC are concerned the results
of this thesis have shown that they are activated and
release mediators which could promote the rejection of
N.brasiliensis.
The results presented in this study have added to
the list of criteria by which MMC are defined in the rat
by showing sin extreme sensitivity to corticosteroids
and has demonstrated that the measurement of RMCPII
provides a valuable marker for the assessment of the
degree of MMC activation at mucosal surfaces. These
results may be of particular interest to the clinician
dealing with human allergy in which heterogeneity within
mast cells is only now being recognised (Strobel, Miller
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Summary. The systemic secretion of rat mucosal mast
cell protease (RMCPII) was examined in Nippostron-
gv/w.r-primed rats injected intravenously with N. brasi-
liensis whole worm antigen. The secretory response in
primed rats was both time- and dose-dependent
whereas no RMCPII was present in the sera of naive
rats challenged with antigen. RMCPII was detected in
the sol and gel phases of intestinal perfusates, the
release of enzyme into the gut lumen occurring very
rapidly after challenge in immune rats. Mucosal
permeability, assessed by measuring the passage of
Evan's blue from the blood into the gut lumen was
both time- and dose-dependent and reflected the
combined capillary and epithelial permeability.
Although the release of RMCPII into the gut lumen
occurred more rapidly than the intraluminal accumu¬
lation of Evan's blue, these two events were highly
correlated. There were, in addition significant correla¬
tions between the systemic and enteric secretion of
RMCPII and the enteric accumulation of Evan's blue.
These results indicate that RMCPII may have a role in
altering intestinal mucosal permeability during sys¬
temic anaphylaxis in the rat.
Correspondence: S. J. King, Dept. of Pathology, Mordun
Research Institute, 408 Gilmerton Road, Edinburgh EH 17
7JH.
INTRODUCTION
Following infection with Nippostrongylus brasiliensis,
rats are susceptible to anaphylactic shock induced by
the injection of whole worm antigen (Ogilvie & Love,
1974). This reaction is characterized by major changes
in the small intestine where increased mucosal permea¬
bility and hypersecretion of mucus are prominent
features (Urquhart, Mulligan, Eadie & Jennings,
1965).
Rat mucosal mast cells contain a distinctive pro¬
tease (RMCPII) (Woodbury, Gruzenski & Lagunoff,
1978a) which is present in large amounts in the
intestinal tissues of rats immune to N. brasiliensis
(Woodbury & Miller, 1982). The enzyme is secreted
systemically in primed rats challenged with antigen
and, in these same rats Evan's blue was observed in the
intestinal lumen thus indicating substantial alterations
in mucosal permeability (Miller, Woodbury, Huntley
& Newlands, 1983).
The present study was undertaken to compare the
systemic secretion of RMCPII by mucosal mast cells
and the permeability of the intestinal mucosa using
Evan's blue as an indicator. The results indicate that
these two events are highly correlated and that
intestinal epithelial permeability may be dissociated
from intestinal mucosal vascular permeability.
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MATERIALS AND METHODS
Animals
Male outbred Wistar rats matched for age (12-20
weeks) and weight (200-400 g) were used for each
experiment. They were watered and fed ad libitum, but
fasted 24 hr before an experiment commenced.
Parasitological techniques
The methods used to culture N. brasiliensis and
infection with third-stage larvae (L3) are those de¬
scribed previously (Nawa & Miller, 1978). The prep¬
aration of whole worm antigen was as described by
Nawa, Miller, Hall & Jarrett (1981).
Injection of Evan's blue antigen mixture
Rats, primed twice by infection 1 and 5 weeks earlier
with 6000 N. brasiliensis L3, were given i.v. by
injection, Evan's blue and whole worm antigen in 1 ml
of saline. The dose was calculated so that, in addition
to 2-5 mg Evan's blue/100 g body weight, rats would
receive 50-800 worm equivalents (w.e.) of antigen in
the 1 ml dose injected.
Preparation of tissues for assay
Rats were bled out under ether anaesthesia and their
small intestines removed. The intestines were divided
into two equal lengths and each portion perfused with
10 ml of saline plus 10 ml of air (Nawa, 1979). Gut
contents were kept for subsequent Evan's blue deter¬
mination. Sera were stored at —20°.
Measurement of RMCPII
RMCPII was measured in both sera and intestinal
perfusates using minor modifications of the radial
immunodiffusion assay (Woodbury & Neurath, 1978;
Woodbury & Miller, 1982). A twenty-well assay gel
was prepared from 15 ml of 1% agarose (BDH, Poole)
in phosphate-bullered-saline (PBS) containing 015 ml
of low titre rabbit anti-RMCPII antibody. Samples
and standards were applied to the gel and precipitin
rings allowed to develop for 48 hr at 4° in a humid
chamber. The gel was then pressed, dried and washed
with three 15 min changes of PBS and stained with
0-5% Coomassie Brilliant Blue R250 (Sigma, Poole) in
ethanol:acetic acid:water (90:20:90). The gel was
destained with 90:20:90 ethanol: acetic acid: water to
visualize the precipitin rings. The diameters of the
rings were measured and the concentrations of
RMCPII in the samples determined.
Intestinal permeability
Intestinal perfusates were centrifuged for 10 min at
10,000 rev/min in a Beckman J2-21 centrifuge at 4°.
The clear supernatants were removed and the pellets
resuspended in 5 ml of saline, homogenized in a
teflon/glass homogenizer and Evan's blue determined
in both the supernatant (sol) and homogenized pellet
(gel) by acetone extraction (Nawa, 1979). More than
90% of the Evan's blue from sera and perfusates was
precipitable with 10% trichloroacetic acid (Table 1).
The value for perfusates was corrected for background
interference from normal gut contents before and after
treatment with 10% trichloroacetic acid (TCA).
Statistical methods
The data were analysed by using a two-tailed Student's
t-test and regression analysis was carried out to
Table 1. The precipitation of albumin-bound Evan's blue: the recovery of Evan's
blue from sera and intestinal perfusates
/rg/ml Evan's blue
Serum Sol* Gel*
A B A B A B
Immune control 405 62 (15-3)t 0'2 0 (0) 2-9 0 (0)
Immune challenge (5 min) 490 48 (9-8) 2-9 0 (0) 2-5 0 1 (4)
Immune challenge (60 min) 332 22 (6-6) 8 0 0-5 (6-25) 18 0-2 (IT)
A = concentration of Evan's blue present in sample.
B = concentration of Evan's blue in sample following TCA precipitation.
* Values corrected for background interference at 620 11m.
t % Evan's blue retained in supernatant following TCA precipitation.
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determine the equations of best fit to the data. Both
analyses were carried out using a Tektronix micro¬
computer.
RESULTS
Time course of RMCPII release and mucosal permeabi¬
lity
Twenty-five immune and 10 naive rats were used in
this experiment. Twenty immune and five naive rats
were injected i.v. with 500 w.e. of whole worm antigen
plus Evan's blue. The remaining ten rats were injected
with Evan's blue in saline. Challenge control rats and
immune and naive rats treated with saline were killed
30 min after injection. Immune animals injected with
antigen were killed at 5, 15, 30 and 60 min after
injection of antigen and Evan's blue.
No RMCPII was detected in the sera of immune rats
injected with saline or of naive rats given saline or
antigen. Immune rats injected i.v. with whole worm
antigen had 146 pg RMCPII/ml serum after 5 min and
755 pg RMCPII/ml serum after 60 min. Regression
analysis of these data (Fig. 1) shows a highly signifi¬
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figure 1. The levels of RMCPII in the sera of primed rats
plotted against the time after challenge with 500 w.e. of whole
worm antigen. On regression analysis r = 0-87 (P<0-001).
For challenge rats 5 (□), 15 (■), 30 (O) and 60 min (•). The
mean value for serum RMCPII + SEM for immune rats given
saline shown at 30 min (o).
Figure 2. The partitioning of RMCPII (mean + SEM)
between the sol and gel phases of intestinal perfusates
following i.v. challenge with worm antigen. Sol phase
(O—O), gel phase (•—•) and total RMCPII from sol and gel
phases (■—■). Immune control at 30 min (□).
RMCPII levels in the sera of immune rats
(Y=A + BX, r = 0-87, R< 0-001).
RMCPII was detected in the sol and gel phases of
the intestinal perfusates from immune rats injected
with antigen (Fig. 2). None was present in the sol or gel
phases of perfusates from immune or naive recipients
of saline or from naive rats given antigen. Although
the concentration of RMCPII in the perfusates of
challenged immune rats was not time-dependent it was
related both to the Evan's blue accumulation in the
intestine and to the serum levels of RMCPII (Table 2).
No correction was made for background values (cf.
Table 1) in either challenge controls or in recipients of
whole worm antigen and as a consequence some Evan's
blue was detected in all intestinal perfusates. These
results are in agreement with Nawa's observations on
primary infections with N. brasiliensis (Nawa, 1979).
However, immune rats given saline had significantly
less Evan's blue intraluminally (34 yug/perfusate) than
their challenged counterparts (187 ^g/perfusate), 30
min after i.v. challenge (P < 0 001, Fig. 3).
Five min after i.v. administration of antigen the
levels of Evan's blue in the intestines of primed rats
increased two-fold. Perfusates from naive rats given
saline (24 /rg/perfusate) contained significantly less
(P< 0-001) Evan's blue than those from naive reci¬
pients of worm antigen (55 /ig/perfusate), and no
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Table 2. Analysis of the relationships between time, enteric and systemic
secretion of RMCPII, and enteric accumulation of Evan's blue
Data n Equation of best fit r
Time vs RMCPII* 20 Y=A+BX 0-25
RMCPIIf vs RMCPII* 20 Y = A + B log X 0-73 (^<0 001)
RMCPII* vs Evan's bluef 20 Y=A + B log T 0-72 (P<0-001)
* RMCPII recovered from both sol and gel phases of perfusate (/rg).
t RMCPII in the sera (/rg/ml).






















Figure 3. The levels of Evan's blue in the gut lumen against
time after challenge with 500 w.e. of whole worm antigen. By
regression analysis r = 0-88 (P< 0 001). For rats 5 (□), 15 (■).
30 (O) and 60 min after challenge (•). Mean + SEM for
immune controls at 30 min (o).
RMCPII was detected in the sera of either group
indicating that, if systemic release of RMCPII had
occurred it was below the level of detection. In primed
rats the accumulation of Evan's blue in the intestines
was a function of the time after challenge (Fig. 3,
Y—A + BX, r = 0-88, P< 0-001), and there was a
highly significant correlation (Y=A+BX, r = 0-87,
P< 0-001) between the concentration of RMCPII in
the serum and the levels of Evan's blue in the gut
lumen (Fig. 4).
0 200 400 600 800
pg RMCPII/ml serum
Figure 4. Regression analysis of the relationship between
levels of RMCPII in the sera and Evan's blue in the gut lumen
5 (□), 15 (■), 30 (O) and 60 min (•); r = 0-87 (PcO-OOl).
The relative contributions of sol and gel phases to
the total Evan's blue detected in the gut lumen are
shown in Fig. 5. Most of the Evan's blue is present in
the sol phase but the gel phase contains Evan's blue as
early as 5 min after challenge. These results clearly
show that Evan's blue is partitioned between the two
phases of the intestinal perfusate.
Dose-response relationship
Eleven primed rats were allocated to four groups and
rats in each group were injected i.v. with Evan's blue
and whole worm antigen. Rats in group I were given
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Figure 5. The relative contribution of sol and gel phases to
total Evan's blue in the gut lumen plotted against time after
challenge with 500 w.e. of whole worm antigen. Sol phase
(O—O), gel phase (•—•) and total Evan's blue (■—■).
Immune recipients of saline, sol phase (o), gel phase ( ♦) and
total (□) shown at 30 min (mean + SEM).
400 w.e. of antigen, in group II 200 w.e., in group III
100 w.e. and in group IV the dose given was 50 w.e. No
control group were available for this experiment. All
rats were killed 1 hr after injection of antigen and
Evan's blue.
The results are summarized in Table 3 and show
that both the systemic secretion of RMCPII and the
Tabic 3. The systemic secretion of RMCPII and intralu¬
minal accumulation of Evan's blue in the small intestine
following i.v. challenge of primed rats with whole worm
antigen
Systemic RMCPII Evan's blue
Treatment* /rg/ml serum /<g/perfusate
Group (w.e.) n (mean + SD) (mean±SD)
I 400 3 312+115 113 + 38
II 200 3 264+171 76 + 69
III 100 3 110+ 67 24+13
IV 50 2 24+ 5 3+ 4
* i.v. worm antigen plus Evan's blue.
intestinal accumulation of Evan's blue are dose-
dependent (for RMCPII Y=A + B log X, r = 0-75,
P<001 and for Evan's blue Y=A + B log X, r = 0-76,
P<001). There was in addition a highly significant
correlation between the concentration of Evan's blue
in the perfusates and the levels of RMCPII in the sera
(Y=A + BX, r—0-97, P < 0 001, Fig. 6).
A second experiment was carried out using twenty-
nine immune and five naive rats. These were allocated













Figure 6. Regression analysis of the levels of RMCPII in the
sera of primed rats and the amount of Evan's blue in the gut
lumen r = 0-97 (P<0 001).
Table 4. The systemic secretion of RMCPII and levels of
Evan's blue detected in the gut lumen following i.v. challenge
with whole worm antigen
Systemic RMCPII Evan's blue
/(g/ml serum ^g/perfusate
Group Treatment n (mean + SEM) (mean + SEM)
I 800 w.e.* 5 458+148 198 + 29
11 400 w.e.* 4 295+147 138 + 31
III 200 w.e.* 5 7+ 2 35+ 7
IV 100 w.e.* 5 6+ 2 24+ 2
V 50 w.e.* 5 11+ 11 44+11
VI Saline* 5 0 21+ 5
VII 400 w.e.f 5 0 24+ 5
* Immune rats given i.v. worm antigen plus Evan's blue,
t Naive rats given i.v. worm antigen plus Evan's blue.
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animals were killed 1 hr after injection and the
concentrations of RMCPII in the sera and of Evan's
blue in the intestinal perfusates were determined. The
results are summarized in Table 4.
No RMCPII was detected in the sera of immune rats
given saline (group VI) or in the sera ofnaive rats given
antigen (group VII). There was, however, a highly
significant dose-dependent (Y=A + BX, r = 0-71,
P< 0-001) release of RMCPII in primed rats given
whole worm antigen and Evan's blue.
The amount of Evan's blue detected in the intestinal
perfusates of saline-injected immune rats and of naive
recipients of antigen did not differ significantly (Table
4). Immune recipients of worm antigen responded by a
dose-dependent increase in the amount of Evan's blue
detected in the gut lumen. The relationship between
dose of antigen and intraluminal Evan's blue levels
was highly significantly correlated (Y=A + BX,
r = 0-84. P< 0-001). On analysis of regression intralu¬
minal Evan's blue levels and systemic RMCPII levels
were found again to be highly significantly correlated
(Y=A + BX,r = 0-78, PcO-OOl).
DISCUSSION
Three major findings arise from this study: (a)
RMCPII is secreted systemically in primed rats in a
dose- and time-dependent manner following i.v. chal¬
lenge with whole worm antigen; (b) the enzyme is
present in large amounts in the intestinal lumen in
these same rats; (c) systemic release of RMCPII is
associated with very substantial changes in mucosal
permeability as measured by the intraluminal accumu¬
lation of Evan's blue.
Our earlier studies (Miller et a/., 1983) indicated that
systemic release of RMCPII was associated with
increased intestinal mucosal permeability since Evan's
blue was observed within the intestinal lumen of
shocked rats. By using Nawa's technique (Nawa,
1979) of intestinal perfusion to recover the intestinal
contents we have now shown that the accumulation of
Evan's blue is both time- and dose-dependent. Furth¬
ermore mucosal permeability is also related to the
enteric and systemic secretion of RMCPII.
The permeability of the intestinal mucosa was
determined by measurement of the intraluminal ac¬
cumulation of Evan's blue dye. This dye has been
shown to combine preferentially with plasma albumin
(Rawson, 1943) and the present results confirm those
of Nawa (1979) in that > 90% of the Evan's blue from
gut contents and from sera was precipitable with 10%
trichloroacetic acid indicating that the dye remains
bound to protein. Consequently, measurement of
Evan's blue in the intestinal lumen largely represents
the translocation of albumin molecules and reflects the
combined vascular and epithelial leak of protein.
The method of extraction of Evan's blue (Nawa,
1979) was modified to recover the dye from both sol
and gel phases of each perfusate. Data from the time
course studies show that the gel phase contained
Evan's blue at the earliest time point analysed
although the contribution of the gel phase to the total
Evan's blue in the perfusate was a minor one. How¬
ever, even after homogenization and extraction of the
gel phase in acetone some dye remained in the pellet,
indicating that the amount of Evan's blue in the gel
phase is likely to be underestimated.
RMCPII is the predominant chymotrypsin-like
protease of mucosal mast cells (Woodbury & Neurath,
1978). It is highly soluble (Woodbury & Neurath,
1978) and putative protease inhibitors do not interfere
with the immunoassay technique (Woodbury, Hunt¬
ley & Miller, unpublished observations). The protease
can be reliably measured by radial immunodiffusion
down to levels of 10 /rg/ml.
Relatively large amounts of RMCPII were present
in the sol and gel phases of perfusates within 5 min of
antigen challenge whereas none was detected in perfu¬
sates from any of the control rats. RMCPII could also
be detected in perfusates within 90 sec of injection of
antigen into primed rats (King, unpublished observa¬
tions). Because these high levels of RMCPII were
detected in the perfusates within 90 sec to 5 min of
challenge they were unlikely to be grossly overesti¬
mated as a consequence of RMCPII breakdown
although some catabolism of the enzyme may have
occurredf at later time intervals. Since the transloca¬
tion of RMCPII into the gut lumen merely requires a
change in epithelial permeability, and since the pass¬
age of albumin-bound Evan's blue is a consequence of
both vascular and epithelial permeability it would
follow that RMCPII release and epithelial permeabi¬
lity occurred before the development of vascular
changes.
The extraction of RMCPII like that of Evan's blue
from the gel phase was probably incomplete and was
presumably dependent upon the nature of the interac¬
tion of RMCPII and the gel components. The gel
phase in addition to containing mucin contains epithe¬
lial cells and DNA from cell breakdown (Ferencz,
Orskov, Orskov & Klemm, 1980). Since RMCPII is a
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highly basic protein it may interact with the acidic
glycoproteins in mucin (Woodbury & Miller, 1982)
and if present in an undegraded form in the gel phase it
may well play some part in altering the solubility of
intestinal mucin.
The intraluminal RMCPII (sol and gel phase)
values correlated highly with the amount of Evan's
blue in the gut lumen. The relationship was not direct
and could mean that there is a rate-limiting step,
possibly, for example, the development of capillary
permeability.
The kinetics of systemic secretion of RMCPII were
similar to those of Evan's blue accumulation in the gut
lumen and these two events were highly correlated. If,
as suggested above, capillary permeability is the
rate-limiting step determining these kinetics, then the
rapid release of RMCPII into the gut lumen is clearly
independent of capillary permeability. By contrast the
permeability of the mucosal epithelium, indicated by
intraluminal RMCPII. is altered very rapidly and this
would be compatible with histological studies demon¬
strating that the epithelium is shed within a few
minutes of challenge (Miller & King, unpublished
observations).
The high concentrations of RMCPII in the intes¬
tinal lumen are indicative of the extent of mucosal
mast cell secretion from the mucosa and suggest that
this could be a major source of the enzyme in blood
during systemic anaphylaxis. The function of
RMCPII has not been ascertained although it has
proteolytic activity against basement membrane type
IV collagen (Sage, Woodbury & Bornstein, 1979) and
is particularly effective in releasing epithelial cells from
intestinal slices in vitro (Woodbury, pers. comm.). It is
possible, therefore, that RMCPII is responsible for
epithelial shedding, although more direct experimen¬
tation would be required to confirm this.
Studies by Seppa (1979) have shown that RMCPI,
biochemically a very similar enzyme (Woodbury,
Katunuma, Kobayashi, Titani & Neurath, 1978) from
rat connective tissue mast cells, is a potent mediator of
vascular permeability in the skin and it is possible that
RMCPII is likewise involved in the mediation of
mucosal vascular permeability. However, monoa¬
mines and leukotrienes released from mucosal mast
cells in conjunction with RMCPII are likely to be the
most functionally significant mediators of mucosal
vascular permeability.
In summary, systemic anaphylaxis in rats primed by
injection with N. brasiliensis and challenged with
whole worm antigen is associated with major changes
in the small intestine. By measuring the accumulation
of RMCPII and Evan's blue in the gut lumen and
RMCPII in the serum, it has been possible to disso¬
ciate the events of mucosal epithelial damage and
permeability from mucosal vascular damage and
permeability. The precise roles of mucosal mast cells
and of RMCPII in the pathogenesis of these changes
remain to be determined.
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ABSTRACT Rats primed by infection with the intestinal
nematode Nippostrongylus brasiliensis and challenged intra¬
venously with soluble whole-worm antigen undergo systemic
anaphylactic shock. The primary lesions are in the gut and
include increased permeability of the mucosa together with
release, into enteric secretions, of a mucosal mast cell (MMC)-
specific serine proteinase, rat mast cell protease II (RMCP-II).
This enzyme is also released into the blood of shocked rats.
These manifestations of anaphylaxis were abolished in rats
previously treated with corticosteroids (methylprednisolone
acetate, 25 mg per kg of body weight, 48 and 24 hr before i.v.
challenge with antigen). Suppression of the response was
associated with depletion of RMCP-II and of MMC from the
intestinal mucosa. Depletion occurred 4-24 hr after treatment
with as little as 1 mg of methylprednisolone per kg. By
contrast, neither connective tissue mast cells nor serum levels
of parasite-specific IgE were depleted in rats given 2 x 25 mg
of methylprednisolone per kg. The capacity of unprimed
treated rats to mount passive cutaneous anaphylaxis was,
however, impaired.
Corticosteroids are potent, widely used anti-inflammatory
drugs, and their therapeutic value in the treatment of allergic
conditions in man and domestic animals is well known.
Although these drugs act at a number of different levels,
perhaps their most significant anti-allergic effect is in pre¬
venting the generation and release of inflammatory media¬
tors (1). For example, they suppress histamine release from
isolated rat and murine mast cells (2, 3), and they act
indirectly to prevent the generation of secondarily formed
mediators (4-6).
Systemic anaphylaxis in the rat is abrogated by prior
treatment of sensitized animals with corticosteroids (7). The
major shock organ responding to anaphylaxis in this species
is the small intestine (8), and the lesions associated with
intestinal anaphylaxis include hyperaemia, secretion of mu¬
cus, and epithelial shedding (9-11). The development of
intestinal lesions is associated with the release, into the
blood circulation and into the gut lumen, of a mucosal mast
cell (MMC)-derived neutral proteinase, rat mast cell
protease II (RMCP-II) (10, 11), and recent studies have
implicated this enzyme in the generation of intestinal epi¬
thelial permeability (11).
Because RMCP-II is a highly soluble product of MMC (12)
and is antigenically distinct from insoluble chymotrypsin-
like enzyme (RMCP-I) in connective tissue mast cells (13),
its release into the blood circulation or gut lumen provides a
unique and highly specific marker of in vivo activation of
MMC. We have, therefore, measured the concentration of
this enzyme within the tissues, in the intestinal secretions,
and in blood in order to analyze the anti-anaphylactic
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
activity of corticosteroids and to measure their effect on the
mucosal mast cell subpopulation in rats subjected to
anaphylactic shock.
MATERIALS AND METHODS
Animals. Male and female outbred Wistar rats matched for
age (30-36 weeks) and weight (350-450 g) were used. They
were watered and fed ad lib, but food was withdrawn 24 hr
before challenge.
Parasitological Techniques. The methods used to culture
the nematode parasite Nippostrongylus brasiliensis and to
infect rats have been described (14). Adult whole-worm
antigen was prepared as described (15).
Treatment of Experimental Animals. Rats were allocated
to groups and were treated with saline or methylpred¬
nisolone acetate (25 mg per kg of body weight) by intra¬
muscular injection 24 and 48 hr before they were challenged
intravenously with Evan's blue (2.5 mg per 100 g of body
weight). The latter was dissolved either in saline alone or in
saline containing 500 worm equivalents (w.e.) (15) of worm
antigen. Treatment schedules are summarized in Table 1.
Quantification of Evan's Blue and RMCP-II. One hour
after intravenous challenge, rats were exsanguinated under
ether anesthesia, and their intestines were excised. Each
intestine was perfused with saline and the concentration of
Evan's blue in the perfusate was determined spectrophoto-
metrically (11). The following tissues were collected:
jejunum (25 cm distal to the pylorus); ileum (10 cm proximal
to the ileo caecal valve); mesenteric lymph node (MLN)
(divided into two portions, one for histology); and the right
lobe of the lung. Each specimen was weighed and homog¬
enized in 3 vol of 0.15 M KC1 (16). The concentrations of
RMCP-II in the tissue homogenates, gut perfusates, and
serum were measured by radial immunodiffusion (11).
Histology and Cell Counts. (0 Carnoy fixation. The follow¬
ing tissues were placed in Carnoy's fluid; jejunum and ileum
(specimens adjacent to those used for protease determina¬
tion), MLN, and the left lobe of the lung. The tissues were
processed and stained with Alcian blue/Safranin as de¬
scribed (16).
(fi) Paraformaldehyde (4%) in phosphate-buffered saline.
Portions of jejunum and ileum and ear pinnae (from naive
rats) were fixed for 6 hr, transferred to 70% ethanol, and
stored at 4°C overnight. The tissues were dehydrated and
processed into wax, and sections were stained for non¬
specific esterase with the substrate napthol AS-D
chloroacetate (Fig. 1) (17). Adjacent sections were stained
with Alcian blue to show mast cells (16).
Mast cells in both jejunum and ileum were counted per
villus crypt unit (VCU) as described (16). Mast cells were
Abbreviations: MMC, mucosal mast cell; CTMC, connective tissue
mast cell; RMCP, rat mast cell protease; w.e., worm equivalent:
MLN, mesenteric lymph node; VCU, villus crypt unit; PCA,
passive cutaneous anaphylaxis.
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Table 1. Measurement of gut permeability and RMCP-II release during anaphylaxis in normal and
corticosteroid-treated rats
Pretreatment/ Evan's blue, Systemic RMCP-II. Enteric RMCP-II,
Group Status n challenge ixg per perfusate ixg per ml of serum /xg per perfusate
I Immune 6 S/Ag 406 ± 41* 90 ± 19+ 797 ± 250+
II Immune 6 C/Ag 88 ± 8 0 0
III Immune 6 S/S 104 ± 2 0 0
IV Immune 6 c/s 124 ± 8 0 0
V Naive 5 S/Ag 64 ± 4 0 0
VI Naive 5 C/Ag 51 ± 6 0 0
VII Naive 5 S/S 72 ± 5 0 0
VIII Naive 5 C/S 69 ± 5 0 0
Immune animals were infected 1 and 3 weeks previously with 5000 N. brasiliensis L3. S, saline; C, methylprednisolone
acetate; Ag, 500 w.e. of whole worm antigen. Values represent mean ± SEM.
*P < 0.001 when compared with each group (Student's t test).
P < 0.001 when compared with each group (Mann-Whitney U test).
not enumerated in lung and MLN, but mast cell density was
scored on an arbitrary scale.
Sections of ear pinnae were examined microscopically and
the total number of mast cells was enumerated. The area of
tissue in which mast cells were counted, excluding cartilage,
was measured by projecting the sections onto equiweight
paper using a photoenlarger and then calculating the area by
weight analysis of the tissue outline.
Passive Cutaneous Anaphylaxis (PCA). Rats were bled via
the tail vein before saline or drug treatment and again
immediately before challenge with worm antigen. Sera were
harvested and double dilutions were injected intradermally
into the shaved backs of recipient rats, which were chal¬
lenged intravenously 48 hr later with worm antigen (1000
w.e.) and Evan's blue (18). PCA titers were expressed as the
reciprocal of the highest dilution that induced blueing to a
diameter of >5 mm on the underside of the skin.
The Effect of Corticosteroid Treatment of PCA. Recipient
rats were injected intradermally with double dilutions of a
serum sample taken from an animal immunized by two
previous infections with N. brasiliensis. The recipients were
immediately injected intramuscularly with either saline or
methylprednisolone (25 mg per kg of body weight). These
treatments were repeated 24 hr later, and PCA titers were
determined after a further 24 hr.
RMCP-II Release as a Consequence of Corticosteroid Treat¬
ment. Fifteen naive rats, allocated to three groups, were bled
via the tail vein before receiving intramuscular injections of
saline, methylprednisolone acetate (25 mg per kg of body
weight), or betamethasone (2 mg per kg of body weight) and
were bled, 1, 4, and 24 hr later; rats given betamethasone
were exsanguinated at 24 hr, and the remainder were given a
second dose of saline or methylprednisolone. Blood samples
were taken 1 and 4 hr later, and the remaining rats were
exsanguinated 24 hr after the second injection. Samples of
jejunum were collected for measurement for RMCP-II con¬
centrations and of the numbers of MMC. Sera were analyzed
for RMCP-II using an ELISA technique as described (10).
Statistical Treatment of Results. Data were analyzed using
a Tektronix microcomputer using either a Student's two-
tailed t test or, where necessary, a Mann-Whitney U test.
Simple regression analysis was performed using the same
computer facilities.
RESULTS
Intestinal Permeability and Secretion of RCMP-II. A highly
significant (P < 0.001, Student's t test) 4-fold increase in the
concentration of Evan's blue occurred in the intestinal
lumen of sensitized animals (group I) challenged intra¬
venously with worm antigen (Table 1). This response was
totally suppressed in sensitized rats that had been previously
treated with methylprednisolone (group II in Table 1).
Similarly, RMCP-II was released into the blood and into
the intestinal lumen of rats in group I, but this response was
again totally suppressed (P < 0.001, Mann-Whitney U test)
in rats previously treated with methylprednisolone (group II,
in Table 1). Saline injection of either untreated or drug-
treated sensitized rats and antigen injection into either
untreated or drug-treated naive rats induced no significant
alteration of mucosal permeability or release of RMCP-II
(Table 1).
Tissue Distribution of RMCP-II. (/) Jejunum: pretreatment
of rats with methylprednisolone acetate significantly (P <
0.001) depleted the jejunum of RMCP-II in both immune and
naive animals (Table 2). Antigen challenge of sensitized rats
was without effect when mucosal concentrations of RMCP-
II were compared with those in immune rats challenged with
saline (Table 2). (if) Ileum: after treatment with cortico¬
steroid, RMCP-II was significantly (P < 0.001) depleted
from both immune and naive rats when compared with
saline-injected controls (Table 2). (Hi) Lung: corticosteroids
reduced the concentration of RMCP-II in lung homogenates
from immune rats (Table 2). The concentrations of RMCP-II
in homogenates from naive rats were too low (<10 /xg per g
of tissue) to be measured by radial immunodiffusion, but
trace amounts of enzyme were detected in naive animals that
had not been treated with corticosteroid (Table 2). (iv)
Mesenteric lymph node: the concentration of RMCP-II in
the nodes of immune rats challenged with antigen was
unaltered when compared with that in rats given saline, but
corticosteroid depleted the immunized node of RMCP-II
(Table 2). The values in nodes of untreated naive rats were
similar to those in the lung at the limit of detection of the
assay system (Table 2).
Mast Cell Changes After Corticosteroid Treatment. Pre¬
treatment of rats with corticosteroid significantly (P < 0.001,
Student's t test) reduced the numbers of MMC in the
jejunum and ileum of naive and immune rats. The results
were very similar whether the cells were detected by their
content of nonspecific esterase (Fig. 1) or with Alcian blue
(Table 3). The numbers of MMC in the jejunal and ileal
mucosae of primed rats were unaltered after challenge with
worm antigen (Table 3). Because of the anisotropic distribu¬
tion of mast cells in the lung and MLN, a semi-quantitative
assessment of cell density was used. Glucocorticoid treat¬
ment of sensitized rats caused an apparent reduction in the
density of mast cells in both tissues, whereas antigen chal¬
lenge was without effect (Table 3). Relatively few mast cells
were present in the lungs of naive rats, and those present in
the MLN were distributed in the capsule, with few being
located in the cortex. Corticosteroids had no discernible
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Table 2. Effect of anaphylaxis and corticosteriod treatment on
distribution of RMCP-II in jejunum, ileum, lung, and MLN in
immune and naive rats
fig of RMCP-II per g (wet weight) of tissue
Group Jejunum Ileum Lung MLN
I 1780 ± 120 471 ± 19 219 ± 24 86 ± 16
11 215 ± 25" 106 ± 10* 126 J- 16+ <10t
III 1840 ± 84 51/ ± 13 182 ±1/ 90 ± 0
IV 165 ± 33* 98 ± 5* 117 ± 148 <10*
V 534 ± 51 195 ± 10 <10 <10
VI 252 ± 57* 61 ± 5* 0 0
VII 576 ± 51 200 ± 6 <10 <10
VIII 210 ± 30* 66 ± 0* 0 0
Groups and treatments are as described in Table 1. Values repre¬
sent mean ± SEM.
*P < 0.001. Analysis of effect of corticosteroid treatment (Student's
r test).
< 0.01.
*P < 0.001 (Mann-Whitney U test).
8f < 0.05.
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effect on lung mast cells in naive rats but slightly decreased
the numbers of mast cells in the cortex of MLN (Table 3).
The Response of Connective Tissue Mast Cells to
Corticosteroid Treatment. Corticosteroid treatment did not
alter the numbers of mast cells in the ear pinnae of naive
rats. Recipients of saline had 56 ± 4 mast cells per mm2; in
corticosteroid-treated rats, there were 53 ± 3 mast cells per
mm2 of tissue. Similarly, antigen challenge of naive rats was
without effect on connective tissue mast cells (CTMC) (55 ±
6 mast cells per mm2). The numbers of CTMC stained with
Alcian blue when compared with the numbers containing
esterase activity were, by simple regression analysis, highly
significantly correlated (y = 12.8 + 0.76x; r = 0.81; P <
0.001).
PCA Reactivity of Serum After Corticosteroid Treatment.
Serum taken from rats before they were treated with
methylprednisolone (PCA titer, 280 ± 114) and serum taken
from the same rats immediately before antigen challenge
(PCA, 280 ± 114) had identical PCA values. Similarly, PCA
titers measured before saline treatment of immune control
rats (176 ± 39) were unaltered 48 hr later.
Effect of Corticosteroid Treatment on PCA. The PCA titer
(40 ± 0) in naive rats injected intradermally with immune







Fig. 1. Tissue sections stained with napthol AS-D chloroacetate
from (Upper) saline-treated and (Lower) corticosteroid-treated rats.
Note the substantial depletion of MMC after treatment. (x275.)
cantly (P < 0.001) decreased when compared with similarly
sensitized rats (352 ± 78) treated with saline.
Serum Levels of RMCP-II After Corticosteroid Treatment.
The concentration of RMCP-II in sera obtained 1, 4, 24, and
48 hr after treatment with methylprednisolone and 1, 4, and
24 hr after treatment with betamethasone was determined by
ELISA. At no time was RMCP-II detected in the blood.
There was, however, depletion of MMC after treatment with
either methylprednisolone (3.7 ± 0.5 MMC per VCU) or




Jejunum Ileum Mast cell density
Alcian blue Esterase Alcian blue Esterase Lung MLN
I 29.6 ± 1.7 30.0 ± 2.0 15.9 ± 1.5 16.0 ± 1.4 + + + + + +
II 3.3 ± 0.3* 3.6 ± 0.2* 2.2 ± 0.4* 2.4 ± 0.4* + + + + +t
III 32.6 ± 1.0 32.9 ± 1.5 17.4 ± 0.8 18.0 ± 1.0 + + + + + +
IV 3.8 ± 0.4* 4.0 ± 0.3* 2.8 ± 0.3* 2.8 ± 0.1* + +t + +1
V 6.8 ± 0.5 7.7 ± 0.3 4.0 ± 0.1 4.3 ± 0.1 -t +
VI 2.1 ± 0.2* 2.5 ± 0.2* 1.4 ± 0.2* 1.3 ± 0.2* + ±t
Vll 7.5 ± 0.5 8.3 ± 0.5 4.2 ± 0.2 4.4 ± 0.4 + +
VIII 2.4 ± 0.2* 2.4 ± 0.2* 1.4 ± 0.2* 1.4 ± 0.1* + + t
Groups and treatments are as described in Table 1. Values represent mean ± SEM. Values for
MMC/VCU when stained with esterase showed a highly significant correlation with those stained with
Alcian blue: for jejunum (y = 0.45 + 0.99.v; r = 0.99) and for ileum (y = 0.07 + l.O.v; r = 0.99).
Subjective mast cell density: (+ + +) substantial increase when compared with naive controls ( + ).
*P < 0.001 significant depletion of mucosal mast cells after corticosteroid treatment.
"'"Some depletion of mast cells after corticosteroid treatment.
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Table 4. Effect of dose and time after administration of
methylprednisolone on concentration of RMCP-II and
number of MMC in jejunum of immune rats
RMCP-II, jug/g MMC/VCU
wet weight Alcian blue Esterase
Methylprednisone,
mg/kg*
Saline control 1935 ± 152 33.7 ± 1.4 32.4 ± 1.0
1 487 ± 45+ 12.3 ± 0.7t 10.4 ± 0.7+
5 285 ± 29+ 6.3 0.5+ 5.9 ± 0.2+
25 292 ± 33+ 4.5 +; 0.5+ 4.7 ± 0.2+
Time, hr+
1 1357 ± 185 22.8 1.1 22.7 ± 2.0
4 1327 ± 82 23.7 1.2 22.6 ± 0.9
24 570 ± 30$ 7.6 ± 0.5§ 8.0 ± 0.7§
24 (saline) 1395 ± 169 23.3 + 2.2 24.9 ± 1.3
Values represent mean ± SEM.
*By regression analysis, Alcian blue vs. esterase: y = -0.45 +
0.99*; r = 0.99.
+Significant depletion when compared with saline controls (P <
0.001, Student's t test).
+By regression analysis, Alcian blue vs. esterase: y = 0.84 + 0.96*;
r = 0.97.
§/> < 0.001 when compared with 24-hr saline group.
betamethasone (5.6 ± 0.2 MMC per VCU) when compared
with mast cell numbers in control rats (10.3 ± 0.5 MMC per
VCU) treated with saline. The numbers of MMC detected by
esterase stain and by Alcian blue were similar, and by
regression analysis there was a highly significant correlation
between the two staining methods (y = 0.19 + 0.94*; r -
0.93; P < 0.001). Similarly, the concentration of RMCP-II
was decreased (P < 0.001) in the jejunum of rats treated with
either methylprednisolone (313 ± 48 jug/g) or betametha¬
sone (493 ± 33 ng/g) when compared with saline controls
(784 ± 24 fig/g). There was, in addition, a highly significant
correlation between the numbers of MMC detected with
esterase stain and the concentration of RMCP-II in the
jejunum of the three groups of rats (y = 164 + 61x; r = 0.87;
P < 0.001).
Dose-Response Relationship. Rats immunized by two pre¬
vious infections with N. brasiliensis were injected intra¬
muscularly with saline or with 1, 5, or 25 mg of
methylprednisolone acetate per kg of body weight 24 and 48
hr before they were killed and bled out. When compared
with saline-treated controls, methylprednisolone caused a
dose-dependent depletion of RMCP-II within 24 hr from the
mucosa (Table 4). The data fitted the following regression
equation: y = */-0.002 + 0.004* (r = 0.81) and indicated
that 5 mg of methylprednisolone per kg of body weight was
as effective in depleting MMC from the jejunum as was 25
mg/kg. The decrease in the numbers of jejunal MMC
(esterase) was highly correlated with the loss of jejunal
RMCP-II (y = -69 + 61*; r = 0.98).
Time Course of Mast Cell Changes. Immune rats were
allocated to groups and given intramuscular injections of 25
mg of methylprednisolone or saline per kg of body weight.
Groups of four rats were killed 1, 4, and 24 hr after
prednisolone treatment and four rats were killed 24 hr after
saline treatment. Samples of jejunum were collected for
histology and for measurement of RMCP-II concentrations.
No significant depletion of either mast cells or RMCP-II was
detected until 24 hr after injection of corticosteroid (Table 4).
These data indicate that mast cell changes occur between 4
and 24 hr after administration of steroid.
DISCUSSION
The neutral serine proteinase RMCP-II is located uniquely
within the granules of a subset of mast cells commonly
referred to as "atypical" or "mucosal mast cells" (19), and
the two principal effects of corticosteroid treatment de¬
scribed in the present study were (/) suppression of the
anaphylactic release of this enzyme into intestinal secretions
and into blood and (ii) depletion of RMCP-II from the
intestinal mucosa. These events may, therefore, be related
to the suppression of intestinal anaphylaxis and to our failure
to detect systemic or enteric release of RMCP-II in primed
antigen-challenged rats.
Our results have confirmed previous reports that
corticosteroids suppress anaphylactic pathology in the gut
(9), there being no detectable permeability changes in the
treated immune rats challenged with worm antigen (Table 1).
In addition, they extend earlier observations on the ability of
corticosteroids to suppress the development of intestinal
mucosal mastocytosis during nematode infection (20, 21) by
showing that fully mature MMC in normal and immune rats
are depleted by corticosteroid treatment. By contrast,
CTMC in the pinna of the ear were apparently unaffected.
This latter finding indicates a further important functional
difference between CTMC and MMC in the rat.
Significant depletion of MMC and RMCP-II occurred
between 4 and 24 hr after exposure to steroid, and this may
explain why in previous studies (7) optimal inhibition of
anaphylactic bronchoconstriction was not observed until
12-24 hr after dexamethasone administration. The extreme
sensitivity of MMC to steroids was indicated by the fact that
treatment with as little as 1 mg of methylprednisolone per kg
of body weight caused a significant decrease in their num¬
bers (Table 4).
Depletion of MMC was in every instance paralleled by a
loss of RMCP-II from the jejunal mucosa. Both MMC and
CTMC were in these studies identified histologically by their
content of glycosaminoglycan and of serine esterases. Nei¬
ther of these granule constituents was depleted from CTMC
after steroid treatment, whereas both were lost from MMC.
Although depletion of MMC occurred between 4 and 24 hr
after treatment, there was no detectable release of RMCP-II
into the serum at 1, 4, or 24 hr. The ultimate fate of MMC
was not established and must await further study.
Corticosteroid treatment of rats passively sensitized
intradermally with immune serum caused a highly significant
but incomplete inhibition of passive cutaneous anaphylaxis.
The binding of IgE to the mast cell surface is not impaired in
vitro by steroids (3, 22) and, in the present study,
corticosteroids failed to suppress the level of circulating IgE.
Consequently, two mechanisms of inhibition of intestinal
anaphylaxis might operate: (i) inhibition of mediator release
from mast cells by corticosteroids and (ii) modification of the
response of target organs to these mast cell-derived media¬
tors. The extent to which the intestinal response was sup¬
pressed by the known capacity of steroids to decrease
permeability in capillary beds (23) or cause vasoconstriction
(24) cannot be determined from the present data. It is
possible that both mechanisms operate in the suppression of
intestinal permeability changes.
Elevation of cAMP (3, 22) and effects on arachidonic acid
metabolism (25) and its inhibition of release from the cell
membrane by lipomodulin-like proteins (26-28) have been
put forward to explain corticosteroid inhibition of mediator
release from CTMC. However, it is not clear whether these
mechanisms are applicable to MMC, as they differ biochemi¬
cally and functionally (29) from CTMC. But it is interesting
to note that one action of corticosteroids may be to impair
mitochondrial function (2), and it is possible that MMC have
a greater energy requirement than CTMC.
In summary, pretreatment of sensitized rats with
corticosteroids suppresses intestinal anaphylaxis and is as¬
sociated with a marked depletion of MMC. However, the
possibility cannot be ruled out that the depletion of MMC is
1218 Immunology: King et al. Proc. Natl. Acad. Sci. USA 82 (1985)
an indirect effect resulting from the primary action by
corticosteroids on other cell types, such as T lymphocytes.
Also, since CTMC remain undepleted from the dermis of the
ear pinna, there appears to be a very important difference
between the two cell populations in terms of steroid sensitiv¬
ity, which may be of potential importance in man, where
MMC have only recently been identified (30).
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The Presence in Blood of Both Glycosaminoglycan and Mucosal Mast Cell
Protease following Systemic Anaphylaxis in the Rat
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Abstract. The appearance in blood of rat mast cell protease II (RMCPII) and glycosaminoglycan (GAG)
was examined in normal and Nippostrongylus brasiliensis-primed rats challenged intravenously with worm an¬
tigen. Systemic release of these two products occurred only in immune recipients of antigen; substantial levels
of RMCPII were also present in the intestinal perfusates of these same rats and there was depletion of both
RMCPII and mucosal mast cells (MMC) from the intestinal mucosa. Depletion of MMC was evident after
staining for proteoglycan or for serine esterase and the mast cell counts with both histochemical techniques
were highly correlated. Taken together, the results suggest that MMC are likely to be the principal source of
secreted GAG and RMCPII.
During the immune expulsion of the gastrointesti¬
nal nematode Nippostrongylus brasiliensis from the
rat, there is discharge of granule contents of mucosal
mast cells (MMC), and depletion of proteoglycan
from these cells [1]. Following intravenous challenge
of primed rats with N. brasiliensis worm antigen, ex¬
tensive mucosal damage ensues which is accompan¬
ied by the systemic and enteric release of a specific
neutral proteinase: rat mast cell protease II (RMCPII)
[2] derived from MMC, and depletion of MMC from
the jejunal mucosa [3]. The present study was under¬
taken to analyse body fluids for the presence of
MMC-derived proteoglycan during systemic anaphy¬
laxis in the rat.
15 female outbred Wistar rats, immunised 3 and 8
weeks earlier by subcutaneous injection with 6,000 N.
brasiliensis larvae [4], were allocated randomly to 3
groups of 4 rats and 1 group of 3 rats and were chal¬
lenged intravenously with 1,000, 500 or 250 worm
equivalents (w.e.) of adult whole worm antigen or sa¬
line. Worm antigen was prepared as described previ¬
ously [5], A further group of 4 naive rats was chal¬
lenged with 500 w.e. intravenously. 1 h after intrave¬
nous challenge, animals were anaesthetised with ether
and bled out. Blood was collected into the anticoagu¬
lant 'Thrombotect' (Abbott) and the plasma was sepa¬
rated by centrifugation and stored at -70°C. Serum,
small intestinal perfusates and samples of jejunum
were collected and the concentrations of RMCPII in
these samples were measured by radial immunodiffu¬
sion [2, 3]. Additionally, adjacent segments of jeju¬
num were placed in either Carnoy's fluid or 4% para¬
formaldehyde prepared with phosphate-buffered sa¬
line. Tissues were embedded in wax and sections were
stained with either Toluidine blue [6] or with naphthol
AS-D chloroacetate to demonstrate serine esterases
[7]. Plasma, gut perfusates and gut homogenates were
analysed for the presence of glycosaminoglycan
(GAG) by a modification of the competitive heparin
binding assay previously described [8], in which poly-
brene-Sepharose was substituted for protamine-Se-
pharose as the binding reagent and the radioactive
tracer and standard were heparan sulphate rather
than heparin.
RMCPII was present only in the sera of immune
rats challenged with worm antigen (fig. 1) and in these
same rats there was a 10-fold increase in the concen¬
tration of GAG in plasma when compared with im¬
mune recipients of saline or naive rats given antigen
(fig. 1). Although the release of RMCPII and GAG
into the blood was, in this experiment, independent of
the dose of antigen, there was a highly significant
correlation between the concentrations of RMCPII
and GAG (y = 2,110+ 17 x, r = 0.93, p< 0.001; fig. 2),
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Fig. 3. Regression analysis demonstrating a highly significant
correlation between the numbers of MMC enumerated after stain¬
ing with Toluidine blue and with naphthol AS-D chloroacetate
(y = -2.3 + 1.1 x, r = 0.98, p < 0.001).
Fig. 1. a Total recoveries of RMCPII (mean ± SEM) in intesti¬
nal perfusates (•) and concentration of enzyme in jejunal mucosa
(/rg/g wet weight tissue, ■) of immune rats given worm antigen or
saline (dose = 0). The number of mucosal mast cells (MMC) per vil¬
lus crypt unit (VCU) detected with Toluidine blue (mean ± SEM,
O) are also shown. Individual symbols showing the concentrations
of RMCPII in perfusates (♦) and gut homogenates (□) and the
number of MMC (O) in naive rats challenged with 500 w.e. of anti¬
gen are also plotted, b The concentrations of RMCPII in serum
(mean ± SEM •) and glycosaminoglycan (GAG) in plasma (mean
± SEM ■) are plotted against the dose of worm antigen. Values
from immune rats injected with saline are plotted at the zero dose
and in naive rats given antigen the values are plotted at 500 w.e. for
RMCPII (O) and for GAG (□).
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Fig. 2. Regression analysis of the concentrations of RMCPII in
serum against GAG in plasma (y = 2,110+17 x, r = 0.93,
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which would suggest that they may have been released
from the same source.
Intestinal perfusates from primed, challenged rats
contained 1,144-2,085 jUg RMCPII (fig. 1), whereas
perfusates from controls were devoid of this enzyme
(fig. 1). There was a concomitant, highly significant
(p < 0.001) depletion of RMCPII and MMC from the
mucosa of primed, challenged rats when compared
with control values (fig. 1). Analysis of gut perfusates
and homogenates showed GAG to be present within
each sample. No decrease from jejunum or increase
within the perfusate was detected. The analysis of
these tissues is, however, likely to be complicated by
endogenous GAG other than that contained in the
mast cells.
Mast cell depletion from the mucosa was detected
both with Toluidine blue (pH 0.5) and with naphthol
AS-D chloroacetate; the correlation between the num¬
bers of mast cells detected with these two methods was
highly significant (y = -2.3 + 1.1 x, r = 0.98, p < 0.001;
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fig. 3), suggesting that proteoglycan and serine ester¬
ases were depleted concomitantly from discharging
MMC.
The results of this study are consistent with data
from previous experiments [2] except that shock was
severe with the lowest dose of worm antigen and was
not augmented by further increasing the challenge
dose. There was, as previously described [2], substan¬
tial secretion of RMCPII into the gut lumen and a
concomitant fall in the mucosal concentration of this
enzyme. These changes were paralleled by a reduction
in the number of MMC detected with either Toluidine
blue or naphthol AS-D chloroacetate. Whilst we were
unable to detect changes in mucosal levels of GAG,
probably for technical reasons associated with a high
background of tissue GAG, there was a tenfold in¬
crease in the concentration of GAG in plasma which
was highly correlated with the release, into serum, of
RMCPII. Although the distribution of RMCPII in
tissues other than the gut have not yet been published,
our own studies have shown that, apart from the lung
in which RMCPII is increased after infection with N.
brasiliensis and which, at most, contains 300 ug
RMCPII/g wet weight, most other organs contain
little or none of this enzyme [9]. Clearly, therefore, the
major source of secreted RMCPII is the enteric mu¬
cosa, and it would seem likely that GAG present in
plasma is also released from this site with MMC being
the most obvious source of these two products.
More conclusive evidence ofthe mucosal mast cell as
the source ofsecreted GAG must await further analysis.
However, it is relevant to note that MMC granule prote¬
oglycan is, like that from the murine mast cell cultured
from bone marrow [ 10], non-heparin proteoglycan [11],
and that the latter cell releases chondroitin sulphate E in
response to immunological stimuli [12], By contrast the
heparin present in rat peritoneal mast cells remains
within the granule matrix, apparently complexed with
the insoluble chymase (RMCPI) [13]. If, as the present
study suggests, granule products of MMC are highly
soluble, this is yet another example of the biochemical
and functional differences between MMC and connec¬
tive tissue mast cells.
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Gut mucosal mast cells in Nippostrongylus-primed rats
are the major source of secreted rat mast cell
protease II following systemic anaphylaxis
The distribution of the predominant chymotrypsin-like enzyme of mucosal mast cells
(rat mast cell protease II: RMCPII) was examined in naive and Nippostrongylus-
primed rats both before and after the induction of systemic anaphylaxis. Anaphylactic
secretion of RMCPII following i.v. challenge of primed rats with worm antigen was
accompanied by significant depletion of this enzyme from the jejunal and gastric
mucosae; the concentrations were not altered in the ileum and colon. Despite signifi¬
cant increases in the levels of RMCPII in lung and mesenteric lymph node following
infection with N. brasiliensis there was no anaphylactic depletion of this enzyme from
these sites. No RMCPII was detected in liver, spleen, kidney or bone marrow either
before or after systemic anaphylaxis. Mucosal mast cells were depleted from the
jejunal, gastric and colonic mucosae following antigen challenge of primed rats.
These data provide further evidence that gastrointestinal mucosal mast cells are the
major source of secreted RMCP II following systemic anaphylaxis in the rat.
1 Introduction
There is now increasing evidence that mast cells constitute a
heterogeneous cell system [1], Two types of mast cell have
been identified in the rat, these are "atypical" or mucosal mast
cells (MMC), located in mucosal membranes such as the
lamina propria of the gastrointestinal tract, and "typical" or
connective tissue mast cells (CTMC) found in the serosal lay¬
ers of the gut, the peritoneal cavity and in the connective
tissues. These two cell types differ both functionally and
biochemically [1]. For example, they contain distinctive gly-
cosaminoglycans within the granule matrix [2] as well as differ¬
ent concentrations of histamine [3, 4]. They also respond
differently to basic secretagogues and anti-allergic compounds
[5, 6]. MMC and CTMC also differ in their content of serine
proteinases; rat mast cell protease II (RMCPII) is present
within the granules of MMC and RMCP I within CTMC [7, 8].
These two proteinases are distinct in their antigenic proper¬
ties, in substrate specificity, and in solubility [9, 10].
The relatively high solubility of RMCP II is associated with its
release into the blood circulation in rats primed with the intes¬
tinal nematode Nippostrongylus brasiliensis and challenged
either i.v. with worm antigen, or intraduodenally with
homologous parasites [11, 12]. By contrast, RMCP I remains
as an insoluble complex with the proteoglycan (heparin) of the
granule matrix [13]. The systemic release of RMCPII is, there¬
fore, an excellent and specific marker for monitoring the se¬
cretory activities of MMC in vivo.
The major tissue source of RMCPII is not known, but pub¬
lished work would seem to suggest that it is the gut. Our own
studies have shown that RMCP II can be detected within the
gut lumen within minutes of i.v. challenge of Nippostrongylus-
[I 5037]
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primed rats with worm antigen [11] and that the appearance of
RMCPII systemically is associated with a depletion of the
jejunal concentration of RMCP II and of intestinal MMC [12].
Taken together these observations provide evidence that the
gut is likely to be the major source of RMCPII.
The present study was in part derived from and is the sequel to
a series of experiments published previously [11] and was
designed to investigate the tissue distribution of RMCP II in
both naive and immune rats and in rats undergoing anaphylac¬
tic shock. The results strongly suggest that gastrointestinal
MMC are the major source of RMCPII.
2 Materials and methods
2.1 Parasitological techniques
The methods used to culture the nematode Nippostrongylus
brasiliensis, to harvest third stage larvae and to infect rats have
been described previously [14]. The preparation of whole
worm antigen has also been described [15] and the soluble
worm antigen (2000 worm equivalent (w.e.)/ml) was stored at
-20 °C.
2.2 Quantification of RMCP II
Male Wistar rats 20-30 weeks old and weighing 350-450 g
were used for all experiments. They were watered and fed ad
libitum, but food was withdrawn 24 h before challenge.
Experimental animals were bled out under ether anesthesia
and the following tissues collected for RMCPII assay:
jejunum, ileum, stomach, colon, trachea, thymus, mesenteric
lymph node (MLN), right lobe of lung, spleen, liver, kidney,
bone marrow harvested from femur, femoral muscle, skin and
peritoneal exudate cells. All samples except muscle, skin,
bone marrow and peritoneal cells were weighed and
homogenized in 3 volumes of 0.15 M KC1 [16]. The trachea was
homogenized in 6 volumes of 0.15 M KC1. Muscle and skin
samples were weighed, diced with scissors and homogenized in
3 volumes of 1.5 M KC1. Bone marrow was obtained by perfus¬
ing the femur with saline and then rapidly freeze-thawing the
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perfusate, cell debris was removed by centrifugation and the
supernatant stored for RMCPII assay. To recover peritoneal
cells, exsanguinated rats were injected i.p. with 40 ml of ice-
cold saline, the peritoneal washings were aspirated and the
cells recovered by centrifugation. They were washed several
times with Hanks' balanced salt solution and mast cells were
counted from an aliquot of cells that had been diluted 1 to 9
parts of 1% Azure A in 50% propylene glycol. The peritoneal
cells were pelleted by centrifugation and resuspended in
approximately 3 volumes of 0.15 M or 1.5 M KC1 and freeze-
thawed rapidly 5-6 times before centrifugation to remove cell
debris; the concentration of RMCPII was assayed in the
supernatant fluids.
The levels of RMCPII in tissues and sera of experimental
animals were measured by radial immunodiffusion [11, 17].
Radial immunodiffusion plates for peritoneal mast cells, skin
and muscle homogenates were set up both in standard buffer
and in 1.5 M KC1, with appropriate RMCPII standard for each
system.
2.3 Histology and cell counts
Samples of jejunum, tongue and left lobe of lung were placed
in Carnoy's fluid. Thymus, MLN, ear pinnae and trachea were
each divided into two samples, one being placed in Carnoy's
fixative and the other used for the immunoassay of RMCPII.
All tissues were fixed for 24 h and processed as described
previously [16]. Mast cells were stained with Alcian blue/Safra-
nin [16], In the trachea, mast cells were enumerated per 1 mm
length of mucosa and intestinal mast cells were counted per
villus crypt unit [16]. Because of the anisotropic nature of the
other tissues, mast cells were enumerated only in the ear pin¬
nae and the density of mast cells in other tissues was scored on
an arbitrary scale.
To demonstrate mast cells containing esterase, samples of
jejunum, ileum colon and stomach were fixed for 6 h in 4%
paraformaldehyde in phosphate-buffered saline and left over¬
night at 4°C in 70% alcohol [18]. Tissues were dehydrated in
alcohol, cleared in xylene and embedded in paraffin wax. Sec¬
tions were stained with naphthol As-D chloroacetate/Fast Gar¬
net GBC [18]. To compare the density of mast cells in different
regions of the gut, a calibrated grid was placed along the mus-
cularis mucosae and the total number of MMC within the grid
area counted. The area of mucosa was calculated with refer¬
ence to the calibrated grid. Mast cells numbers are expressed/
mm2 mucosae.
2.4 Statistical analysis
Data were analyzed using a Student's 2-tailed t-test and by
simple analysis of regression using a Tektronix microcom¬
puter.
3 Results
3.1 Kinetics of RMCP II release blood and its concentrations in
enteric tissues
Ten naive rats and 30 animals primed twice by infection
5 weeks and 10 days earlier with 6000 N. brasiliensis third-
stage larvae were used. Twenty-five immune and 5 naive rats
were injected i.v. with 1 ml of saline containing 500 w.e. of
antigen, the remaining 10 rats (5 naive and 5 immune) were
injected with saline alone. Challenge control rats and immune
and naive rats given saline were killed 30 min after injection.
Immune rats were exsanguinated 5, 15, 30, 60 and 240 min
after injection with antigen. The time course of appearance of
RMCPII in the sera has already been published [11] but is
included in Table 1 for information. Also shown in Table 1 are
the concentrations of RMCP II in the jejunal mucosa and the
numbers of MMC per villus crypt unit the jejunum.
Significant decreases occurred in both the numbers of MMC
and the jejunal concentrations of RMCPII (Table 1), the
reductions being most substantial 4 h after challenge
(Table 1). Analysis of regression showed the numbers of
MMC in the mucosa and the concentrations of RMCP II in the
jejunum to be significantly correlated (y = 391 + 82 x; r = 0.84;
p < 0.001, Fig.
3.2 Intestinal MMC as the major source of secreted RMCPII
The possibility that RMCP II had been released from sources
other than the gut was considered and the distribution of
RMCPII within other tissues was examined in immune and
naive rats. The concentrations of RMCPII in samples of lung,
Table 1. The levels of RMCPII in the serum and jejunum and numbers of MMC in Nippostrongylus-primed and naive rats
Mean ± SEM
Group Challenge Timea) Serumb) Jejunum MMC/VCUC)
(i.v.) (min) (pig RMCP (pgRMCPII/g
Il/ml) wet weight)
Immune Saline 30 0 3180 ±137 33.3 ±1.0
Immune 500 w.e. 5 121± 27 2280 ± 239*d) 24.3 ±3.6*
Immune 500 w.e. 15 190+ 43 2152 ± 472 18.5 ±3.7**
Immune 500 w.e. 30 351 ± 95 2280 ± 305* 19.4±2.9***
Immune 500 w.e. 60 630 ±132 2184 ±289* 16.4 ± 4.8**
Immune 500 w.e. 240 560 ± 125 1275 ± 65*** 16.0 ± 2.5***
Naive 500 w.e. 30 0 1260 ± 60*** 10.8 ±2.6***
Naive Saline 30 0 796 ±111*** 10.1 ±0,8***
a) Time after challenge.
b) Published data from King and Miller (1984).
c) Numbers of MMC per villus crypt unit in the je
junum.
d) *p<0.05; **p<0.01; ***p<0.001 when compared
with immune saline challenge group (Student's t
test).
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trachea, thymus, ear pinnae and MLN are therefore recorded
in Table 2. When compared with naive controls, RMCPII
levels in immune rats were significantly increased (p< 0.001)
in both lung and MLN although it should be stressed that
concentrations in the jejunum were tenfold greater than those
in lung. Challenge of immune rats with antigen did not alter
the concentrations of RMCPII in lung or trachea. The amount
of RMCP II in thymus and MLN increased 1 h after challenge
(Table 2) but the levels at 4 h were similar to those in immune
rats given saline (Table 2).
Histologically, mast cell densities were increased in lung and










Figure 1. The relationship between mast cell density and the concen¬
tration of RMCPII in the jejunal tissues. Individual values plotted as
(O) 5 min, (□) 15 min, (O) 30 min, (♦) 60 min, (O) 240 min, (♦)
immune saline, (•) naive saline, (■) naive challenge, (y = 391 + 82 x;
r = 0.84; p< 0.001).
(Table 3). No changes were detected in mast cells in any organ
apart from the intestine (Tables 1 and 3) following challenge.
Granule exocytosis was observed only in occasional mast cells
in the adventitia surrounding the thymus and tongue, none
was noted in ear pinnae.
Preparations of peritoneal cells containing 1 x 106-6 x 106
mast cells from both primed and naive rats did not contain any
detectable RMCPII nor did ear pinnae (Table 2). This was
true for cells and tissues extracted in0.15 mKCI andalsol.5 m
KC1, and assayed by radial immunodiffusion.
A second experiment was carried out to further examine the
tissue distribution of RMCP II, and to analyze release of
RMCP II from sites other than the jejunum. The experimental
design and challenge regimes were similar to those described
in the first experiment and are summarized in Table 4. Rats
were bled out under ether anesthesia 30 min after injection of
antigen or saline and the concentrations of RMCPII in
jejunum, stomach, ileum and colon were determined. In all
four tissues there was a highly significant (p < 0.001) increase
in the concentration of RMCPII in immune rats when com¬
pared with naive controls (Table 4). Antigen challenge of
primed rats was without effect on the concentrations of
RMCP II in colon and ileum. By contrast, there was signifi¬
cant depletion of RMCP II from both stomach and jejunum
when compared with the levels in immune rats treated with
saline (Table 4).
We were consistently unable to detect RMCPII in liver, kid¬
ney, spleen or bone marrow and also in homogenates of skin
and muscle prepared and assayed in 1.5 m KC1, even though
this concentration of salt did not alter the concentrations of
RMCPII detected in the standards.
Histological examination of the four gastrointestinal mucosal
tissues revealed an increase in the numbers of MMC present in
immune rats when compared with naive controls (Table 4).
Table 2. The distribution of RMCPII in tissues, other than the jejunum of naive and N. brasiliensis-primed rats
Group Challenge Time |ig RMCP Il/gm wet weight tissue (mean ± SE)
status (i.v.) (min)
Ear Lung Thymus MLN Trachea
pinna
Immune Saline 30 0 300 ±16 43+2 90110 322160
Immune 500 w.e. 60 0 280 ± 25 84110**a) 1791 5*** 448148
Immune 500 w.e. 240 NDb) 237124 461 1 971 8 420167
Naive Saline 30 0 451 0*** 40+3 01 0"* 323118
a) **p <0.01 and ***p<0.001 when com¬
pared with immune saline challenge
group (Student's t-test).
b) ND = Not determined.
Table 3. Assessment of mast cell changes in tissues other than gut
a) Mast cell density was a subjective assess¬
ment: (+ + + ) substantially increased in
immune rats when compared with naive
controls in which mast cells were either
present (+) or completely absent (-).
b) Intraepithelial mast cells counted per
1 mm length of tracheal mucosa.
c) Mast cells counted per mm2 as described
previously [19].
d) Mast cell depletion.
e) Exocytosis of mast cells in adventitia.
Group Challenge Time MMC per mm Mast cells Mast cell density"'
status (i.v.) (min) tracheab) per mm2
ear pinna1'1 Lung MLN Tongue Thymus
Immune Saline 30 46.21 4.2 57.7 + 2.5 + + + + + + + +
Immune 500 w.e. 60 30.51 6.7 68.713.8 + + + + + + + +
Immune 500 w.e. 240 31.0110.2 ND + +d> + +d) + +e)
Naive Saline 30 34.21 1.2 74.813.8 + + +
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Table 4. The concentration of RMCPII (A) and number of mast cells (B) of naive and Nippostrongylus-primed rats at four sites along the
gastrointestinal tract





























a) I = immune; N = naive; Ag = antiqen; S = saline.
b) *p<0.01, ***p<0.001 when compared with group I
(Student's t-test).






94 ± 3 580 ± 22
66 ±7**" 391 ±24***
63 ±5*** 194 ±17***
68 ±3*** 192 ± 6***
489 ± 19 161 ± 11
433 ±32 113 ±10*
176 ± 7*** 81 ± 3***
176 ± 9*** 86 ± 4***
a) *p<0.01, **p<0.005, ***p<0.001 when compared
with group I (Student's t-test).
Giuup slalus and treatment as in Table 4(A).
Table 5. The relationship between mast cell density and concentra¬
tion of RMCPII in stomach, jejunum, ileum and colon
Tissue Equation of best fit r P
Stomach y = 67 + 1.2x 0.72 <0.001
Jejunum y = 155 + 4.8x 0.97 <0.001
Ileum y = 188 + 1.6x 0.88 <0.001
Colon y = 280 + -9125/x 0.70 <0.001
Antigen challenge was without effect on the numbers of mast
cells/mm2 in the ileal mucosa, whereas there were significant
reductions in the numbers of mast cells in stomach, jejunum
and colon following anaphylactic shock (Table 4). Regression
analyses of the relationships between mast cell density and the
concentration of RMCPII for each organ showed to be a
highly significantly correlated. The relationships are sum¬
marized in Table 5.
4 Discussion
This study unequivocally demonstrates that the unique serine
proteinase RMCPII which is a granule product of MMC [7] is
most abundant in the gastrointestinal tracts of both naive and
Nippostrongylus-primed rat. Furthermore, following i.v. chal¬
lenge of immune rats with whole worm antigen the concentra¬
tions of this enzyme were reduced in the gastric and jejunal
mucosae. In the absence of significant depletion from other
sites, it would seem likely that the gut is the major source of
secreted RMCP II following systemic anaphylaxis in the rat.
Analysis of other tissues showed RMCPII to be absent from
most sites and, when present, the concentrations were much
lower than those in the jejunal and ileal mucosae (Tables 2
and 4). We were consistently unable to detect RMCPII activ¬
ity in muscle, skin and peritoneal mast cells, even when
assayed in the presence of 1.5 m KC1, nor could RMCPII be
detected in peritoneal mast cell extracts by enzyme-linked
immunosorbent assay (data not shown).
Within the gastrointestinal tract there is considerable variation
in the levels of RMCP IT, the highest concentration occurred in
the jejunum and corresponded with maximal numbers of
MMC. However, although there was a 2-3-fold difference in
concentrations of RMCP II in jejunum relative to ileum, there
was no such difference in density of mast cells in these organs.
This is in agreement with earlier observations [4, 20] that
when the numbers of MMC are expressed per unit area they
are comparable in both jejunum and ileum. It may be
expected that for an equal weight of tissue that there would be
more mucosa relative to muscle in jejunum when compared
with ileum, thus a 2-3-fold difference in RMCPII concentra¬
tion may reflect a difference in the amount of mucosal tissue
homogenized. Alternatively, MMC in jejunum may contain
more RMCPII than their counterparts in the ileum.
The density of mast cells and the concentrations of RMCP II
were, by regression analysis, highly correlated in stomach,
jejunum, ileum and colon (Table 5). Within each tissue an
increase in the concentration of RMCP II was accompanied by
a similar increase in MMC density following infection with N.
brasiliensis. This increase was maximal in jejunum, there
being almost a 3-fold increase in both mast cell numbers and
RMCPII concentrations (Table 4) following infection. In¬
creased levels of RMCPII were also recorded in lung and
MLN following infection with N. brasiliensis. Mast cell infiltra¬
tion of MLN has been reported in Nippostrongylus-infccted
rats [21] and pulmonary mastocytosis has been observed to be
associated with larval migration [22]. The results suggest that a
proportion of the additional mast cells induced by parasite
infection are MMC.
Depletion of RMCP II occurred only in jejunum and stomach
following anaphylactic shock and was associated with a
decrease in the number of mast cells in these tissues. Although
there was significant depletion of MMC from the colonic
mucosa this was not reflected by RMCPII concentrations
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which did not alter following anaphylaxis. The reasons for this
are not clear although it is possible that the released enzyme is
not so rapidly cleared from colonic tissues as from stomach
and jejunum. Neither the number of MMC nor the concentra¬
tion of RMCP II in ileum were altered following anaphylaxis.
In all four tissues (Table 4), infection with N. brasiliensis pro¬
voked a highly significant increase in the density of MMC
when compared with uninfected controls.
One interesting finding was that MLN and thymus had
increased levels of RMCP II 60 min after challenge with worm
antigen. Serum RMCP II concentrations were maximal at this
time and the lymphatic drainage from the gut to MLN could be
a source of increased enzyme concentrations in this tissue.
Since hemoconcentration is a characteristic feature of anaphy¬
laxis in the rat [23] an alternative explanation is that the
experimental animals were insufficiently exsanguinated; the
increased levels in thymus and MLN might therefore reflect
the accumulation of plasma-derived RMCP II.
The release of RMCP II and its depletion from the jejunum
may be related to the gross mucosal damage associated with
systemic anaphylaxis in the rat. The lesions occurring during
anaphylactic enteropathy include epithelial shedding, hy-
peraemia, mucus secretion and increased mucosal perme¬
ability [11, 12, 24], A study of the distribution of secreted
RMCP II showed that epithelial permeability changes pre¬
ceded pentration of enzyme into the vessels draining the villi
since 1-2 mg of RMCP II were secreted into the intestinal
lumen within 5 min of i.v. challenge with worm antigen
whereas blood concentrations were not maximal for another
55 min [11]; these high concentrations of enzyme persisted in
the gut lumen for up to 60 min after challenge [11]. The latter
observations are perhaps the most compelling evidence that
the gut is the major source of secreted RMCP II.
In summary, the present results add further support to previ¬
ous studies [11, 12] suggesting that the measurement of
extracellular RMCP II provides a unique and selective assay
for monitoring the in vivo activity predominantly of gastroin¬
testinal MMC in hypersensitivity or other immunologically
mediated responses. They do so by demonstrating that the gut
mucosa is the major source of RMCP II in naive and Nippo-
strongylus-immune rats.
Received April 3, 1985; in revised form September 7, 1985.
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